TWI681986B - Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element - Google Patents

Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element Download PDF

Info

Publication number
TWI681986B
TWI681986B TW104143876A TW104143876A TWI681986B TW I681986 B TWI681986 B TW I681986B TW 104143876 A TW104143876 A TW 104143876A TW 104143876 A TW104143876 A TW 104143876A TW I681986 B TWI681986 B TW I681986B
Authority
TW
Taiwan
Prior art keywords
liquid crystal
group
crystal alignment
diamine
component
Prior art date
Application number
TW104143876A
Other languages
Chinese (zh)
Other versions
TW201630979A (en
Inventor
三木徳俊
軍司里枝
橋本淳
若林暁子
保坂和義
Original Assignee
日商日產化學工業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日產化學工業股份有限公司 filed Critical 日商日產化學工業股份有限公司
Publication of TW201630979A publication Critical patent/TW201630979A/en
Application granted granted Critical
Publication of TWI681986B publication Critical patent/TWI681986B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nonlinear Science (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Liquid Crystal (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polymerisation Methods In General (AREA)

Abstract

本發明提供一種液晶配向處理劑,其係可取得即使長時間暴露高溫及光照射後,仍有安定之垂直安定性、電壓保持率下降受到抑制、快速緩和累積之殘留電荷、及能減輕ODF方式下之液晶配向不均之液晶配向膜。 The invention provides a liquid crystal alignment treatment agent, which can obtain stable vertical stability even after long-term exposure to high temperature and light irradiation, voltage retention reduction is suppressed, rapid accumulation of residual charge is reduced, and ODF can be reduced The following liquid crystal alignment film with uneven liquid crystal alignment.

一種含有下述(A)成分、(B)成分及(C)成分之液晶配向處理劑。 A liquid crystal alignment treatment agent containing the following components (A), (B) and (C).

(A)成分:藉由含有具有下述式[1]構造之二胺及具有下述式[2]構造之二胺之二胺成分與四羧酸成分之反應而得之聚醯亞胺前驅物或將該聚醯亞胺前驅物予以醯亞胺化之聚醯亞胺。 (A) Component: a polyimide precursor obtained by reacting a diamine component containing a diamine having the following formula [1] and a diamine having the following formula [2] and a tetracarboxylic acid component Or the polyimide which is the imidized precursor of the polyimide.

(B)成分:藉由含有具有下述式[2]構造之二胺之二胺成分與四羧酸成分之反應而得之聚醯亞胺前驅物或將該聚醯亞胺前驅物予以醯亞胺化之聚醯亞胺。 (B) Component: a polyimide precursor obtained by the reaction of a diamine component containing a diamine having the structure of the following formula [2] and a tetracarboxylic acid component or the polyimide precursor is compounded The imidized polyimide.

(C):藉由含有具有選自由羧基(COOH基)及羥基(OH基)所成選之至少一種取代基之二胺之二胺成分與四羧酸成分之反應而得之聚醯亞胺前驅物或將該聚醯亞胺前驅物予以 醯亞胺化之聚醯亞胺。 (C): Polyimide obtained by reacting a diamine component containing a diamine having at least one substituent selected from a carboxyl group (COOH group) and a hydroxyl group (OH group) and a tetracarboxylic acid component Precursor or the polyimide precursor Amidimated polyimide.

Figure 104143876-A0202-11-0002-1
Figure 104143876-A0202-11-0002-1

式中之記號定義係如說明書中所述。 The definition of the symbol in the formula is as described in the specification.

Description

液晶配向處理劑、液晶配向膜及液晶顯示元件 Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element

本發明係關於一種液晶配向處理劑、由該液晶配向處理劑所得之液晶配向膜及使用該液晶配向膜之液晶顯示元件。 The present invention relates to a liquid crystal alignment treatment agent, a liquid crystal alignment film obtained from the liquid crystal alignment treatment agent, and a liquid crystal display element using the liquid crystal alignment film.

作為實現薄型‧輕量之顯示裝置,液晶顯示元件現在廣泛受到使用。通常,在此液晶顯示元件中使用決定液晶配向狀態用之液晶配向膜。 As a thin and light-weight display device, liquid crystal display elements are now widely used. Generally, a liquid crystal alignment film for determining the state of liquid crystal alignment is used in this liquid crystal display element.

作為液晶配向膜所要求之特性之一,則有將相對於基板面之液晶分子之配向傾斜角保持在任意之值,即所謂之液晶預傾角之控制。已知此預傾角之大小係能藉由選擇構成液晶配向膜之聚醯亞胺構造而改變者。再藉由聚醯亞胺之構造而控制預傾角之技術當中,使用具有側鏈之二胺化合物作為聚醯亞胺原料之一部分之方法,由於能因應此二胺化合物之使用比例而控制預傾角,而較容易取得目的之預傾角,故係有用作為增大預傾角之手段(參照專利文獻1)。又,如此般增大液晶之預傾角用之二胺化合物在用以改善預傾角之安定性或製程依賴性之構造上亦受到探討, 作為在此所用之側鏈構造,已提出如包含苯基或環己基等之環構造者(參照專利文獻2)。 As one of the characteristics required for the liquid crystal alignment film, there is control to maintain the alignment tilt angle of the liquid crystal molecules relative to the substrate surface at an arbitrary value, so-called liquid crystal pretilt angle. It is known that the size of this pretilt angle can be changed by selecting the structure of the polyimide constituting the liquid crystal alignment film. In the technology of controlling the pretilt angle by the structure of polyimide, the method of using a diamine compound having a side chain as a part of the raw material of polyimide can control the pretilt angle according to the proportion of the diamine compound used. It is easier to obtain the intended pretilt angle, so it is useful as a means to increase the pretilt angle (see Patent Document 1). In addition, the diamine compound used to increase the pretilt angle of the liquid crystal in this way has also been discussed in terms of the structure for improving the stability or process dependence of the pretilt angle. As a side chain structure used here, a ring structure including a phenyl group, a cyclohexyl group, or the like has been proposed (see Patent Document 2).

在液晶顯示元件之製作中必須要有在已形成液晶配向膜之基板2枚之間(晶格間隙)填充液晶之步驟。至此,填充液晶一般係利用大氣壓與真空之壓力差,在2枚基板間填充液晶之真空注入方式。但,於此方式之情況,由於液晶注入口係僅設置在基板之單側,故為了填充液晶則需要較長之時間,進而難以簡略化液晶顯示元件之製造步驟。尤其,在近年來已實用化之液晶TV或大型螢幕之製造中,此一課題已成為大問題。 In the production of the liquid crystal display element, there must be a step of filling the liquid crystal between two substrates (lattice gap) on which the liquid crystal alignment film has been formed. So far, liquid crystal filling is a vacuum injection method in which liquid crystal is filled between two substrates by using the pressure difference between atmospheric pressure and vacuum. However, in this case, since the liquid crystal injection port is provided only on one side of the substrate, it takes a long time to fill the liquid crystal, and it is difficult to simplify the manufacturing steps of the liquid crystal display element. In particular, in the manufacture of liquid crystal TVs or large screens that have been put into practical use in recent years, this subject has become a big problem.

因此,為了解決上述真空注入方式中之問題點,已開發出液晶滴下方式(ODF(One Drop Filling)方式)。此方式係藉由在已形成液晶配向膜之基板上滴下液晶,在真空中貼合另一面基板後,使密封材進行UV硬化,而填充液晶之方式。另一方面,伴隨加深液晶顯示元件之高精細化,則逐漸變得必須要抑制顯示不均。在液晶滴下方式中,至今係藉由減低液晶之滴下量或提升貼合時之真空度等之減輕吸附水或雜質之影響之製造步驟最佳化而獲得解決。但,伴隨液晶顯示元件製造產線之大型化,單靠目前之製造步驟之最佳化,仍逐漸變得無法抑制顯示不均,故需要比過往能夠更加減少配向不均之液晶配向膜。 Therefore, in order to solve the above problems in the vacuum injection method, a liquid crystal dropping method (ODF (One Drop Filling) method) has been developed. This method is a method of filling liquid crystal by dripping liquid crystal on a substrate on which a liquid crystal alignment film has been formed, bonding the other substrate in a vacuum, and then curing the sealing material by UV. On the other hand, as the definition of liquid crystal display elements becomes higher, it becomes necessary to suppress display unevenness. In the liquid crystal dropping method, it has been solved by optimizing the manufacturing steps to reduce the influence of adsorbed water or impurities by reducing the dropping amount of liquid crystal or increasing the vacuum degree during bonding. However, with the enlargement of the production lines of liquid crystal display devices, the optimization of the current manufacturing steps alone has gradually become unable to suppress display unevenness, so a liquid crystal alignment film that can reduce the alignment unevenness more than in the past is required.

此外,隨著液晶顯示元件之高精細化,從抑制液晶顯示元件之對比下降或減少殘影現象之觀點,即使 在此處所使用之液晶配向膜當中,高電壓保持率,或施加直流電壓時之累積電荷為少,或快速緩和因直流電壓所累積之電荷等特性亦逐漸變得重要。 In addition, as liquid crystal display elements become more sophisticated, from the viewpoint of suppressing the decrease in contrast of the liquid crystal display elements or reducing the afterimage phenomenon, even Among the liquid crystal alignment films used here, characteristics such as a high voltage retention rate, a small accumulated charge when a DC voltage is applied, or a rapid relaxation of the charge accumulated due to a DC voltage also gradually become important.

聚醯亞胺系之液晶配向膜中,作為到因直流電壓所產生之殘影消失為止之時間為較短者,已知有使用聚醯胺酸或含醯亞胺基之聚醯胺酸,以及含有特定構造之3級胺之液晶配向處理劑者(參照專利文獻3),及使用含有將具有吡啶骨架等之特定二胺化合物使用當作原料之可溶性聚醯亞胺之液晶配向處理劑者(參照專利文獻4)等。 In the liquid crystal alignment film of the polyimide system, as the time until the afterimage caused by the DC voltage disappears, it is known to use polyamic acid or polyimide acid containing an imido group, And those containing a liquid crystal alignment treatment agent containing a tertiary amine with a specific structure (see Patent Document 3), and those using a soluble polyimide containing a specific diamine compound having a pyridine skeleton as a raw material (Refer to Patent Document 4).

又,作為高電壓保持率且到因直流電壓所產生之殘影消失為止之時間為較短者,已知有使用除含有聚醯胺酸或其醯亞胺化聚合物等之外,另極少量含有從分子內含有1個羧酸基之化合物、分子內含有1個羧酸酐基之化合物及分子內含有1個3級胺基之化合物所選出之化合物之液晶配向處理劑者(參照專利文獻5)。 In addition, as the high voltage retention rate and the time until the afterimage caused by the DC voltage disappears is short, it is known to use a polar electrode other than polyamic acid or its imidized polymer. A liquid crystal alignment treatment agent containing a small amount of a compound selected from a compound containing a carboxylic acid group in the molecule, a compound containing a carboxylic acid anhydride group in the molecule, and a compound containing a tertiary amine group in the molecule (see Patent Literature) 5).

[先前技術文獻] [Prior Technical Literature] [專利文獻] [Patent Literature]

[專利文獻1]日本特開平2-282726號公報 [Patent Document 1] Japanese Patent Laid-Open No. 2-282726

[專利文獻2]日本特開平9-278724號公報 [Patent Document 2] Japanese Patent Laid-Open No. 9-278724

[專利文獻3]日本特開平9-316200號公報 [Patent Document 3] Japanese Patent Laid-Open No. 9-316200

[專利文獻4]日本特開平10-104633號公報 [Patent Document 4] Japanese Patent Laid-Open No. 10-104633

[專利文獻5]日本特開平8-76128號公報 [Patent Document 5] Japanese Patent Laid-Open No. 8-76128

[發明之概要] [Summary of the invention]

液晶配向膜在為了進行控制相對於基板之液晶角度,即控制液晶預傾角上,仍係亦受到使用者。尤其,在VA模式或PSA模式等下,由於必須使液晶垂直地配向,故對液晶配向膜要求能使液晶垂直配向之能力(亦稱垂直配向性或高預傾角)。並且,對於液晶配向膜而言,不僅高垂直配向性變得重要,對於其知安定性亦逐漸變得重要。尤其,為了取得高亮度而使用大發熱量且光照射量大之背光之液晶顯示元件,例如,汽車導航系統或大型電視則有長時間暴露在高溫及光照射之環境下使用或放置的情況。在此種嚴苛條件下,則會引起垂直配向性降低之情況、無法取得初期顯示特性,或產生顯示不均等之問題。 In order to control the liquid crystal angle with respect to the substrate, that is, to control the liquid crystal pretilt angle, the liquid crystal alignment film is still subject to users. In particular, in the VA mode or PSA mode, etc., since the liquid crystal must be vertically aligned, the liquid crystal alignment film is required to be capable of vertically aligning the liquid crystal (also known as vertical alignment or high pretilt angle). In addition, for the liquid crystal alignment film, not only high vertical alignment becomes important, but also its stability is gradually becoming important. In particular, in order to obtain high brightness, a liquid crystal display element that uses a large amount of heat and a large amount of light-illuminated backlight, such as a car navigation system or a large TV, may be used or placed for a long time under high temperature and light irradiation. Under such severe conditions, it may cause a decrease in vertical alignment, failure to obtain initial display characteristics, or problems such as uneven display.

又,ODF方式中,由於係將液晶直接滴在配向膜上,故在液晶滴下時會在配向膜上造成物理性壓力,或有必要在面板全區域上填充液晶之外,尚有必要增加液晶之滴下點。因此,在液晶滴下部分或液晶之液滴與鄰接之液滴相接之部分,會產生滴下痕跡或格子不均即產生所稱之配向不均,並且在將此作成液晶顯示元件時,則有產生因配向不均所造成之顯示不均的問題。此配向不均認為係由於形成於基板上之液晶配向膜表面上所附著之吸附水或雜質,在ODF步驟中受到已滴下之液晶拂掃集中,在 液晶滴下部分或液晶之液滴彼此相接之部分上因吸附水或雜質之量相異而產生者。 In addition, in the ODF method, the liquid crystal is directly dropped on the alignment film. Therefore, when the liquid crystal is dropped, physical pressure is caused on the alignment film, or it is necessary to fill the entire area of the panel with liquid crystal, and it is necessary to increase the liquid crystal. Dripping point. Therefore, in the liquid crystal dropping part or the part where the liquid crystal droplets are in contact with the adjacent liquid droplets, there will be dripping traces or uneven grids, that is, the so-called uneven alignment, and when this is made into a liquid crystal display element, there are The problem of uneven display due to uneven alignment occurs. This uneven alignment is considered to be due to the adsorption of water or impurities adhering to the surface of the liquid crystal alignment film formed on the substrate, which was concentrated by the dripping of the liquid crystal in the ODF step. The liquid crystal dropping portion or the liquid crystal droplets are connected to each other due to different amounts of adsorbed water or impurities.

並且,關於液晶顯示元件之電特性之一之電壓保持率,亦被要求在如上述般之嚴苛條件下之高安定性。即,電壓保持率若因來自背光之光照射而降低時,則會導致容易產生液晶顯示元件之顯示不良之一之燒印不良(亦稱為線燒印),進而無法取得高信賴性之液晶顯示元件。因此,對液晶配向膜除了要求初期特性良好,另要求例如即使長時間暴露在光照射下後,其電壓保持率仍不易降低。更進一步,對於另一種燒印不良即面燒印,亦要其藉由來自背光之光照射,因直流電壓所累積之殘留電荷之緩和較為快速之液晶配向膜。 In addition, the voltage retention rate, which is one of the electrical characteristics of the liquid crystal display element, is also required to have high stability under severe conditions as described above. That is, if the voltage retention rate decreases due to light irradiation from the backlight, it may cause burn-in failure (also known as line burn-in), which is one of the display defects of the liquid crystal display element, and the liquid crystal with high reliability cannot be obtained Display element. Therefore, the liquid crystal alignment film is required not only to have good initial characteristics but also to have a low voltage retention rate even after being exposed to light irradiation for a long time. Furthermore, for another type of poor burn-in, that is, surface burn-in, it also requires a liquid crystal alignment film that is irradiated with light from the backlight and the residual charge accumulated by the DC voltage is relaxed more quickly.

因此,本發明之目的在於提供一種液晶配向膜,其係即使長時間暴露在高溫及光照射下後,仍顯示安定垂直安定性,抑制電壓保持率降低,且快速緩和因直流電壓所累積之殘留電荷,又,能減輕ODF方式下所產生之液晶配向不均。此外,本發明尚提供取得上述液晶配向膜用之液晶配向處理劑、及具備上述液晶配向膜之液晶顯示元件。 Therefore, the object of the present invention is to provide a liquid crystal alignment film which exhibits stable vertical stability even after being exposed to high temperature and light irradiation for a long time, suppresses the decrease in voltage retention rate, and quickly alleviates the accumulation of residual DC voltage Charge, in addition, can reduce the uneven alignment of the liquid crystal generated in the ODF mode. In addition, the present invention provides a liquid crystal alignment treatment agent for obtaining the liquid crystal alignment film, and a liquid crystal display element provided with the liquid crystal alignment film.

本發明者經過精心研究之結果,發現包含具有特定構造之3種聚合物之液晶配向處理劑在用以達成上述目的上極為有效,進而完成本發明。即,本發明係具有 以下之要旨者。 As a result of careful research by the present inventors, it has been found that a liquid crystal alignment treatment agent containing three kinds of polymers having a specific structure is extremely effective in achieving the above-mentioned object, and then completed the present invention. That is, the present invention has The following gist.

(1)一種液晶配向處理劑,其係含有下述(A)成分、(B)成分及(C)成分。 (1) A liquid crystal alignment treatment agent containing the following components (A), (B) and (C).

(A)成分:藉由使含有具有下述式[1]構造之二胺及具有下述式[2]構造之二胺之二胺成分與四羧酸成分反應而得之聚醯亞胺前驅物或將該聚醯亞胺前驅物予以醯亞胺化之聚醯亞胺。 (A) Component: a polyimide precursor obtained by reacting a diamine component containing a diamine having the structure of the following formula [1] and a diamine having the structure of the following formula [2] with a tetracarboxylic acid component Or the polyimide which is the imidized precursor of the polyimide.

(B)成分:藉由使具有下述式[2]構造之二胺之二胺成分與四羧酸成分反應而得之聚醯亞胺前驅物或將該聚醯亞胺前驅物予以醯亞胺化之聚醯亞胺。 (B) Component: a polyimide precursor obtained by reacting a diamine component of a diamine having the structure of the following formula [2] with a tetracarboxylic acid component, or the polyimide precursor is compounded Aminated polyimide.

(C):藉由使含有具有選自由羧基(COOH基)及羥基(OH基)所成群之至少一種取代基之二胺之二胺成分與四羧酸成分反應而得之聚醯亞胺前驅物或將該聚醯亞胺前驅物予以醯亞胺化之聚醯亞胺。 (C): Polyimide obtained by reacting a diamine component containing a diamine having at least one substituent selected from the group consisting of a carboxyl group (COOH group) and a hydroxyl group (OH group) with a tetracarboxylic acid component The precursor or the polyimide which has been imidized by the polyimide precursor.

Figure 104143876-A0202-12-0006-2
(X1表示選自由單鍵、-(CH2)a-(a為1~15之整數)、-O-、-CH2O-、-CONH-、-NHCO-、-CON(CH3)-、-N(CH3)CO-、-COO-及-OCO-所成群之至少一種結合基。X2表示單鍵或-(CH2)b-(b為1~15之整數)。X3表示選自由單鍵、-(CH2)c-(c為1~15之整數)、-O-、-CH2O-、-COO-及-OCO-所成群之至少一種。X4表示選自由苯環、環己烷環及雜環所成群之至少一種2價環狀基,或具有類固醇骨 架之碳數17~51之2價有機基,且前述環狀基上之任意氫原子可被碳數1~3之烷基、碳數1~3之烷氧基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子所取代。X5表示選自由苯環、環己烷環及雜環所成群之至少一種環狀基,且此等環狀基上之任意氫原子可被碳數1~3之烷基、碳數1~3之烷氧基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子所取代。n表示0~4之整數。X6表示選自由碳數1~18之烷基、碳數2~18之烯基、碳數1~18之含氟烷基、碳數1~18之烷氧基及碳數1~18之含氟烷氧基所成群之至少一種)。
Figure 104143876-A0202-12-0006-2
(X 1 means selected from a single bond, -(CH 2 ) a- (a is an integer from 1 to 15), -O-, -CH 2 O-, -CONH-, -NHCO-, -CON(CH 3 ) -, -N(CH 3 )CO-, -COO-, and -OCO- at least one binding group. X 2 represents a single bond or -(CH 2 ) b -(b is an integer of 1-15). X 3 represents at least one selected from the group consisting of a single bond, -(CH 2 ) c- (c is an integer from 1 to 15), -O-, -CH 2 O-, -COO-, and -OCO-. X 4 represents at least one divalent cyclic group selected from the group consisting of benzene ring, cyclohexane ring and heterocyclic ring, or a divalent organic group having a steroid skeleton and a carbon number of 17 to 51, and any of the aforementioned cyclic groups The hydrogen atom can be replaced by an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom . X 5 represents at least one cyclic group selected from the group consisting of benzene ring, cyclohexane ring and heterocyclic ring, and any hydrogen atom on these cyclic groups may be 1 to 3 alkoxy groups, C 1 to 3 fluorine-containing alkyl groups, C 1 to 3 fluorine-containing alkoxy groups or fluorine atoms. n represents an integer of 0 to 4. X 6 represents a group selected from carbon Alkyl groups with 1 to 18 carbon atoms, alkenyl groups with 2 to 18 carbon atoms, fluoroalkyl groups with 1 to 18 carbon atoms, alkoxy groups with 1 to 18 carbon atoms and fluoroalkoxy groups with 1 to 18 carbon atoms At least one of the groups).

[化2]-W 1 -W 2 -W 3 -W 4 [2](W1表示選自由-O-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-OCO-、-CON(CH3)-及-N(CH3)CO-所成群之至少一種結合基。W2表示選自由單鍵、碳數1~20之伸烷基、非芳香族環及芳香族環所成群之至少一種。W3表示選自由單鍵、-O-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-COO-、-OCO-、-CON(CH3)-、-N(CH3)CO-及-O(CH2)m-(m表示1~5之整數)所成群之至少一種。W4表示含氮芳香族雜環。 [Chem 2] -W 1 -W 2 -W 3 -W 4 [2] (W 1 represents selected from -O-, -NH-, -N(CH 3 )-, -CONH-, -NHCO-,- CH 2 O-, -OCO-, -CON(CH 3 )-, and -N(CH 3 )CO- at least one kind of binding group. W 2 represents a single bond, a carbon number of 1 to 20 alkylene At least one group consisting of a group, a non-aromatic ring and an aromatic ring. W 3 represents selected from a single bond, -O-, -NH-, -N(CH 3 )-, -CONH-, -NHCO-,- COO-, -OCO-, -CON(CH 3 )-, -N(CH 3 )CO- and -O(CH 2 ) m- (m represents an integer from 1 to 5) at least one group. W 4 Represents a nitrogen-containing aromatic heterocycle.

(2)上述(1)之液晶配向處理劑,其中具有前述式[1]構造之二胺係僅使用於前述(A)成分中之二胺成分。 (2) The liquid crystal alignment treatment agent of (1) above, wherein the diamine having the structure of the aforementioned formula [1] is used only as the diamine component of the aforementioned (A) component.

(3)如上述(1)之液晶配向處理劑,其中將前述(A)成分中之前述具有式[1]所示構造之二胺對二胺成分全體之使用 比例(莫耳%)設成1.0時,前述(B)成分中之前述具有式[1]所示構造之二胺對二胺成分全體之使用比例(莫耳%)為0.01~0.8之比率。 (3) The liquid crystal alignment treatment agent according to (1) above, wherein the diamine component having the structure represented by the formula [1] in the aforementioned (A) component is used for the entire diamine component When the ratio (mol%) is set to 1.0, the use ratio (mol%) of the diamine having the structure shown in formula [1] to the entire diamine component in the component (B) is 0.01 to 0.8.

(4)如上述(1)或(3)之液晶配向處理劑,其中將前述(A)成分中之具有前述式[1]所示構造之二胺對二胺成分全體之使用比例(莫耳%)設成1.0時,前述(C)成分中之前述具有式[1]所示構造之二胺對二胺成分全體之使用比例(莫耳%)為0.01~0.3之比率。 (4) The liquid crystal alignment treatment agent according to (1) or (3) above, wherein the use ratio of the diamine having the structure represented by the formula [1] to the entire diamine component in the component (A) (mol %) When set to 1.0, the use ratio (mol %) of the diamine to the entire diamine component having the structure shown in formula [1] in the component (C) is a ratio of 0.01 to 0.3.

(5)如上述(1)~(4)中任一項之液晶配向處理劑,其中前述具有選自由羧基(COOH基)及羥基(OH基)所成群之至少一種取代基之二胺係僅使用於前述(C)成分中之二胺成分。 (5) The liquid crystal alignment treatment agent according to any one of (1) to (4) above, wherein the aforementioned diamine system having at least one substituent selected from the group consisting of a carboxyl group (COOH group) and a hydroxyl group (OH group) Only used for the diamine component of the aforementioned (C) component.

(6)如上述(1)~(5)中任一項之液晶配向處理劑,其中前述具有式[1]構造之二胺為下述式[1a]所示者。 (6) The liquid crystal alignment treatment agent according to any one of (1) to (5) above, wherein the diamine having the structure of formula [1] is represented by the following formula [1a].

Figure 104143876-A0202-12-0008-3
(X表示前述式[1]之構造。n1表示1~4之整數)。
Figure 104143876-A0202-12-0008-3
(X represents the structure of the aforementioned formula [1]. n1 represents an integer of 1 to 4).

(7)如上述(1)~上述(6)中任一項之液晶配向處理劑,其中前述具有式[2]構造之二胺為下述式[2a]所示者。 (7) The liquid crystal alignment treatment agent according to any one of (1) to (6) above, wherein the diamine having the structure of formula [2] is represented by the following formula [2a].

Figure 104143876-A0202-12-0008-4
(W表示前述式[2]之構造。p1表示1~4之整數)。
Figure 104143876-A0202-12-0008-4
(W represents the structure of the aforementioned formula [2]. p1 represents an integer of 1 to 4).

(8)如上述(1)~(7)中任一項之液晶配向處理劑,其中前述具有選自由羧基及羥基所成群之至少一種取代基之二胺為下述式[3a]所示者。 (8) The liquid crystal alignment treatment agent according to any one of (1) to (7) above, wherein the diamine having at least one substituent selected from the group consisting of carboxyl groups and hydroxyl groups is represented by the following formula [3a] By.

Figure 104143876-A0202-12-0009-5
(Y表示下述式[3-1]或式[3-2]之構造。m1表示1~4之整數)。
Figure 104143876-A0202-12-0009-5
(Y represents the structure of the following formula [3-1] or formula [3-2]. m1 represents an integer of 1 to 4).

Figure 104143876-A0202-12-0009-6
(a及b係各自表示0~4之整數)。
Figure 104143876-A0202-12-0009-6
(a and b are each an integer from 0 to 4).

(9)如上述(1)~(8)中任一項之液晶配向處理劑,其中前述(A)成分、(B)成分及(C)成分中之四羧酸成分包含下述之式[4]之四羧酸二酐。 (9) The liquid crystal alignment treatment agent according to any one of (1) to (8) above, wherein the tetracarboxylic acid component of the aforementioned (A) component, (B) component and (C) component includes the following formula [ 4] The tetracarboxylic dianhydride.

Figure 104143876-A0202-12-0009-7
(Z表示選自由下述式[4a]~式[4k]之構造所成群之至少一種之構造)。
Figure 104143876-A0202-12-0009-7
(Z represents at least one structure selected from the group consisting of the following formula [4a] to formula [4k]).

Figure 104143876-A0202-12-0010-8
(Z1~Z4係各自獨立表示選自由氫原子、甲基、氯原子及苯環所成群之至少一種。Z5及Z6係各自獨立表示氫原子或甲基)。
Figure 104143876-A0202-12-0010-8
(Z 1 to Z 4 each independently represent at least one selected from the group consisting of a hydrogen atom, a methyl group, a chlorine atom, and a benzene ring. Z 5 and Z 6 each independently represent a hydrogen atom or a methyl group).

(10)如上述(1)~(9)中任一項之液晶配向處理劑,其中含有選自由N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮及γ-丁內酯所成群之至少一種溶劑。 (10) The liquid crystal alignment treatment agent according to any one of (1) to (9) above, which contains a member selected from the group consisting of N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone and γ- At least one solvent grouped by butyrolactone.

(11)如上述(1)~(10)中任一項之液晶配向處理劑,其中含有選自由1-己醇、環己醇、1,2-乙二醇、1,2-丙二醇、丙二醇單丁基醚、乙二醇單丁基醚、二丙二醇二甲基醚及下述式[D1]~式[D3]之溶劑所成群之至少一種溶劑。 (11) The liquid crystal alignment treatment agent according to any one of (1) to (10) above, which contains a compound selected from the group consisting of 1-hexanol, cyclohexanol, 1,2-ethylene glycol, 1,2-propylene glycol, and propylene glycol At least one solvent grouped by monobutyl ether, ethylene glycol monobutyl ether, dipropylene glycol dimethyl ether, and solvents of the following formula [D1] to formula [D3].

Figure 104143876-A0202-12-0010-9
(D1表示碳數1~3之烷基。D2表示碳數1~3之烷基。D3表示碳數1~4之烷基)。
Figure 104143876-A0202-12-0010-9
(D 1 represents an alkyl group having 1 to 3 carbon atoms. D 2 represents an alkyl group having 1 to 3 carbon atoms. D 3 represents an alkyl group having 1 to 4 carbon atoms).

(12)如上述(1)~上述(11)中任一項之液晶配向處理劑,其中前述液晶配向處理劑含有具有選自由環氧基、異氰酸酯基、環氧丙烷基及環碳酸酯基所成群之至少一種之基之交聯性化合物,具有選自由羥基、羥基烷基及低級烷氧基烷基所成群之至少一種之基之交聯性化合物,或具有聚合性不飽和鍵基之交聯性化合物。 (12) The liquid crystal alignment treatment agent according to any one of (1) to (11) above, wherein the liquid crystal alignment treatment agent contains a compound selected from the group consisting of an epoxy group, an isocyanate group, a propylene oxide group, and a cyclocarbonate group A crosslinkable compound of at least one group of groups, having a crosslinkable compound of at least one group selected from the group consisting of hydroxy, hydroxyalkyl, and lower alkoxyalkyl groups, or having a polymerizable unsaturated bond group Of cross-linking compounds.

(13)一種液晶配向膜,其係由如上述(1)~(12)中任一項之液晶配向處理劑所得者。 (13) A liquid crystal alignment film obtained from the liquid crystal alignment treatment agent according to any one of (1) to (12) above.

(14)一種液晶配向膜,其係藉由噴墨法塗佈上述(1)~(12)中任一項之液晶配向處理劑所得者。 (14) A liquid crystal alignment film obtained by applying the liquid crystal alignment treatment agent according to any one of (1) to (12) above by an inkjet method.

(15)一種液晶顯示元件,其係具有如上述(13)或(14)之液晶配向膜。 (15) A liquid crystal display device having the liquid crystal alignment film as described in (13) or (14) above.

(16)如上述(13)或(14)之液晶配向膜,其係使用於液晶顯示元件,該液晶顯示元件係在具備電極之一對基板之間具有液晶層而成,並且係經由在前述一對基板之間配置包含因活性能量線及熱之至少一者而進行聚合之聚合性化合物之液晶組成物,對前述電極間施加電壓而使前述聚合性化合物進行聚合之步驟所製造者。 (16) The liquid crystal alignment film as described in (13) or (14) above, which is used for a liquid crystal display element which has a liquid crystal layer between a pair of substrates provided with electrodes, and is A liquid crystal composition containing a polymerizable compound polymerized by at least one of active energy rays and heat is disposed between a pair of substrates, and a voltage is applied between the electrodes to polymerize the polymerizable compound.

(17)一種液晶顯示元件,其係具有如上述(16)之液晶配向膜。 (17) A liquid crystal display device having the liquid crystal alignment film as described in (16) above.

(18)上述(13)或(14)之液晶配向膜,其係使用於液晶顯示元件,該液晶顯示元件係在具備電極之一對基板之間具有液晶層而成,並且係經由在前述一對基板之間配置包含因活性能量線及熱之至少一者而進行聚合之聚合基之液晶配 向膜,且對前述電極間施加電壓而使前述聚合性基進行聚合之步驟所製造者。 (18) The liquid crystal alignment film of (13) or (14) above, which is used in a liquid crystal display element having a liquid crystal layer between a pair of substrates provided with electrodes, and A liquid crystal formulation including polymer groups polymerized by at least one of active energy rays and heat is disposed between the substrates It is manufactured by the step of applying a voltage to the film to polymerize the polymerizable group.

(19)一種液晶顯示元件,其係具有如上述(18)之液晶配向膜。 (19) A liquid crystal display device having the liquid crystal alignment film as described in (18) above.

本發明之液晶配向處理劑能取得一種即使長時間暴露在高溫及光照射下後,仍顯示安定垂直配向性之液晶配向膜。又,能取得一種能減輕在ODF方式下產生之液晶配向不均之液晶配向膜。並且,能取得一種即使長時間暴露在光照射下後,電壓保持率下降受到抑制,且快速緩和因直流電壓所累積之殘留電荷之液晶配向膜。 The liquid crystal alignment treatment agent of the present invention can obtain a liquid crystal alignment film that shows stable vertical alignment even after long-term exposure to high temperature and light irradiation. In addition, a liquid crystal alignment film that can reduce the liquid crystal alignment unevenness generated in the ODF method can be obtained. Moreover, even after long-term exposure to light irradiation, a drop in the voltage retention rate is suppressed, and a liquid crystal alignment film that quickly relaxes the residual charge accumulated by the DC voltage can be obtained.

依據本發明為何能取得具有上述優異特性之液晶顯示元件之理由並非十分明確,但幾呼可推測如以下之理由。 The reason why the liquid crystal display device having the above-mentioned excellent characteristics can be obtained according to the present invention is not very clear, but several reasons can be speculated as the following reasons.

特定聚合物(A)中之特定構造(1)含有苯環、環己烷環、雜環或具有類固醇骨架之碳數17~51之2價有機基。與使液晶垂直配向之先前技術之長鏈烷基相比,此等環及有機基之側鏈構造較為剛性,且對於紫外線等之光為較安定之構造。因此,與先前技術相比,由具有特定構造(1)之液晶配向處理劑所得之液晶配向膜,顯示高垂直配向性,且即使長時間暴露在光照射下,仍能抑制垂直配向性之變化。此外,即使暴露在光照射下,仍能不使電壓保持率降低,且能抑制因直流電壓而使殘留電荷累積之側鏈 成分之分解物。 The specific structure (1) in the specific polymer (A) contains a benzene ring, a cyclohexane ring, a heterocyclic ring, or a divalent organic group having a steroid skeleton and a carbon number of 17 to 51. Compared with the long-chain alkyl group of the prior art that vertically aligns the liquid crystal, the side chain structure of these rings and organic groups is more rigid, and the structure is more stable to light such as ultraviolet rays. Therefore, compared with the prior art, the liquid crystal alignment film obtained from the liquid crystal alignment treatment agent having a specific structure (1) shows high vertical alignment, and even if it is exposed to light irradiation for a long time, the change in vertical alignment can be suppressed . In addition, even when exposed to light irradiation, the voltage retention rate is not reduced, and side chains that accumulate residual charge due to DC voltage can be suppressed Decomposition of ingredients.

又,特定構造(1)由於為高疎水性構造,在液晶顯示元件製作步驟中,能抑制所產生之吸附水或雜質附著於液晶配向膜表面上。因此,能減少ODF方式下所產生之液晶配向不均。 In addition, since the specific structure (1) is a highly water-based structure, it is possible to suppress the generated adsorbed water or impurities from adhering to the surface of the liquid crystal alignment film during the manufacturing process of the liquid crystal display element. Therefore, the liquid crystal alignment unevenness generated in the ODF method can be reduced.

另外,特定聚合物(A)及(B)中之特定構造(2)所具有之含氮雜環與特定聚合物(C)中之羧基或羥基藉由稱為鹽形成或氫鍵之靜電相互作用而結合,故在含氮芳香族雜環與羧基或羥基之間變得容易引起電荷之移動。藉此,已移動之電荷能有效率地在聚醯亞胺系聚合物之分子內及分子間移動,故能快速緩和因直流電壓所累積之殘留電荷。因此,具有由本發明之液晶配向處理劑所得之液晶配向膜之液晶顯示元件成為信賴性優異者。 In addition, the nitrogen-containing heterocyclic ring included in the specific structure (2) in the specific polymers (A) and (B) and the carboxyl group or hydroxyl group in the specific polymer (C) are electrostatically interacted with each other by a salt formation or hydrogen bonding. It is combined by action, so it becomes easy to cause the charge to move between the nitrogen-containing aromatic heterocycle and the carboxyl group or hydroxyl group. By this, the moved charges can efficiently move within and between the molecules of the polyimide-based polymer, so that the residual charge accumulated by the DC voltage can be quickly relaxed. Therefore, a liquid crystal display element having a liquid crystal alignment film obtained from the liquid crystal alignment treatment agent of the present invention is one with excellent reliability.

本發明書中,「份」、「%」在未特別界定時,分別係意指「質量份」、「質量%」。 In the present invention, "parts" and "%" mean "mass parts" and "mass %", respectively, unless otherwise defined.

<特定構造(1)‧特定二胺(1)> <Specific structure (1)‧Specific diamine (1)>

本發明中之特定二胺(1)具有下述式[1]之特定構造(1)。 The specific diamine (1) in the present invention has a specific structure (1) of the following formula [1].

Figure 104143876-A0202-12-0013-10
Figure 104143876-A0202-12-0013-10

X1、X2、X3、X4、X5、X6及n係如上述所定義,但X1在從原料取得性或合成容易度之觀點,以單鍵、-(CH2)a-(a為1~15之整數)、-O-、-CH2O-或-COO-為佳。較佳為單鍵、-(CH2)a-(a為1~10之整數)、-O-、-CH2O-或-COO-。 X 1 , X 2 , X 3 , X 4 , X 5 , X 6 and n are as defined above, but X 1 is a single bond, -(CH 2 ) a from the viewpoint of availability of raw materials or ease of synthesis -(a is an integer from 1 to 15), -O-, -CH 2 O- or -COO- is preferred. Preferably, it is a single bond, -(CH 2 ) a- (a is an integer from 1 to 10), -O-, -CH 2 O-, or -COO-.

X2係以單鍵或-(CH2)b-(b為1~10之整數)為佳。 X 2 is preferably a single bond or -(CH 2 ) b- (b is an integer from 1 to 10).

X3在從合成容易度之觀點,以單鍵、-(CH2)c-(c為1~15之整數)、-O-、-CH2O-或-COO-為佳。較佳為單鍵、-(CH2)c-(c為1~10之整數)、-O-、-CH2O-或-COO-。 X 3 is preferably a single bond, -(CH 2 ) c- (c is an integer of 1 to 15), -O-, -CH 2 O-, or -COO- from the viewpoint of ease of synthesis. It is preferably a single bond, -(CH 2 ) c- (c is an integer from 1 to 10), -O-, -CH 2 O- or -COO-.

X4在合成容易度之觀點,以苯環、環己烷環或具有類固醇骨架之碳數17~51之有機基為佳。 From the viewpoint of ease of synthesis, X 4 is preferably a benzene ring, a cyclohexane ring, or an organic group having 17 to 51 carbon atoms having a steroid skeleton.

X5係以苯環或環己烷環為佳。 X 5 series is preferably a benzene ring or a cyclohexane ring.

X6係以碳數1~18之烷基、碳數2~18之烯基、碳數1~10之含氟烷基、碳數1~18之烷氧基或碳數1~10之含氟烷氧基為佳。較佳為碳數1~12之烷基、碳數2~18之烯基或碳數1~12之烷氧基。特佳為碳數1~9之烷基、碳數2~12之烯基或碳數1~9之烷氧基。 X 6 is composed of an alkyl group having 1 to 18 carbon atoms, an alkenyl group having 2 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 18 carbon atoms, or one containing 1 to 10 carbon atoms. Fluoroalkoxy is preferred. It is preferably an alkyl group having 1 to 12 carbons, an alkenyl group having 2 to 18 carbons or an alkoxy group having 1 to 12 carbons. Particularly preferred are alkyl groups having 1 to 9 carbons, alkenyl groups having 2 to 12 carbons or alkoxy groups having 1 to 9 carbons.

n在從原料取得性或合成容易度之觀點,以0~3為佳。較佳為0~2。 n is preferably 0~3 from the viewpoint of availability of raw materials or ease of synthesis. It is preferably 0~2.

X1、X2、X3、X4、X5、X6及n之理想組合,可舉出如與在國際公開公報WO2011/132751(2011.10.27公開)第13頁~34頁之表6~表47所掲載之(2-1)~(2-629)相同組合。尚且,國際公開公報之各表中,本發明中之X1~X6係標示作為Y1~Y6,故應將Y1~Y6改讀成 X1~X6。又,國際公開公報之各表所掲載之(2-605)~(2-629)中,本發明中之具有類固醇骨架之碳數17~51之有機基係標示成具有類固醇骨架之碳數12~25之有機基,故應將具有類固醇骨架之碳數12~25之有機基改讀成具有類固醇骨架之碳數17~51之有機基。 The ideal combination of X 1 , X 2 , X 3 , X 4 , X 5 , X 6 and n is listed in Table 6 on pages 13 to 34 of International Publication WO2011/132751 (published on 2011.10.27) ~The same combination of (2-1)~(2-629) contained in Table 47. In addition, in the tables of the International Publication, X 1 to X 6 in the present invention are marked as Y1 to Y6, so Y1 to Y6 should be read as X 1 to X 6 . In addition, in (2-605) to (2-629) contained in the tables of the International Publication, the organic groups having carbon numbers 17 to 51 having a steroid skeleton in the present invention are marked as carbon numbers 12 having a steroid skeleton The organic group of ~25, so the organic group with carbon number 12~25 with steroid skeleton should be read into the organic group with carbon number 17~51 with steroid skeleton.

其中,亦以(2-25)~(2-96)、(2-145)~(2-168)、(2-217)~(2-240)、(2-268)~(2-315)、(2-364)~(2-387)、(2-436)~(2-483)或(2-603)~(2-615)之組合為佳。特佳之組合為(2-49)~(2-96)、(2-145)~(2-168)、(2-217)~(2-240)、(2-603)~(2-606)、(2-607)~(2-609)、(2-611)、(2-612)或(2-624)。 Among them, also (2-25)~(2-96), (2-145)~(2-168), (2-217)~(2-240), (2-268)~(2-315 ), (2-364)~(2-387), (2-436)~(2-483) or (2-603)~(2-615) combination is better. The best combination is (2-49)~(2-96), (2-145)~(2-168), (2-217)~(2-240), (2-603)~(2-606 ), (2-607)~(2-609), (2-611), (2-612) or (2-624).

特定二胺(1)尤其係以使用下述式[1a]之二胺為佳。 The specific diamine (1) is particularly preferably a diamine using the following formula [1a].

Figure 104143876-A0202-12-0015-11
Figure 104143876-A0202-12-0015-11

X表示前述式[1]之構造。又,式[1a]中之X1、X2、X3、X4、X5、X6及n之詳細,以及較佳之組合係如同前述式[1]中所述。 X represents the structure of the aforementioned formula [1]. In addition, the details and preferred combinations of X 1 , X 2 , X 3 , X 4 , X 5 , X 6 and n in the formula [1a] are as described in the aforementioned formula [1].

n1表示1~4之整數。其中亦以1之整數為佳。 n1 represents an integer from 1 to 4. Among them, an integer of 1 is also preferred.

具體而言,可舉出如國際公開公報WO2013/125595(2013.8.29公開)第15頁~19頁記載之式[2-1]~式[2-6]、式[2-9]~式[2-31]之二胺。尚且,國際公開公報WO2013/125595之記載中,式[2-1]~式[2-3]中之R2及式 [2-4]~式[2-6]中之R4表示選自由碳數1~18之烷基、碳數1~18之含氟烷基、碳數1~18之烷氧基及碳數1~18之含氟烷氧基所成群之至少一種。又,式[2-13]中之A4表示碳數3~18之直鏈狀或分枝狀烷基。此外,式[2-4]~式[2-6]中之R3表示選自由-O-、-CH2O-、-COO-及-OCO-所成群之至少一種。 Specifically, the formula [2-1] to formula [2-6] and formula [2-9] to formula as described in pages 15 to 19 of International Publication WO2013/125595 (published on 2013.8.29) can be given. [2-31] Diamine. Yet, according to International Publication WO2013 / 125595 of the formula [2-1] to the formula [2-3], and R 2 in the formula [2-4] to Formula [2-6] is selected from the group consisting of R 4 represents At least one type of a C 1-18 alkyl group, a C 1-18 fluorine-containing alkyl group, a C 1-18 alkoxy group, and a C 1-18 fluorine-containing alkoxy group. In addition, A 4 in formula [2-13] represents a linear or branched alkyl group having 3 to 18 carbon atoms. In addition, R 3 in Formula [2-4] to Formula [2-6] represents at least one selected from the group consisting of -O-, -CH 2 O-, -COO-, and -OCO-.

其中,從能展現安定預傾角,能減輕在ODF方式下產生之液晶配向不均,且抑制長時間暴露在光照射下後之電壓保持率降低之效果為高之觀點,理想之二胺為如國際公開公報WO2013/125595記載之式[2-1]~式[2-6]、式[2-9]~式[2-13]或式[2-22]~式[2-31]之二胺。 Among them, from the viewpoint that it can exhibit a stable pretilt angle, can reduce the liquid crystal alignment unevenness generated in the ODF method, and suppress the reduction of the voltage retention rate after long-term exposure to light irradiation, the ideal diamine is as follows According to the formula [2-1] to formula [2-6], formula [2-9] to formula [2-13] or formula [2-22] to formula [2-31] described in International Publication WO2013/125595 Diamine.

從上述之觀點,特定二胺(1)之使用比例,在特定聚合物(A)中係相對於二胺成分全體,以10~70莫耳%為佳。較佳為15~70莫耳%,特佳為20~60莫耳%。在特定聚合物(B)中係相對於二胺成分全體,以0~40莫耳%為佳。較佳為0~30莫耳%,特佳為0~25莫耳%。在特定聚合物(C)中,則以0~20莫耳%為佳。較佳為0~10莫耳%。 From the above viewpoint, the use ratio of the specific diamine (1) in the specific polymer (A) is preferably 10 to 70 mol% relative to the entire diamine component. It is preferably 15 to 70 mol%, and particularly preferably 20 to 60 mol%. In the specific polymer (B), it is preferably 0 to 40 mol% relative to the entire diamine component. It is preferably 0 to 30 mol%, and particularly preferably 0 to 25 mol%. In the specific polymer (C), 0-20 mole% is better. It is preferably 0 to 10 mol%.

又,因應聚醯亞胺系聚合物對溶劑之溶解性、作成液晶配向膜時之液晶配向性,以及液晶顯示元件之光學特性等之特性,特定二胺(1)係能使用1種或將2種以上混合使用。 In addition, depending on the solubility of the polyimide-based polymer in the solvent, the liquid crystal alignment property when the liquid crystal alignment film is formed, and the optical characteristics of the liquid crystal display element, the specific diamine (1) can use one type or Two or more types are mixed for use.

<特定構造(2)‧特定二胺(2)> <Specific Structure (2)‧Specific Diamine (2)>

本發明之特定二胺(2)具有下述式[2]之特定構造。 The specific diamine (2) of the present invention has a specific structure of the following formula [2].

[化12]-W 1 -W 2 -W 3 -W 4 [2] [化12] -W 1 -W 2 -W 3 -W 4 [2]

W1、W2、W3及W4係如上述定義所示,但其中各自係以如以下者為佳。 W 1 , W 2 , W 3 and W 4 are as defined above, but each of them is preferably the following.

W1係以-O-、-NH-、-CONH-、-NHCO-、-CH2O-、-OCO-、-CON(CH3)-或-N(CH3)CO-為佳。從合成容易度之觀點,較佳者為-O-、-NH-、-CONH-、-NHCO-、-CH2O-、-OCO-或-CON(CH3)-。特佳者為-O-、-CONH-或-CH2O-。 W 1 is preferably -O-, -NH-, -CONH-, -NHCO-, -CH 2 O-, -OCO-, -CON(CH 3 )-, or -N(CH 3 )CO-. From the viewpoint of ease of synthesis, preferred is -O-, -NH-, -CONH-, -NHCO-, -CH 2 O-, -OCO-, or -CON(CH 3 )-. Particularly preferred are -O-, -CONH- or -CH 2 O-.

W2表示選自由單鍵、碳數1~20之伸烷基、非芳香族環及芳香族環所成群之至少一種。碳數1~20之伸烷基可為直鏈狀,亦可為分枝。又,可具有不飽和鍵。從合成容易度之觀點,其中以碳數1~10之伸烷基為佳。 W 2 represents at least one selected from the group consisting of a single bond, an alkylene group having 1 to 20 carbon atoms, a non-aromatic ring, and an aromatic ring. The alkylene group having 1 to 20 carbon atoms may be linear or branched. In addition, it may have an unsaturated bond. From the viewpoint of ease of synthesis, alkylene having 1 to 10 carbon atoms is preferred.

作為非芳香族環之具體例,可舉出如環丙烷環、環丁烷環、環戊烷環、環己烷環、環庚烷環、環辛烷環、環壬烷環、環癸烷環、環十一烷環、環十二烷環、環十三烷環、環十四烷環、環十五烷環、環十六烷環、環十七烷環、環十八烷環、環十九環、環二十烷環、三環二十烷環、三環二十二烷環、蘇夯環庚烷環、十氫萘環、降莰烯環及金剛烷環等。其中亦以環丙烷環、環丁烷環、環戊烷環、環己烷環、環庚烷環、降莰烯環或金剛烷環為佳。 Specific examples of the non-aromatic ring include cyclopropane ring, cyclobutane ring, cyclopentane ring, cyclohexane ring, cycloheptane ring, cyclooctane ring, cyclononane ring, cyclodecane ring Ring, cycloundecane ring, cyclododecane ring, cyclotridecane ring, cyclotetradecane ring, cyclopentadecane ring, cyclohexadecane ring, cycloheptadecane ring, cyclooctadecane ring, Ring nineteen ring, ring eicosane ring, tricyclic eicosane ring, tricyclic behenane ring, fused ring heptane ring, decahydronaphthalene ring, norbornene ring and adamantane ring, etc. Among them, cyclopropane ring, cyclobutane ring, cyclopentane ring, cyclohexane ring, cycloheptane ring, norbornane ring or adamantane ring are also preferred.

作為芳香族環之具體例,可舉出如苯環、萘環、四氫萘環、莫環、茚環、茀環、蒽環、菲環及萉環等。其中亦以苯環、萘環、四氫萘環、茀環或蒽環為佳。 Specific examples of the aromatic ring include benzene ring, naphthalene ring, tetrahydronaphthalene ring, molybdenum ring, indene ring, stilbene ring, anthracene ring, phenanthrene ring, and phlebo ring. Among them, benzene ring, naphthalene ring, tetrahydronaphthalene ring, stilbene ring or anthracene ring is also preferred.

W2係以單鍵、碳數1~10之伸烷基、環丙烷環、環丁烷環、環戊烷環、環己烷環、環庚烷環、降莰烯環、金剛烷環、苯環、萘環、四氫萘環、茀環或蒽環為佳。從合成容易度之觀點以及從長時間暴露在光照射下後因直流電壓所累積之殘留電荷之緩和變得較快之觀點,其中亦以單鍵、碳數1~5之伸烷基、環己烷環或苯環為佳。 W 2 is a single bond, an alkylene group having a carbon number of 1 to 10, a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, a cyclohexane ring, a cycloheptane ring, a norbornene ring, an adamantane ring, A benzene ring, a naphthalene ring, a tetrahydronaphthalene ring, a stilbene ring or an anthracene ring is preferred. From the point of view of ease of synthesis and from the point of view that the relaxation of the residual charge accumulated due to the DC voltage after long-term exposure to light irradiation becomes faster, among which are also single bonds, alkylene groups with 1 to 5 carbon atoms, Hexane ring or benzene ring is preferred.

W3係以單鍵、-O-、-COO-、-OCO-或-O(CH2)m-(m表示1~5之整數)為佳。從合成容易度之觀點,較佳者為單鍵、-O-、-OCO-或-O(CH2)m-(m為1~5)。 W 3 is preferably a single bond, -O-, -COO-, -OCO- or -O(CH 2 ) m- (m represents an integer of 1 to 5). From the viewpoint of ease of synthesis, a single bond, -O-, -OCO-, or -O(CH 2 ) m- (m is 1 to 5) is preferred.

W4表示含氮芳香族雜環,且含有選自由下述式[a]、式[b]及式[c]所成群之至少一個構造。 W 4 represents a nitrogen-containing aromatic heterocyclic ring, and contains at least one structure selected from the group consisting of the following formula [a], formula [b], and formula [c].

Figure 104143876-A0202-12-0018-12
(Z表示碳數1~5之烷基)。
Figure 104143876-A0202-12-0018-12
(Z represents an alkyl group having 1 to 5 carbon atoms).

更具體而言,可舉出如吡咯環、咪唑環、噁唑環、噻唑環、吡唑環、吡啶環、嘧啶環、喹啉環、砒唑林環、異喹啉環、咔唑環、嘌呤環、噻二唑環、嗒嗪環、砒唑林環、三嗪環、吡唑啶環、三唑環、吡嗪環、苯並咪唑環、苯並咪唑環、噌啉環、啡啉環、吲哚環、喹喔啉環、苯並噻唑環、酚噻嗪環、噁二唑環及吖啶環等。其中亦以吡咯環、咪唑環、吡唑環、吡啶環、嘧啶環、嗒嗪環、三嗪環、三唑環、吡嗪環、苯並咪唑環或苯並咪唑環 為佳。從長時間暴露在光照射下後因直流電壓所累積之殘留電荷之緩和變得較快之觀點,較佳者為吡咯環、咪唑環、吡唑環、吡啶環或嘧啶環。特佳者為咪唑環或吡啶環。又,式[2]中之W3係以結合在不與W4所含之式[a]、式[b]及式[c]相鄰之取代基上為佳。 More specifically, examples include a pyrrole ring, an imidazole ring, an oxazole ring, a thiazole ring, a pyrazole ring, a pyridine ring, a pyrimidine ring, a quinoline ring, an oxazoline ring, an isoquinoline ring, a carbazole ring, Purine ring, thiadiazole ring, triazine ring, pyazolidine ring, triazine ring, pyrazolidine ring, triazole ring, pyrazine ring, benzimidazole ring, benzimidazole ring, cinnoline ring, morpholine Ring, indole ring, quinoxaline ring, benzothiazole ring, phenolthiazine ring, oxadiazole ring, acridine ring, etc. Among them, a pyrrole ring, an imidazole ring, a pyrazole ring, a pyridine ring, a pyrimidine ring, a triazine ring, a triazine ring, a triazole ring, a pyrazine ring, a benzimidazole ring or a benzimidazole ring are also preferable. From the viewpoint that the relaxation of the residual charge accumulated by the direct current voltage after exposure to light for a long time becomes faster, the pyrrole ring, imidazole ring, pyrazole ring, pyridine ring or pyrimidine ring is preferred. Particularly preferred are imidazole ring or pyridine ring. In addition, W 3 in formula [2] is preferably bound to a substituent that is not adjacent to formula [a], formula [b], and formula [c] contained in W 4 .

理想之W1、W2、W3及W4之組合展示於表1~表31。 The ideal combinations of W 1 , W 2 , W 3 and W 4 are shown in Table 1 to Table 31.

Figure 104143876-A0202-12-0019-13
Figure 104143876-A0202-12-0019-13

Figure 104143876-A0202-12-0020-14
Figure 104143876-A0202-12-0020-14

Figure 104143876-A0202-12-0020-15
Figure 104143876-A0202-12-0020-15

Figure 104143876-A0202-12-0021-16
Figure 104143876-A0202-12-0021-16

Figure 104143876-A0202-12-0021-17
Figure 104143876-A0202-12-0021-17

Figure 104143876-A0202-12-0022-18
Figure 104143876-A0202-12-0022-18

Figure 104143876-A0202-12-0022-19
Figure 104143876-A0202-12-0022-19

Figure 104143876-A0202-12-0023-20
Figure 104143876-A0202-12-0023-20

Figure 104143876-A0202-12-0023-21
Figure 104143876-A0202-12-0023-21

Figure 104143876-A0202-12-0024-22
Figure 104143876-A0202-12-0024-22

Figure 104143876-A0202-12-0024-23
Figure 104143876-A0202-12-0024-23

Figure 104143876-A0202-12-0025-24
Figure 104143876-A0202-12-0025-24

Figure 104143876-A0202-12-0025-25
Figure 104143876-A0202-12-0025-25

Figure 104143876-A0202-12-0026-26
Figure 104143876-A0202-12-0026-26

Figure 104143876-A0202-12-0026-27
Figure 104143876-A0202-12-0026-27

Figure 104143876-A0202-12-0027-28
Figure 104143876-A0202-12-0027-28

Figure 104143876-A0202-12-0027-29
Figure 104143876-A0202-12-0027-29

Figure 104143876-A0202-12-0028-30
Figure 104143876-A0202-12-0028-30

Figure 104143876-A0202-12-0028-31
Figure 104143876-A0202-12-0028-31

Figure 104143876-A0202-12-0029-32
Figure 104143876-A0202-12-0029-32

Figure 104143876-A0202-12-0029-33
Figure 104143876-A0202-12-0029-33

Figure 104143876-A0202-12-0030-34
Figure 104143876-A0202-12-0030-34

Figure 104143876-A0202-12-0030-35
Figure 104143876-A0202-12-0030-35

Figure 104143876-A0202-12-0031-36
Figure 104143876-A0202-12-0031-36

Figure 104143876-A0202-12-0031-37
Figure 104143876-A0202-12-0031-37

Figure 104143876-A0202-12-0032-38
Figure 104143876-A0202-12-0032-38

Figure 104143876-A0202-12-0032-39
Figure 104143876-A0202-12-0032-39

Figure 104143876-A0202-12-0033-40
Figure 104143876-A0202-12-0033-40

Figure 104143876-A0202-12-0033-41
Figure 104143876-A0202-12-0033-41

Figure 104143876-A0202-12-0034-42
Figure 104143876-A0202-12-0034-42

Figure 104143876-A0202-12-0034-43
Figure 104143876-A0202-12-0034-43

其中,以(a-43)~(a-49)、(a-57)~(a-63)、(a-218)~(a-224)、(a-232)~(a-238)、(a-323)~(a-329)、(a-337)~(a-343)、(a-428)~(a-434)或(a-442)~(a-448)之組合為佳。從長時間暴露在光照射下後因直流電壓所累積之殘留電荷之緩和變得較快之觀點,較佳者為(a-44)、(a-45)、(a-58)或(a-59)之組合。 Among them, (a-43)~(a-49), (a-57)~(a-63), (a-218)~(a-224), (a-232)~(a-238) , (A-323)~(a-329), (a-337)~(a-343), (a-428)~(a-434) or (a-442)~(a-448) combination Better. From the viewpoint that the relaxation of the residual charge accumulated by the DC voltage becomes faster after being exposed to light for a long time, the preferred ones are (a-44), (a-45), (a-58) or (a -59) combination.

特定二胺(2)特別係以使用下述式[2a]之二胺為佳。 The specific diamine (2) is particularly preferably a diamine using the following formula [2a].

Figure 104143876-A0202-12-0035-44
Figure 104143876-A0202-12-0035-44

W表示前述式[2]之構造。W1、W2、W3、及W4之詳細內容及理想組合係如前述式[2]之記載所述。p1表示1~4之整數。從合成容易度之觀點,以1為佳。 W represents the structure of the aforementioned formula [2]. The details and ideal combinations of W 1 , W 2 , W 3 , and W 4 are as described in the aforementioned formula [2]. p1 represents an integer from 1 to 4. From the viewpoint of ease of synthesis, 1 is preferable.

從上述之觀點,特定二胺(2)之使用比例係以下述之使用比例為佳。在特定聚合物(A)中,相對於二胺成分全體,以1~60莫耳%為佳。較佳者為5~50莫耳%,特佳者為10~50莫耳%。在特定聚合物(B)中,相對於二胺成分全體,以5~100莫耳%為佳。較佳者為10~95莫耳%,特佳者為15~95莫耳%。在特定聚合物(C)中,以0~20莫耳%為佳。較佳者為0~10莫耳%,特佳者為0莫耳%。 From the above viewpoint, the specific diamine (2) is preferably used in the following ratio. In the specific polymer (A), it is preferably 1 to 60 mol% relative to the entire diamine component. The better one is 5~50 mol%, and the best one is 10~50 mol%. In the specific polymer (B), it is preferably 5 to 100 mol% relative to the entire diamine component. The better is 10 to 95 mol%, and the particularly good is 15 to 95 mol%. In the specific polymer (C), 0-20 mole% is preferable. The better one is 0~10 mol%, and the best one is 0 mol%.

又,因應聚醯亞胺系聚合物對溶劑之溶解性、作成液晶配向膜時之液晶配向性,以及液晶顯示元件之光學特性等之特性,特定二胺(2)係能使用1種或將2種以上混合使用。 In addition, depending on the solubility of the polyimide-based polymer in the solvent, the liquid crystal alignment property when the liquid crystal alignment film is formed, and the optical characteristics of the liquid crystal display element, the specific diamine (2) can use one type or Two or more types are mixed for use.

<特定二胺(3)> <Specific diamine (3)>

本發明中之特定二胺(3)具有選自由羧基(COOH基)及羥基(OH基)所成群之至少一種之取代基。 The specific diamine (3) in the present invention has at least one substituent selected from the group consisting of a carboxyl group (COOH group) and a hydroxyl group (OH group).

具體而言,以使用下述式[3a]之二胺為佳。 Specifically, it is preferable to use the diamine of the following formula [3a].

Figure 104143876-A0202-12-0036-45
Figure 104143876-A0202-12-0036-45

Y表示下述式[3-1]或式[3-2]之構造。 Y represents the structure of the following formula [3-1] or formula [3-2].

m1表示1~4之整數。 m1 represents an integer from 1 to 4.

Figure 104143876-A0202-12-0036-46
Figure 104143876-A0202-12-0036-46

a表示0~4之整數。從原料取得性或合成容易度之觀點,其中亦以0或1之整數為佳。 a represents an integer from 0 to 4. From the viewpoint of availability of raw materials or ease of synthesis, an integer of 0 or 1 is also preferable.

式[3-2]中,b表示0~4之整數。從原料取得性或合成容易度之觀點,其中亦以0或1之整數為佳。 In formula [3-2], b represents an integer of 0~4. From the viewpoint of availability of raw materials or ease of synthesis, an integer of 0 or 1 is also preferable.

更具體而言,可舉出如2,4-二胺基酚、3,5-二胺基酚、3,5-二胺基苄基醇、2,4-二胺基苄基醇、4,6-二胺基間苯二酚、2,4-二胺基安息香酸、2,5-二胺基安息香酸或3,5-二胺基安息香酸等。 More specifically, examples include 2,4-diaminophenol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, and 4 ,6-Diaminoresorcinol, 2,4-diaminobenzoic acid, 2,5-diaminobenzoic acid or 3,5-diaminobenzoic acid, etc.

從抑制長時間暴露在光照射下後之電壓保持率之降低,且因直流電壓所累積之殘留電荷之緩和變得較快之觀點,其中亦以2,4-二胺基酚、3,5-二胺基酚、3,5-二胺基苄基醇或3,5-二胺基安息香酸為佳。 From the viewpoint of suppressing the decrease in the voltage retention rate after prolonged exposure to light irradiation, and the relaxation of the residual charge accumulated by the DC voltage becomes faster, among which 2,4-diaminophenol, 3,5 -Diaminophenol, 3,5-diaminobenzyl alcohol or 3,5-diaminobenzoic acid is preferred.

從上述之觀點,特定二胺(3)之使用比例係以下述之使用比例為佳。在特定聚合物(A)中,相對於二胺成分全體,以0~20莫耳%為佳。較佳者為0~10莫耳%,特佳者為0莫耳%。在特定聚合物(B)中,相對於二胺 成分全體,以0~20莫耳%為佳。較佳者為0~10莫耳%,特佳者為0莫耳%。在特定聚合物(C)中,以40~100莫耳%為佳。較佳者為50~100莫耳%,特佳者為60~100莫耳%。 From the above viewpoint, the specific diamine (3) is preferably used in the following ratio. In the specific polymer (A), it is preferably 0 to 20 mol% relative to the entire diamine component. The better one is 0~10 mol%, and the best one is 0 mol%. In the specific polymer (B), relative to the diamine The whole composition is preferably 0-20 mole %. The better one is 0~10 mol%, and the best one is 0 mol%. In the specific polymer (C), 40 to 100 mole% is preferable. The better one is 50~100 mol%, and the best one is 60~100 mol%.

又,因應聚醯亞胺系聚合物對溶劑之溶解性、作成液晶配向膜時之液晶配向性,以及液晶顯示元件之光學特性等之特性,特定二胺(3)係能使用1種或將2種以上混合使用。 In addition, according to the characteristics of the solubility of the polyimide-based polymer in the solvent, the liquid crystal alignment when forming the liquid crystal alignment film, and the optical characteristics of the liquid crystal display element, the specific diamine (3) can use one type or Two or more types are mixed for use.

<特定聚合物(A)~特定聚合物(C)> <Specific polymer (A)~Specific polymer (C)>

本發明中之特定聚合物(A)、(B)及(C)係分別意指上述之(A)成分、(B)成分及(C)成分,且為聚醯亞胺前驅物或聚醯亞胺(亦總稱為聚醯亞胺系聚合物)。此等係以使二胺成分與四羧酸成分反應而得之聚醯亞胺前驅物或聚醯亞胺為佳。 The specific polymers (A), (B), and (C) in the present invention mean the aforementioned (A) component, (B) component, and (C) component, respectively, and are polyimide precursors or polyimides Imines (also collectively referred to as polyimide-based polymers). These are preferably a polyimide precursor or polyimide obtained by reacting a diamine component and a tetracarboxylic acid component.

聚醯亞胺前驅物具有下述式[A]之構造。 The polyimide precursor has the structure of the following formula [A].

Figure 104143876-A0202-12-0037-47
(R1表示4價之有機基。R2表示2價之有機基。A1及A2係各自獨立表示氫原子或碳數1~8之烷基。A3及A4係各自獨立表示氫原子、碳數1~5之烷基或乙醯基。nA表示正之整數)。
Figure 104143876-A0202-12-0037-47
(R 1 represents a tetravalent organic group. R 2 represents a divalent organic group. A 1 and A 2 each independently represent a hydrogen atom or an alkyl group having 1 to 8 carbon atoms. A 3 and A 4 each independently represent hydrogen Atom, alkyl or acetyl group with 1 to 5 carbon atoms. nA represents a positive integer).

作為前述二胺成分,可舉出如分子內具有2個1級或2級胺基之二胺。作為四羧酸成分,可舉出如四羧酸化合物、四羧酸二酐、四羧酸二鹵化物化合物、四羧酸二烷基酯化合物或四羧酸二烷基酯二鹵化物化合物。 Examples of the aforementioned diamine component include diamines having two primary or secondary amine groups in the molecule. Examples of the tetracarboxylic acid component include tetracarboxylic acid compounds, tetracarboxylic dianhydrides, tetracarboxylic acid dihalide compounds, tetracarboxylic acid dialkyl ester compounds or tetracarboxylic acid dialkyl ester dihalide compounds.

聚醯亞胺系聚合物由於係將下述式[B]之四羧酸二酐與下述式[C]之二胺作為原料,從較能簡便取得之理由,以由下述式[D]之重複單位之構造式所構成之聚醯胺酸或使該聚醯胺酸醯亞胺化而成之聚醯亞胺為佳。從液晶配向膜之物理性及化學性安定性之觀點,其中亦以聚醯亞胺為佳。 The polyimide-based polymer uses tetracarboxylic dianhydride of the following formula [B] and diamine of the following formula [C] as raw materials. It is more easily obtained from the reason that the following formula [D ] The polyamic acid formed by the structural formula of the repeating unit or the polyimide made by the imidization of the polyamic acid is preferred. From the viewpoint of the physical and chemical stability of the liquid crystal alignment film, polyimide is also preferred.

Figure 104143876-A0202-12-0038-48
(R1及R2係與式[A]中所定義者相同)。
Figure 104143876-A0202-12-0038-48
(R 1 and R 2 are the same as defined in formula [A]).

Figure 104143876-A0202-12-0038-49
(R1、R2及nA係與前述式[A]中所定義者相同)。
Figure 104143876-A0202-12-0038-49
(R 1 , R 2 and nA are the same as defined in the aforementioned formula [A]).

又,亦能藉由通常之合成手法,對上述取得之式[D]之聚合物導入式[A]中之A1及A2之碳數1~8之烷基、及 式[A]中之A3及A4之碳數1~5之烷基或乙醯基。 In addition, the polymer of formula [D] obtained above can be introduced into the alkyl group of 1 to 8 carbon atoms of A 1 and A 2 in formula [A] and into formula [A] by the usual synthetic method A 3 and A 4 have a carbon number of 1 to 5 alkyl or acetyl.

在不損及本發明之效果範圍內,本發明之特定聚合物(A)、(B)及(C)中,除前述之特定二胺以外,亦能使用其他之二胺(亦稱為其他二胺)。 As long as the effects of the present invention are not impaired, in the specific polymers (A), (B) and (C) of the present invention, in addition to the aforementioned specific diamines, other diamines (also known as other Diamine).

具體而言,可舉出如下述之式[D1]~式[D6]所示之二胺。 Specifically, the diamine shown by following formula [D1]-formula [D6] is mentioned.

Figure 104143876-A0202-12-0039-50
Figure 104143876-A0202-12-0039-50

Figure 104143876-A0202-12-0039-51
Figure 104143876-A0202-12-0039-51

並且,可舉出如國際公開公報WO2013/125595(2013.8.29公開)第19頁~23頁記載之其他二胺,同公報第23頁~24頁記載之式[DA1]~式[DA12]及式[DA15]~式[DA20]所示之二胺、及同公報第26頁記載之式[DA27]及式[DA28]所示之二胺。 In addition, other diamines as described in pages 19 to 23 of International Publication WO2013/125595 (published on 2013.8.29), and formulas [DA1] to [DA12] described in pages 23 to 24 of the publication and The diamine represented by formula [DA15] to formula [DA20], and the diamine represented by formula [DA27] and formula [DA28] described on page 26 of the same publication.

其他二胺係使用於特定聚合物(A)、(B)及(C)之任意之特定聚合物之二胺成分皆可,且能使用於此等全部特定聚合物之二胺成分,或任意一者之特定聚合物之二 胺成分。 Other diamines can be used for any specific polymer of specific polymers (A), (B) and (C), and can be used for all of these specific polymers, or any One specific polymer two Amine components.

又,從因應聚醯亞胺系聚合物對溶劑之溶解性、作成液晶配向膜時之液晶配向性,以及液晶顯示元件之光學特性等之特性,其他二胺係能使用1種或將2種以上混合使用。 In addition, according to the characteristics of the solubility of the polyimide-based polymer in the solvent, the liquid crystal alignment when the liquid crystal alignment film is formed, and the optical characteristics of the liquid crystal display element, other diamine systems can use one type or two types The above are mixed.

特定聚合物(A)、(B)及(C)之至少任意之一聚合物中之四羧酸成分中係以使用下述式[4]之四羧酸二酐(亦稱為特定四羧酸成分)為佳。較佳係全部之特定聚合物皆係使用特定四羧酸成分。 The tetracarboxylic acid component in at least any one of the specific polymers (A), (B), and (C) is a tetracarboxylic dianhydride (also called specific tetracarboxylic acid) of the following formula [4] Acid component) is preferred. Preferably, all specific polymers use specific tetracarboxylic acid components.

Figure 104143876-A0202-12-0040-52
Figure 104143876-A0202-12-0040-52

Z表示選自由前述式[4a]~式[4k]之構造所成群之至少一種之構造。從合成容易度或製造聚合物時之聚合反應性容易度之觀點,Z係以式[4a]、式[4c]、式[4d]、式[4e]、式[4f]、式[4g]或式[4k]為佳。較佳者為式[4a]、式[4e]、式[4f]、式[4g]或式[4k]。特佳者為式[4e]、式[4f]、式[4g]或式[4k]。 Z represents at least one structure selected from the group consisting of the structures of the aforementioned formula [4a] to formula [4k]. From the viewpoint of ease of synthesis or ease of polymerization reactivity when manufacturing a polymer, Z is represented by formula [4a], formula [4c], formula [4d], formula [4e], formula [4f], and formula [4g] Or type [4k] is better. Preferably, it is formula [4a], formula [4e], formula [4f], formula [4g] or formula [4k]. Particularly preferred are formula [4e], formula [4f], formula [4g] or formula [4k].

特定四羧酸成分之使用比例,在相對於全四羧酸成分,以1莫耳%以上為佳。較佳者為5莫耳%以。特佳者為10莫耳%以上,從能抑制長時間暴露在光照射下後之電壓保持率降低之觀點,最佳者為10~90莫耳%。 The use ratio of the specific tetracarboxylic acid component is preferably 1 mol% or more relative to the total tetracarboxylic acid component. The better is 5 mol%. The most preferable one is 10 mol% or more. From the viewpoint of suppressing the decrease in the voltage retention rate after prolonged exposure to light irradiation, the best one is 10 to 90 mol%.

又,在使用前述式[4e]、式[4f]、式[4g]或式[4k]之構造之四羧酸成分時,藉由將其使用量作成四羧酸成分全體之20莫耳%以上,即能取得所欲之效果。較佳為30莫耳%以上。並且,四羧酸成分亦可全部皆為式[4e]、式[4f]、式[4g]或式[4k]之構造之四羧酸成分。 In addition, when the tetracarboxylic acid component having the structure of the above formula [4e], formula [4f], formula [4g] or formula [4k] is used, the amount of the tetracarboxylic acid component is 20 mole% of the total tetracarboxylic acid component Above, you can get the desired effect. It is preferably 30 mol% or more. Furthermore, all of the tetracarboxylic acid components may be tetracarboxylic acid components having the structure of formula [4e], formula [4f], formula [4g] or formula [4k].

在不損及本發明之效果範圍內,於全部特定聚合物中,亦能使用特定四羧酸成分以外之其他四羧酸成分。 As long as the effect of the present invention is not impaired, other tetracarboxylic acid components other than the specific tetracarboxylic acid component can be used in all specific polymers.

具體而言,可舉出如國際公開公報WO2013/125595(2013.8.29公開)第27頁~28頁記載之其他四羧酸成分。又,因應各種特性,特定四羧酸成分及其他四羧酸成分係能使用1種或將2種以上混合使用。 Specifically, there can be mentioned other tetracarboxylic acid components as described in pages 27 to 28 of International Publication WO2013/125595 (published on 2013.8.29). In addition, depending on various characteristics, the specific tetracarboxylic acid component and other tetracarboxylic acid component systems can be used alone or in combination of two or more.

特定聚合物(A)係為使含有特定二胺(1)及特定二胺(2)之二胺成分與四羧酸成分進行反應而得之聚醯亞胺前驅物或將該聚醯亞胺前驅物予以醯亞胺化之聚醯亞胺。 The specific polymer (A) is a polyimide precursor obtained by reacting a diamine component containing a specific diamine (1) and a specific diamine (2) with a tetracarboxylic acid component or the polyimide The precursor is polyimide which is imidized.

於此之際,特定二胺(1)及特定二胺之使用比例係如以下所述。即,相對於二胺成分全體,特定二胺(1)係以10~70莫耳%為佳。較佳者為15~70莫耳%,特佳者為20~60莫耳%。又,相對於二胺成分全體,特定二胺(2)係以1~60莫耳%為佳。較佳者為5~50莫耳%,特佳者為10~50莫耳%。此外,特定二胺(3)中,從能減輕ODF方式下產生之液晶配向不均之觀點,相對於二胺成分全體,特定二胺(3)係以0~20莫耳%為佳。較佳者為0~10 莫耳%,特佳者為0莫耳%,即不使用特定二胺(3)。 On this occasion, the specific diamine (1) and the use ratio of the specific diamine are as follows. That is, the specific diamine (1) is preferably 10 to 70 mol% relative to the entire diamine component. The better is 15 to 70 mol%, and the particularly good is 20 to 60 mol%. In addition, the specific diamine (2) is preferably 1 to 60 mol% relative to the entire diamine component. The better one is 5~50 mol%, and the best one is 10~50 mol%. In addition, in the specific diamine (3), from the viewpoint of reducing the unevenness of liquid crystal alignment generated in the ODF method, the specific diamine (3) is preferably 0 to 20 mol% relative to the entire diamine component. The better one is 0~10 Molar%, especially the best is 0 mol%, that is, no specific diamine is used (3).

特定聚合物(B)係為使含有特定二胺(2)之二胺成分與四羧酸成分進行反應而得之聚醯亞胺前驅物或將該聚醯亞胺前驅物予以醯亞胺化之聚醯亞胺。於此之際,特定二胺(2)之使用比例係如以下所述。即,相對於二胺成分全體,特定二胺(2)係以5~100莫耳%為佳。較佳者為10~95莫耳%,特佳者為15~95莫耳%。又,在特定二胺(1)中,相對於二胺成分全體,以0~40莫耳%為佳。較佳者為0~30莫耳%,特佳者為0~25莫耳%。 The specific polymer (B) is a polyimide precursor obtained by reacting a diamine component containing a specific diamine (2) with a tetracarboxylic acid component or the polyimide precursor is imidate The polyimide. On this occasion, the specific use ratio of the diamine (2) is as follows. That is, the specific diamine (2) system is preferably 5 to 100 mol% relative to the entire diamine component. The better is 10 to 95 mol%, and the particularly good is 15 to 95 mol%. In addition, in the specific diamine (1), it is preferably 0 to 40 mol% relative to the entire diamine component. The better one is 0~30 mol%, and the best one is 0~25 mol%.

但,特定聚合物(B)中之特定二胺(1)對二胺成分全體之使用比例(莫耳%),當在將特定聚合物(A)中之特定二胺(1)之使用比例(莫耳%)設成1.0時,其比率係為未滿1.0之使用比例(莫耳%)。於此之際,其比率為0之情況,即,特定聚合物(B)之二胺成分在未使用特定二胺(1)時,在從抑制長時間暴露光照射下後之電壓保持率降低,且因直流電壓所累積之殘留電荷之緩和變快之觀點上為佳。又,特定聚合物(B)在使用特定二胺(1)時,前述比率係以0.01~0.9為佳。較佳者為0.01~0.8,特佳者為0.05~0.7。 However, the use ratio of specific diamine (1) in the specific polymer (B) to the entire diamine component (mol %), when the use ratio of the specific diamine (1) in the specific polymer (A) (Mohr%) is set to 1.0, the ratio is the use ratio (Mohr%) less than 1.0. On this occasion, when the ratio is 0, that is, when the diamine component of the specific polymer (B) is not used for the specific diamine (1), the voltage retention rate after suppressing the exposure to light for a long period of time decreases , And the viewpoint that the relaxation of the residual charge accumulated by the DC voltage becomes faster is preferable. When the specific polymer (B) uses the specific diamine (1), the aforementioned ratio is preferably 0.01 to 0.9. The better one is 0.01~0.8, and the best one is 0.05~0.7.

此外,特定二胺(3)中,相對於二胺成分全體,以0~20莫耳%為佳。較佳者為0~10莫耳%,在從能減輕ODF方式下產生之液晶配向不均之觀點,特佳者為0莫耳%,即,特定聚合物(B)之二胺成分不使用特定二胺(3)。 In addition, in the specific diamine (3), it is preferably 0 to 20 mol% relative to the entire diamine component. The preferred value is 0 to 10 mol %. From the viewpoint of reducing the unevenness of liquid crystal alignment generated by the ODF method, the most preferred value is 0 mol %, that is, the diamine component of the specific polymer (B) is not used. Specific diamine (3).

特定聚合物(C)係為使含有特定二胺(3)之二胺 成分與四羧酸成分進行反應而得之聚醯亞胺前驅物或將該聚醯亞胺前驅物予以醯亞胺化之聚醯亞胺。於此之際,特定二胺(3)之使用比例係如以下述所述。即,相對於二胺成分全體,特定二胺(3)係以40~100莫耳%為佳。較佳者為50~100莫耳%,特佳者為60~100莫耳%。又,在特定二胺(1)中,相對於二胺成分全體,以0~20莫耳%為佳。較佳者為0~10莫耳%。但,特定聚合物(C)中之特定二胺(1)對二胺成分全體之使用比例(莫耳%),在將特定聚合物(A)中之特定二胺(1)之使用比例(莫耳%)設成1.0時,其比率為未滿1.0之使用比例(莫耳%)。於此之際,其比率為0時,即,在特定聚合物(C)之二胺成分未使用特定二胺(1)之情況,在抑制長時間暴露在光照射下後之電壓保持率降低,且因直流電壓所累蓄之殘留電荷之緩和變快之觀點上為佳。又,特定聚合物(C)未使用特定二胺(1)時,前述比率係以0.01~0.4為佳。較佳者為0.01~0.3,特佳者為0.01~0.2。 The specific polymer (C) is a diamine containing a specific diamine (3) The polyimide precursor obtained by reacting the component with the tetracarboxylic acid component or the polyimide obtained by subjecting the polyimide precursor to imidization. On this occasion, the use ratio of the specific diamine (3) is as described below. That is, the specific diamine (3) is preferably 40 to 100 mol% relative to the entire diamine component. The better one is 50~100 mol%, and the best one is 60~100 mol%. In addition, in the specific diamine (1), it is preferably 0 to 20 mol% relative to the entire diamine component. The better one is 0~10 mol%. However, the use ratio of the specific diamine (1) in the specific polymer (C) to the entire diamine component (mol %), when using the specific diamine (1) in the specific polymer (A) ( When the mole %) is set to 1.0, the ratio is less than 1.0 (Mohr %). At this time, when the ratio is 0, that is, when the specific diamine component (C) of the specific polymer (C) does not use the specific diamine (1), the reduction in the voltage retention rate after long-term exposure to light irradiation is suppressed , And the viewpoint that the relaxation of the residual charge accumulated by the DC voltage becomes faster is preferable. When the specific polymer (C) does not use the specific diamine (1), the aforementioned ratio is preferably 0.01 to 0.4. The better one is 0.01~0.3, and the best one is 0.01~0.2.

並且,相對於二胺成分全體,特定二胺(3)係以0~20莫耳%為佳。較佳者為0~10莫耳%,在抑制長時間暴露在光照射下後之電壓保持率降低,且因直流電壓所累蓄之殘留電荷之緩和變快之觀點上,特佳者為0莫耳%,即,特定聚合物(C)之二胺成分不使用特定二胺(3)。 In addition, the specific diamine (3) is preferably 0 to 20 mol% relative to the entire diamine component. It is preferably 0 to 10 mol %. From the viewpoint of suppressing the decrease in the voltage retention rate after prolonged exposure to light irradiation, and the relaxation and increase in the residual charge accumulated by the DC voltage, the most preferred is 0 Molar %, that is, the specific diamine (3) is not used for the diamine component of the specific polymer (C).

本發明中,製作全部之特定聚合物,即,製作此等聚醯亞胺系聚合物用之方法並無特限定。通常係使二胺成分與四羧酸成分進行反應而取得。一般而言,可舉 出如使選自由四羧酸二酐及其四羧酸之衍生物所成群之至少一種之四羧酸成分與由1種或複數種之二胺所構成之二胺成分進行反應,而取得聚醯胺酸之方法。具體而言,可使用使四羧酸二酐與1級或2級二胺進行縮聚合而取得聚醯胺酸之方法、使四羧酸與1級或2級二胺進行脫水縮聚合反應而取得聚醯胺酸之方法,或使四羧酸二鹵化物與1級或2級二胺進行反應而取得聚醯胺酸之方法。 In the present invention, the method for producing all the specific polymers, that is, the method for producing these polyimide-based polymers is not particularly limited. It is usually obtained by reacting a diamine component and a tetracarboxylic acid component. Generally speaking, It is obtained by reacting at least one tetracarboxylic acid component selected from the group consisting of tetracarboxylic dianhydride and its derivatives with a diamine component consisting of one or more diamines. Polyamide method. Specifically, the method of polycondensing a tetracarboxylic dianhydride and a 1st or 2nd diamine by polycondensation, and the dehydration condensation polymerization reaction of a tetracarboxylic acid and a 1st or 2nd diamine can be used. A method of obtaining polyamic acid, or a method of reacting tetracarboxylic acid dihalide with level 1 or level 2 diamine to obtain polyamic acid.

欲取得聚醯胺酸烷基酯,可使用使將羧酸基予以二烷基酯化而成之四羧酸與1級或2級二胺進行縮聚合之方法、使將羧酸基予以二烷基酯化而成之四羧酸二鹵化物與1級或2級二胺進行反應之方法,或將聚醯胺酸之羧基轉換成酯之方法。 To obtain polyalkyl amides, a method of polycondensation of a tetracarboxylic acid obtained by esterifying a carboxylic acid group with a dialkyl group and a 1st or 2nd stage diamine can be used. The method of reacting the tetracarboxylic acid dihalide formed by alkyl esterification with the 1st or 2nd level diamine, or the method of converting the carboxyl group of the polyamic acid into an ester.

欲取得聚醯亞胺,可使用使前述聚醯胺酸或聚醯胺酸烷基酯進行閉環而作成聚醯亞胺之方法。 To obtain polyimide, a method of forming a polyimide by ring-closing the aforementioned polyamic acid or polyalkylamino acid can be used.

二胺成分與四羧酸成分之反應,通常係使二胺成分與四羧酸成分在有機溶劑中進行。此時使用之有機溶劑只要會溶解所生成之聚醯亞胺前驅物者,即無特別限定。於下述舉出反應所使用之有機溶劑之具體例,但並非係受限於此等例者。 The reaction of the diamine component and the tetracarboxylic acid component is usually carried out by allowing the diamine component and the tetracarboxylic acid component in an organic solvent. The organic solvent used at this time is not particularly limited as long as it dissolves the produced polyimide precursor. Specific examples of organic solvents used in the reaction are given below, but not limited to these examples.

可舉出例如,N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮、γ-丁內酯、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、二甲亞碸或1,3-二甲基-咪唑啉酮等。又,聚醯亞胺前驅物之溶劑溶解性為高時,能使用甲基乙基酮、環己酮、環戊酮、4-羥基-4-甲基-2-戊酮或下述式[D-1]~式[D- 3]之溶劑。 For example, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, γ-butyrolactone, N,N-dimethylformamide, N,N-dimethyl Ethylacetamide, dimethyl sulfoxide or 1,3-dimethyl-imidazolidinone, etc. In addition, when the solvent solubility of the polyimide precursor is high, methyl ethyl ketone, cyclohexanone, cyclopentanone, 4-hydroxy-4-methyl-2-pentanone or the following formula can be used: D-1]~Form [D- 3] The solvent.

Figure 104143876-A0202-12-0045-53
(D1表示碳數1~3之烷基。D2表示碳數1~3之烷基。D3表示碳數1~4之烷基)。
Figure 104143876-A0202-12-0045-53
(D 1 represents an alkyl group having 1 to 3 carbon atoms. D 2 represents an alkyl group having 1 to 3 carbon atoms. D 3 represents an alkyl group having 1 to 4 carbon atoms).

此等係可單獨使用,亦可混合使用。並且,即使係不會使聚醯亞胺前驅物溶解之溶劑,但只要在所生成之聚醯亞胺前驅物不析出之範圍內,亦可混合於上述溶劑中使用。又,由於有機溶劑中之水分會成為阻礙聚合反應,並且使生成之聚醯亞胺前驅物水解之原因,故有機溶劑係以使用經脫水乾燥者為佳。 These systems can be used alone or in combination. Moreover, even if it is a solvent which does not dissolve the polyimide precursor, it can be mixed and used in the above-mentioned solvent as long as the polyimide precursor produced does not precipitate. In addition, since the water in the organic solvent may hinder the polymerization reaction and cause the polyimide precursor to be hydrolyzed, the organic solvent is preferably a dehydrated and dried one.

使二胺成分與四羧酸成分在有機溶劑中進行反應時,可舉出如攪拌使二胺成分分散或溶解於有機溶劑而成之溶液,且直接添加四羧酸成分,或使其分散或溶解於有機溶劑而添加之方法;相反地對使四羧酸成分分散或溶解於有機溶劑而成之溶液添加二胺成分之方法;交互添加二胺成分與四羧酸成分之方法等,使用此等任意之一種方法皆可。又,在分別使用複數種二胺成分及四羧酸成分進行反應時,可預先在已混合之狀態下進行反應,亦可個別依序進行反應,又亦可混合個別已反應之低分子量體使其反應而作成聚合物。此時之聚合溫度能選自-20℃~ 150℃之任意溫度,較佳為-5℃~100℃之範圍。又,反應係能在任意濃度下進行,但濃度過低時則變得難以取得高分子量聚合物,又濃度過高時則反應液之黏性變得過高而變得難以均勻攪拌。因此,以1~50%為佳,較佳為5~30%。亦能夠聚合反應初期係在高濃度下進行,其後再追加有機溶劑。 When the diamine component and the tetracarboxylic acid component are reacted in an organic solvent, for example, a solution obtained by stirring to disperse or dissolve the diamine component in an organic solvent, and the tetracarboxylic acid component is directly added or dispersed or The method of dissolving in an organic solvent and adding; conversely, the method of adding a diamine component to a solution of dispersing or dissolving a tetracarboxylic acid component in an organic solvent; the method of alternately adding a diamine component and a tetracarboxylic acid component, etc., use this Either method is acceptable. In addition, when a plurality of diamine components and tetracarboxylic acid components are used for the reaction, the reaction may be carried out in a mixed state in advance, or the reaction may be carried out sequentially in sequence, or the individual low molecular weight bodies may be mixed to make It reacts to make a polymer. The polymerization temperature at this time can be selected from -20℃~ Any temperature of 150°C is preferably in the range of -5°C to 100°C. In addition, the reaction system can be carried out at an arbitrary concentration, but when the concentration is too low, it becomes difficult to obtain a high molecular weight polymer, and when the concentration is too high, the viscosity of the reaction solution becomes too high, making it difficult to uniformly stir. Therefore, it is preferably 1-50%, preferably 5-30%. It is also possible to proceed at a high concentration in the initial stage of the polymerization reaction, and then add an organic solvent thereafter.

在聚醯亞胺前驅物之聚合反應中,二胺成分之合計莫耳數與四羧酸成分之合計莫耳數之比係以0.8~1.2為佳。與通常之聚合反應相同,此莫耳比越接近1.0時,所生成之聚醯亞胺前驅物之分子量變大。 In the polymerization reaction of the polyimide precursor, the ratio of the total molar number of the diamine component to the total molar number of the tetracarboxylic acid component is preferably 0.8 to 1.2. Similar to the normal polymerization reaction, the closer the molar ratio is to 1.0, the larger the molecular weight of the polyimide precursor produced.

聚醯亞胺係為使前述聚醯亞胺前驅物閉環而得之聚醯亞胺,醯胺酸基之閉環率(亦稱為醯亞胺化率)並不一定要係100%,能因應其用途或目的而任意進行調整。其中在本發明中,全部之特定聚合物係以將聚醯亞胺前驅物予以醯亞胺化之聚醯亞胺為佳。此時之醯亞胺化率係以如以下所述為佳。即,特定聚合物(A)係以50~90%為佳。較佳者為55~90%,特佳者為60~90%。特定聚合物(B)係以50~95%為佳。較佳者為55~95%,特佳者為60~95%,特定聚合物(C)係以50~90%為佳。較佳者為60~90%,特佳者為60~80%。 Polyimide is a polyimide obtained by ring-closing the aforementioned polyimide precursor. The ring-closing rate of the amino acid group (also known as the rate of imidization) does not necessarily need to be 100%. It can be arbitrarily adjusted for its use or purpose. Among them, in the present invention, all the specific polymers are preferably polyimide which is imidized by the polyimide precursor. In this case, the rate of acyl imidization is preferably as described below. That is, the specific polymer (A) is preferably 50 to 90%. The better one is 55~90%, and the best one is 60~90%. The specific polymer (B) is preferably 50-95%. The better is 55~95%, the particularly good is 60~95%, and the specific polymer (C) is preferably 50~90%. The better one is 60~90%, and the best one is 60~80%.

作為使聚醯亞胺前驅物進行醯亞胺化之方法,可舉出如直接加熱聚醯亞胺前驅物溶液之熱醯亞胺化,或對聚醯亞胺前驅物溶液添加觸媒之觸媒醯亞胺化。使聚醯亞胺前驅物在溶液中進行熱醯亞胺化時之溫度為 100℃~400℃,較佳為120℃~250℃,但將因醯亞胺化反應所生成之水排除至系統外並同時進行為佳。 As a method for subjecting the polyimide precursor to imidization, there may be mentioned, for example, directly heating the thermal imidization of the polyimide precursor solution, or adding a catalyst to the polyimide precursor solution. The medium is imidized. The temperature at which the polyimide precursor is thermally imidized in the solution is 100°C to 400°C, preferably 120°C to 250°C, but it is preferable to exclude the water generated by the amide imidization reaction from the system and proceed simultaneously.

聚醯亞胺前驅物之觸媒醯亞胺化係能對聚醯亞胺前驅物溶液添加鹼性觸媒與酸酐,藉由在-20~250℃,較佳在0~180℃下進行攪拌來實施。鹼性觸媒之量為醯胺酸基之0.5~30莫耳倍,較佳為2~20莫耳倍,酸酐之量為醯胺酸基之1~50莫耳倍,較佳為3~30莫耳倍。作為鹼性觸媒,可舉出如吡啶、三乙基胺、三甲基胺、三丁基胺或三辛基胺等。其中,由於吡啶具有使反應進行所需之適度鹼性,故為佳。作為酸酐,可舉出如無水乙酸、無水偏苯三甲酸或無水苯均四酸等。其中,若使用無水乙酸則反應結束後之純化會變得容易,故為佳。由觸媒醯亞胺化所成之醯亞胺化率係能藉由調節觸媒量、反應溫度及反應時間而控制。 The catalyst of the polyimide precursor can be added to the polyimide precursor solution with an alkaline catalyst and anhydride, by stirring at -20~250℃, preferably 0~180℃ To implement. The amount of the alkaline catalyst is 0.5 to 30 mole times of the amide acid group, preferably 2 to 20 mole times, and the amount of the acid anhydride is 1 to 50 mole times of the amide acid group, preferably 3 to 30 mole times. Examples of the alkaline catalyst include pyridine, triethylamine, trimethylamine, tributylamine, and trioctylamine. Among them, pyridine is preferred because it has a moderate basicity required for the reaction to proceed. Examples of the acid anhydride include anhydrous acetic acid, anhydrous trimellitic acid, anhydrous pyromellitic acid, and the like. Among them, if anhydrous acetic acid is used, purification after completion of the reaction becomes easy, which is preferable. The imidization rate formed by catalyst imidization can be controlled by adjusting the amount of catalyst, reaction temperature and reaction time.

從聚醯亞胺前驅物或聚醯亞胺之反應溶液回收經生成之聚醯亞胺前驅物或聚醯亞胺時,只需將反應溶液投入溶劑中使其沉澱即可。作為沉澱使用之溶劑,可舉出如甲醇、乙醇、異丙基醇、丙酮、己烷、丁基賽珞蘇、庚烷、甲基乙基酮、甲基異丁基酮、甲苯、苯或水等。投入於溶劑後沉澱之聚合物經過濾回收後,能在常壓或壓下,常溫或加熱下進行乾燥。又,使經沉澱回收之聚合物再溶解於有機溶劑,重複再沉澱回收之操作2~10次,即能減少聚合物中之雜質。作為此時之溶劑,可舉出例如,醇類、酮類或烴等,若使用選自此等3種類以上之溶劑, 由於能更加提升純化之效率,故為佳。 When recovering the generated polyimide precursor or polyimide from the reaction solution of the polyimide precursor or polyimide, it is only necessary to put the reaction solution in a solvent to precipitate it. As the solvent used for precipitation, for example, methanol, ethanol, isopropyl alcohol, acetone, hexane, butylcellulose, heptane, methyl ethyl ketone, methyl isobutyl ketone, toluene, benzene or Water etc. After the polymer precipitated after being put in the solvent is filtered and recovered, it can be dried at normal pressure or under normal temperature or heating. In addition, the polymer recovered by precipitation is redissolved in an organic solvent, and the operation of reprecipitation and recovery is repeated 2 to 10 times to reduce impurities in the polymer. Examples of the solvent at this time include alcohols, ketones, and hydrocarbons. If three or more solvents selected from these are used, It is better because it can further improve the efficiency of purification.

聚醯亞胺系聚合物之分子量在考量到由此所得之液晶配向膜之強度、液晶配向膜形成時之作業性及塗膜性時,以GPC(Gel Permeation Chromatography)法所測量之重量平均分子量係以5,000~1,000,000為佳。其中亦以10,000~150,000為佳。 The weight average molecular weight of the polyimide-based polymer is measured by the GPC (Gel Permeation Chromatography) method when considering the strength of the liquid crystal alignment film obtained therefrom, the workability at the time of forming the liquid crystal alignment film, and the coating film performance It is preferably 5,000~1,000,000. Among them, 10,000~150,000 is better.

如先前所述,從本發明中之全部特定聚合物即使長時間暴露在高溫及光照射下後,仍能顯示安定垂直安定性,且即使長時間暴露在光照射下後,仍能抑制電壓保持率降低之觀點,以將上述聚醯亞胺前驅物予以觸媒醯亞胺化而成之聚醯亞胺為佳。此時之醯亞胺化率係以在上述範圍內為佳。 As mentioned previously, all the specific polymers in the present invention can show stable vertical stability even after long-term exposure to high temperature and light irradiation, and even after long-term exposure to light irradiation, voltage retention can be suppressed From the viewpoint of reduction of the rate, the polyimide obtained by subjecting the above-mentioned polyimide precursor to catalyst imidization is preferred. At this time, the rate of acyl imidization is preferably within the above range.

<液晶配向處理劑> <Liquid crystal alignment treatment agent>

液晶配向處理劑中之特定聚合物(A)、(B)及(C)之使用比例,在相對於特定聚合物(A)100份而言,特定聚合物(B)係以30~300份,特定聚合物(C)係以60~500份為佳。較佳者係特定聚合物(B)為50~250份,特定聚合物(C)為100~350份,特佳者係特定聚合物(B)為50~200份,特定聚合物(C)為100~300份。 The use ratio of the specific polymers (A), (B) and (C) in the liquid crystal alignment treatment agent is 30 to 300 parts relative to 100 parts of the specific polymer (A) The specific polymer (C) is preferably 60 to 500 parts. Preferably, the specific polymer (B) is 50 to 250 parts, the specific polymer (C) is 100 to 350 parts, and the particularly preferred is the specific polymer (B) is 50 to 200 parts, the specific polymer (C) For 100~300 copies.

液晶配向處理劑中之全部聚合物成分,可全部皆為特定聚合物,亦可混合有其以外之其他聚合物。此時,其以外之其他聚合物之含量,相對於全部特定聚合物100份而言,以0.5~15份為佳。較佳者為1~10份。作 為期以外之其他聚合物,可舉出如纖維素系聚合物、丙烯酸聚合物、甲基丙烯酸聚合物、聚苯乙烯、聚醯胺或聚矽氧烷等。 All the polymer components in the liquid crystal alignment treatment agent may be all specific polymers or may be mixed with other polymers. At this time, the content of other polymers is preferably 0.5 to 15 parts relative to 100 parts of all specific polymers. Preferably, it is 1~10 servings. Make Examples of other polymers than those mentioned above include cellulose-based polymers, acrylic polymers, methacrylic polymers, polystyrene, polyamide, and polysiloxane.

液晶配向處理劑中之溶劑,從藉由塗佈而形成均勻液晶配向膜之觀點,液晶配向處理劑中之溶劑含量係以70~99.9%為佳。此含量係能根據作為目的之液晶配向膜之膜厚而適宜改變。 The solvent in the liquid crystal alignment treatment agent is preferably 70 to 99.9% from the viewpoint of forming a uniform liquid crystal alignment film by coating. This content can be suitably changed according to the film thickness of the liquid crystal alignment film as the objective.

本發明之液晶配向處理劑所使用之溶劑只要係會使全部特定聚合物溶解之溶劑(亦稱為良溶劑),即無特別限定。於下述舉出良溶劑之具體例,但並非係受限於此等者。 The solvent used in the liquid crystal alignment treatment agent of the present invention is not particularly limited as long as it dissolves all specific polymers (also referred to as good solvents). Specific examples of good solvents are given below, but not limited to these.

可舉出例如,N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮、二甲亞碸、γ-丁內酯、1,3-二甲基-咪唑啉酮、甲基乙基酮、環己酮、環戊酮或4-羥基-4-甲基-2-戊酮等。 For example, N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, di Methylene sulfoxide, γ-butyrolactone, 1,3-dimethyl-imidazolidinone, methyl ethyl ketone, cyclohexanone, cyclopentanone or 4-hydroxy-4-methyl-2-pentanone, etc. .

其中,亦以使用N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮或γ-丁內酯為佳。 Among them, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone or γ-butyrolactone is also preferably used.

並且,特定聚合物對溶劑之溶解性為高時,則以使用前述式[D-1]~式[D-3]之溶劑為佳。 In addition, when the solubility of the specific polymer in the solvent is high, it is preferable to use the solvent of the aforementioned formula [D-1] to formula [D-3].

液晶配向處理劑中之良溶劑係以佔液晶配向處理劑所包含之溶劑全體之10~100%為佳。較佳者為20~90%。特佳者為30~80%。 The good solvent in the liquid crystal alignment treatment agent is preferably 10 to 100% of the total solvent contained in the liquid crystal alignment treatment agent. The better is 20~90%. The best is 30~80%.

液晶配向處理劑在不損及本發明之效果範圍內,亦能使用提升塗佈液晶配向處理劑時之液晶配向膜之塗膜性或 表面平滑性之溶劑(亦稱為貧溶劑)。於下述舉出貧溶劑之具體例,但並非係受限於此等者。 The liquid crystal alignment treatment agent can also be used to improve the coating properties of the liquid crystal alignment film when the liquid crystal alignment treatment agent is applied, without impairing the effects of the present invention. Solvent for surface smoothness (also called lean solvent). Specific examples of the poor solvent are given below, but not limited to these.

具體地可舉出如國際公開公報WO2013/125595(2013.8.29公開)第35頁~37頁記載之貧溶劑。 Specific examples include the poor solvents described in pages 35 to 37 of International Publication WO2013/125595 (published on August 29, 2013).

其中亦以使用1-己醇、環己醇、1,2-乙二醇、1,2-丙二醇、丙二醇單丁基醚、乙二醇單丁基醚、二丙二醇二甲基醚或前述式[D-1]~式[D-3]之溶劑佳。 Among them, 1-hexanol, cyclohexanol, 1,2-ethylene glycol, 1,2-propylene glycol, propylene glycol monobutyl ether, ethylene glycol monobutyl ether, dipropylene glycol dimethyl ether or the aforementioned formula are also used [D-1]~The solvent of formula [D-3] is good.

此等貧溶劑係以佔液晶配向處理劑所包含之溶劑全體之1~70%為佳。較佳者為1~60%。特佳者為5~60%。 These poor solvents preferably account for 1 to 70% of the total solvent contained in the liquid crystal alignment treatment agent. The better is 1~60%. The best is 5~60%.

在不損及本發明之效果範圍內,以在液晶配向處理劑中導入具有選自環氧基、異氰酸酯基、環氧丙烷基及環碳酸酯基所成群之基之交聯性化合物,具有選自由羥基、羥基烷基及低級烷氧基烷基所成群之基之交聯性化合物,或具有聚合性不飽和鍵基之交聯性化合物(亦總稱為特定交聯性化合物)為佳。此時,有必要在化合物中具有2個以上此等之基。 Within the scope of not detracting from the effects of the present invention, by introducing a crosslinkable compound having a group selected from an epoxy group, an isocyanate group, a glycidyl group, and a cyclic carbonate group into the liquid crystal alignment treatment agent, it has Cross-linkable compounds selected from the group consisting of hydroxy, hydroxyalkyl, and lower alkoxyalkyl groups, or cross-linkable compounds with a polymerizable unsaturated bond group (also collectively referred to as specific cross-linkable compounds) are preferred . In this case, it is necessary to have two or more of these groups in the compound.

作為具有環氧基或異氰酸酯基之交聯性化合物之例,具體地可舉出如國際公開公報WO2013/125595(2013.8.29公開)第37頁~38頁記載之具有環氧基或異氰酸酯基之交聯性化合物。 As an example of the crosslinkable compound having an epoxy group or an isocyanate group, specific examples include those having an epoxy group or an isocyanate group as described in pages 37 to 38 of International Publication WO2013/125595 (published on 2013.8.29) on pages 37 to 38. Crosslinkable compounds.

作為具有環氧丙烷基之交聯性化合物,具體地可舉出如國際公開公報WO2011/132751第58頁~59頁記載之式[4a]~式[4k]所示之交聯性化合物。 Specific examples of the crosslinkable compound having a propylene oxide group include the crosslinkable compounds represented by Formula [4a] to Formula [4k] described in pages 58 to 59 of International Publication WO2011/132751.

作為具有環碳酸酯基之交聯性化合物,具體 地可舉出如國際公開公報WO2012/014898第76頁~82頁記載之式[5-1]~式[5-42]所示之交聯性化合物。 As a crosslinkable compound having a cyclic carbonate group, specifically Examples of the cross-linkable compounds are represented by formula [5-1] to formula [5-42] described in pages 76 to 82 of International Publication WO2012/014898.

作為具有選自由羥基、羥基烷基及低級烷氧基烷基所成群之至少一種基之交聯性化合物,具體地可舉出如國際公開公報2013/125595(2013.8.29公開)第39頁~40頁記載之三聚氰胺衍生物或苯胍胺衍生物,及國際公開公報WO2011/132751(2011.10.27公開)第62頁~66頁記載之式[6-1]~式[6-48]所示之交聯性化合物。 Examples of the cross-linkable compound having at least one group selected from the group consisting of hydroxy, hydroxyalkyl, and lower alkoxyalkyl include International Publication Gazette 2013/125595 (published on 2013.8.29), page 39. The melamine derivative or benzoguanamine derivative described on page ~40, and the formula [6-1] to formula [6-48] described on pages 62 to 66 of the International Publication WO2011/132751 (published on October 27, 2011) The cross-linking compound shown.

作為具有聚合性不飽和鍵之交聯性化合物,具體地可舉出如國際公開公報WO2013/125595(2013.8.29公開)第40頁~41頁記載之具有聚合性不飽和鍵之交聯性化合物。 As the crosslinkable compound having a polymerizable unsaturated bond, specifically, a crosslinkable compound having a polymerizable unsaturated bond as described in pages 40 to 41 of International Publication WO2013/125595 (published on 2013.8.29) is described. .

液晶配向處理劑中之特定交聯性化合物之含量,在相對於全部聚合物成分100份而言,以0.1~100份為佳。為了使交聯反應進行且展現目的效果,較佳者為0.1~50份。特佳者為1~30份。 The content of the specific crosslinkable compound in the liquid crystal alignment treatment agent is preferably 0.1 to 100 parts relative to 100 parts of the total polymer component. In order to allow the cross-linking reaction to proceed and to exhibit the desired effect, it is preferably 0.1 to 50 parts. The best ones are 1~30 copies.

本發明之液晶配向處理劑中,為了促進液晶配向膜中之電荷移動,且促進元件之電荷流失,能添加國際公開公報WO2011/132751(2011.10.27公開)第69頁~73頁記載之式[M1]~式[M156]之含氮雜環胺。即使直接將此胺添加至液晶配向處理劑亦無妨,但以適當溶劑作為濃度0.1~10%,較佳為1~7%之溶液後再添加為佳。作為此溶劑,只要係會使特定聚合物溶解之有機溶劑,即無特別限定。 In the liquid crystal alignment treatment agent of the present invention, in order to promote the charge movement in the liquid crystal alignment film and promote the charge loss of the device, the formula described in pages 69 to 73 of International Publication WO2011/132751 (published on 2011.10.27) can be added [ M1]~ Nitrogen-containing heterocyclic amine of formula [M156]. Even if this amine is directly added to the liquid crystal alignment treatment agent, it is okay, but it is better to use an appropriate solvent as a solution with a concentration of 0.1 to 10%, preferably 1 to 7%, and then add it. The solvent is not particularly limited as long as it is an organic solvent that can dissolve a specific polymer.

在不損及本發明之效果範圍內,液晶配向處 理劑中,能使用提升塗佈液晶配向處理劑時之液晶配向膜之膜厚均勻性或表面平滑性之化合物。並且,能使用提升液晶配向膜與基板之密著性之化合物等。 As long as the effect of the present invention is not compromised, the liquid crystal alignment As the physical agent, a compound that enhances the uniformity of the thickness of the liquid crystal alignment film or the surface smoothness when the liquid crystal alignment treatment agent is applied can be used. In addition, a compound that enhances the adhesion between the liquid crystal alignment film and the substrate can be used.

作為提升液晶配向膜之膜厚均勻性或表面平滑性之化合物,可舉出如氟系界面活性劑、聚矽氧系界面活性劑、非離子系界面活性劑等。具體地可舉出如國際公開公報WO2013/125595(2013.8.29公開)第42頁~43頁記載之界面活性劑。 Examples of the compound that improves the film thickness uniformity or surface smoothness of the liquid crystal alignment film include fluorine-based surfactants, polysiloxane-based surfactants, and nonionic surfactants. Specific examples include surfactants described on pages 42 to 43 of International Publication WO2013/125595 (published on 2013.8.29).

此等界面活性劑之使用量,在相對於液晶配向處理劑所含有之全部聚合物成分100質量份而言,以0.01~2質量份為佳,較佳者為0.01~1質量份。 The use amount of these surfactants is preferably 0.01 to 2 parts by mass, and more preferably 0.01 to 1 part by mass relative to 100 parts by mass of all polymer components contained in the liquid crystal alignment treatment agent.

作為提升液晶配向膜與基板之密著性之化合物具體例,可舉出如含官能性矽烷之化合物或含環氧基之化合物。具體地可舉出如國際公開公報WO2013/125595(2013.8.29公開)第43頁~44頁記載之化合物。 As a specific example of the compound that enhances the adhesion between the liquid crystal alignment film and the substrate, there may be mentioned a compound containing a functional silane or a compound containing an epoxy group. Specifically, the compounds described on pages 43 to 44 of International Publication WO2013/125595 (published on 2013.8.29) can be mentioned.

此等使與基板密著之化合物之使用比例,在相對於液晶配向處理劑所含有之全部聚合物成分100份而言,以0.1~30份為佳,較佳為1~20份。若未滿0.1份,則無法期待密著性提升之效果,若多於30份,則有液晶配向處理劑之保存安定性變差的情況。 The use ratio of the compound adhering to the substrate is preferably 0.1 to 30 parts, and preferably 1 to 20 parts relative to 100 parts of all polymer components contained in the liquid crystal alignment treatment agent. If it is less than 0.1 part, the effect of improving the adhesiveness cannot be expected, and if it exceeds 30 parts, the storage stability of the liquid crystal alignment treatment agent may be deteriorated.

在不損及本發明之效果範圍內,液晶配向處理劑中,除上述以外之化合物,亦可添加使液晶配向膜之介電率或導電性等之電特性變化為目的之介電體或導電物質。 Within the scope of the effects of the present invention, compounds other than the above may be added to the liquid crystal alignment treatment agent, and a dielectric or conductive material may be added for the purpose of changing the electrical characteristics such as the dielectric constant or conductivity of the liquid crystal alignment film. substance.

<液晶配向膜‧液晶顯示元件> <Liquid crystal alignment film‧Liquid crystal display element>

本發明之液晶配向處理劑塗佈在基板上並燒成後,以摩擦處理或光照射等施以配向處理,而能使用作為液晶配向膜。又,垂直配向用途等之情況下,即使未施以配向處理,仍能使用作為液晶配向膜。作為此時使用之基板,只要係高透明性基板即無特別限定,除能使用玻璃基板,亦能使用丙烯酸基板或聚碳酸酯基板等之塑膠基板等。從製程簡單化之觀點,以使用已形成有液晶驅動用之ITO電極等之基板為佳。又,反射型之液晶顯示元件中,若僅係使用單側基板,亦能使用矽晶圓等之不透明基板,作為此時之電極,亦能使用鋁等之反射光之材料。 The liquid crystal alignment treatment agent of the present invention is applied to a substrate and fired, and then subjected to alignment treatment by rubbing treatment or light irradiation, and can be used as a liquid crystal alignment film. Furthermore, in the case of vertical alignment applications, etc., even if no alignment treatment is applied, it can be used as a liquid crystal alignment film. The substrate used at this time is not particularly limited as long as it is a highly transparent substrate. In addition to a glass substrate, a plastic substrate such as an acrylic substrate or a polycarbonate substrate can be used. From the viewpoint of simplification of the manufacturing process, it is preferable to use a substrate on which ITO electrodes for liquid crystal driving have been formed. In addition, in the reflective liquid crystal display element, if only a single-sided substrate is used, an opaque substrate such as a silicon wafer can also be used. As an electrode at this time, a material that reflects light such as aluminum can also be used.

液晶配向處理劑之塗佈方法並無特別限定,工業上一般係以網版印刷、平板印刷、柔版印刷或噴墨法等實施之方法。作為其他塗佈方法,則有浸漬法、輥塗佈法、狹縫塗佈法、旋塗法或噴霧法等,亦可因應目的使用此等。 The coating method of the liquid crystal alignment treatment agent is not particularly limited, and the industry generally adopts screen printing, offset printing, flexographic printing, or inkjet method. As other coating methods, there are a dipping method, a roll coating method, a slit coating method, a spin coating method, or a spray method, etc., and these may be used depending on the purpose.

將液晶配向處理劑塗佈於基板上後,藉由加熱板、熱循環型烤箱或IR(紅外線)型烤箱等之加熱手段,且因應液晶配向處理劑所使用之溶劑,在30~300℃,較佳係在30~250℃之溫度下使溶劑蒸發而能作成液晶配向膜。燒成後之液晶配向膜之厚度若過厚時,在液晶顯示元件之消費電力之面上則變得不利,若過薄時,則有液晶顯示元件之信賴性降低之情況,故已5~300nm為佳,較佳為10~100nm。使液晶水平配向或傾斜配向時,以摩擦或偏光紫 外線照射等,對燒成後之液晶配向膜進行處理。 After the liquid crystal alignment treatment agent is coated on the substrate, by heating means such as a hot plate, a thermal cycle oven or an IR (infrared) type oven, and according to the solvent used by the liquid crystal alignment treatment agent, at 30 to 300°C, Preferably, the solvent is evaporated at a temperature of 30 to 250°C to form a liquid crystal alignment film. If the thickness of the liquid crystal alignment film after firing is too thick, it will be unfavorable on the power consumption surface of the liquid crystal display element. If it is too thin, the reliability of the liquid crystal display element may be reduced, so it is 5~ 300 nm is preferred, preferably 10-100 nm. When aligning the liquid crystal horizontally or obliquely, rub or polarize purple Treatment of the liquid crystal alignment film after firing with external radiation, etc.

本發明之液晶顯示元件係為藉由上述手法取得附有由本發明之液晶配向處理劑所得之液晶配向膜之基板後,使用公知方法製作液晶晶胞而後作成液晶顯示元件者。 The liquid crystal display element of the present invention is obtained by obtaining the substrate with the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention by the above-mentioned method, using a known method to produce a liquid crystal cell, and then forming a liquid crystal display element.

作為液晶晶胞之製作方法,可例示例如,準備在已形成液晶配向膜之一對基板,在單一基板之液晶配向膜上散佈間隔器,使液晶配向膜面朝向內側貼合另一基板,減壓注入液晶而密封之方法;或在已散佈間隔器之液晶配向膜面上滴下液晶後,貼合基板而密封之方法(ODF方式)等。 As a method for manufacturing the liquid crystal cell, for example, a pair of substrates having a liquid crystal alignment film formed thereon, and a spacer is spread on the liquid crystal alignment film of a single substrate, so that the liquid crystal alignment film surface is bonded to the other substrate toward the inside, reducing The method of pressure injection of liquid crystals for sealing; or the method of dropping liquid crystals on the liquid crystal alignment film surface of the dispersed spacers, bonding the substrate and sealing (ODF method), etc.

本發明之液晶配向處理劑係亦理想使用於晶顯示元件,而該液晶顯示元件係在具備電極之一對基板之間具有液晶層而成,並且係經由在前述一對基板之間配置包含因活性能量線及熱之至少一者而進行聚合之聚合性化合物之液晶組成物,對前述電極間施加電壓而使前述聚合性化合物進行聚合之步驟所製造者。在此,活性能量線適宜為紫外線。紫外線之波長為300~400nm,較佳為310~360nm。藉由加熱進行聚合時,加熱溫度為40~120℃,較佳為60~80℃。又,亦可同時進行紫外線與加熱。 The liquid crystal alignment treatment agent of the present invention is also ideally used in a crystal display element, and the liquid crystal display element is formed by having a liquid crystal layer between a pair of substrates provided with electrodes, and is arranged between the pair of substrates A liquid crystal composition of a polymerizable compound polymerized by at least one of an active energy ray and heat is manufactured by applying a voltage between the electrodes to polymerize the polymerizable compound. Here, the active energy rays are suitably ultraviolet rays. The wavelength of ultraviolet rays is 300~400nm, preferably 310~360nm. When the polymerization is performed by heating, the heating temperature is 40 to 120°C, preferably 60 to 80°C. In addition, ultraviolet rays and heating may be performed simultaneously.

上述液晶顯示元件係藉由PSA方式而控制液晶分子之預傾者。PSA方式中,預先在液晶材料中混入少量光聚合性化合物,例如光聚合性單體,組成液晶晶胞後,在對液晶層施加規定電壓之狀態下,對光聚合性化合物照射紫外線等,藉由生成之聚合物而控制液晶分子之預傾。聚合 物生成時之液晶分子之配向狀態在移除電壓後仍會受到記憶,故藉由控制形成於液晶層之電場等,而能調整液晶分子之預傾。又,PSA方式中由於不需要摩擦處理,故適合難以藉由摩擦處理而控制預傾之垂直配向型之液晶層之形成。即,本發明之液晶顯示元件係為藉由上述手法而取得附有由液晶配向處理劑所得之液晶配向膜之基板後,製作液晶晶胞,藉由照射紫外線及加熱之至少一者而使聚合性化合物進行聚合,而能作成控制液晶分子之配向者。 The above liquid crystal display device controls the pretilt of liquid crystal molecules by the PSA method. In the PSA method, a small amount of photopolymerizable compound, such as a photopolymerizable monomer, is mixed in the liquid crystal material in advance to form a liquid crystal cell, and then the photopolymerizable compound is irradiated with ultraviolet rays while applying a predetermined voltage to the liquid crystal layer. The pretilt of liquid crystal molecules is controlled by the resulting polymer. polymerization The alignment state of the liquid crystal molecules at the time of object generation is still remembered after the voltage is removed, so the pretilt of the liquid crystal molecules can be adjusted by controlling the electric field formed in the liquid crystal layer. In addition, since the PSA method does not require rubbing treatment, it is suitable for the formation of a vertical alignment type liquid crystal layer whose pretilt is difficult to control by rubbing treatment. That is, the liquid crystal display element of the present invention is to obtain a substrate with a liquid crystal alignment film obtained by a liquid crystal alignment treatment agent by the above-mentioned method, and then produce a liquid crystal cell, and polymerize by irradiating at least one of ultraviolet rays and heating Sexual compounds polymerize and can be made to control the alignment of liquid crystal molecules.

若舉出PSA方式下之製作液晶晶胞之一例,例如以下所述。即,使用上述製作方法製作液晶晶胞。於此時之液晶中混合因熱或紫外線照射而聚合之聚合性化合物。作為聚合性化合物,可舉出如於分子內具有一個以上丙烯酸酯基或甲基丙烯酸酯基等之聚合性不飽和基之化合物。於此之際,相對於液晶成分100份,聚合性化合物係以0.01~10份為佳,較佳者為0.1~5份。聚合性化合物若未滿0.01份,則聚合性化合物不會聚合而變得無法控制液晶配向,若多於10份時,未反應之聚合性化合物變多,進而導致液晶顯示元件之燒印特性降低。製作液晶晶胞後,對液晶晶胞施加交流或直流之電壓,並同時施加熱或照射紫外線而使聚合性化合物進行聚合。藉此,即能控制液晶分子之配向。 An example of the production of a liquid crystal cell under the PSA method is as follows. That is, the liquid crystal cell is produced using the above production method. The liquid crystal at this time is mixed with a polymerizable compound polymerized by heat or ultraviolet radiation. Examples of the polymerizable compound include compounds having one or more polymerizable unsaturated groups such as acrylate group or methacrylate group in the molecule. At this time, the polymerizable compound is preferably 0.01 to 10 parts relative to 100 parts of the liquid crystal component, preferably 0.1 to 5 parts. If the polymerizable compound is less than 0.01 part, the polymerizable compound will not polymerize and the liquid crystal alignment will not be controlled. If it is more than 10 parts, the unreacted polymerizable compound will increase, which will result in the deterioration of the burn-in characteristics of the liquid crystal display element . After the liquid crystal cell is fabricated, an AC or DC voltage is applied to the liquid crystal cell, and heat or ultraviolet rays are simultaneously applied to polymerize the polymerizable compound. In this way, the alignment of the liquid crystal molecules can be controlled.

更進一步,本發明之液晶配向處理劑係亦能使用於液晶顯示元件,且該液晶顯示元件係在具備電極之一對基板之間具有液晶層而成,並且係經由在前述一對基 板之間配置包含因活性能量線及熱之至少一者而進行聚合之聚合基之液晶配向膜,且對前述電極間施加電壓而使前述聚合性基進行聚合之步驟所製造者,即亦能使用於SC-PVA模式。在此,活性能量線適合為紫外線。紫外線之波長為300~400nm,較佳者為310~360nm。藉由加熱進行聚合時,加熱溫度為40~120℃,較佳為60~80℃。又,亦可同時進行紫外線與加熱。 Furthermore, the liquid crystal alignment treatment agent of the present invention can also be used for a liquid crystal display element, and the liquid crystal display element is formed by having a liquid crystal layer between a pair of substrates having electrodes, A liquid crystal alignment film including a polymer group polymerized by at least one of active energy rays and heat is disposed between the plates, and a voltage is applied between the electrodes to polymerize the polymerizable group, that is, Used in SC-PVA mode. Here, the active energy rays are suitably ultraviolet rays. The wavelength of ultraviolet rays is 300~400nm, preferably 310~360nm. When the polymerization is performed by heating, the heating temperature is 40 to 120°C, preferably 60 to 80°C. In addition, ultraviolet rays and heating may be performed simultaneously.

為了取得包含因活性能量線及熱之至少一者而進行聚合之聚合性基之液晶配向膜,可舉出如將此包含聚合性基之化合物添加於液晶配向處理劑中的方法,或使用包含聚合性基之聚合物成分的方法。 In order to obtain a liquid crystal alignment film containing a polymerizable group polymerized by at least one of active energy rays and heat, a method of adding the compound containing a polymerizable group to a liquid crystal alignment treatment agent, or using Method of polymer component based polymer component.

若舉出製作SC-PVA模式之液晶晶胞之一例,例如以下所述。即,使用上述製作方法製作液晶晶胞。其後,對液晶晶胞施加交流或直流之電壓,並同時施加熱或照射紫外線,即能控制液晶分子之配向。 As an example of producing an SC-PVA mode liquid crystal cell, for example, the following will be described. That is, the liquid crystal cell is produced using the above production method. Thereafter, the voltage of AC or DC is applied to the liquid crystal cell, and heat or ultraviolet radiation is simultaneously applied to control the alignment of the liquid crystal molecules.

[實施例] [Example]

以下例舉實施例更加詳細說明本發明,但本發明並非係受此等所限定而解釋者。以下所使用之略稱係如以下所示。 The following examples illustrate the present invention in more detail, but the present invention is not limited by these and is to be interpreted. The abbreviations used below are shown below.

(特定二胺(1)) (Specific diamine (1))

A1:1,3-二胺基-4-[4-(反-4-n-庚基環己基)苯氧基]苯 A1: 1,3-diamino-4-[4-(trans-4-n-heptylcyclohexyl)phenoxy]benzene

A2:1,3-二胺基-5-[4-(反-4-n-庚基環己基)苯氧基甲 基]苯 A2: 1,3-diamino-5-[4-(trans-4-n-heptylcyclohexyl)phenoxymethyl Benzene

A3:1,3-二胺基-4-{4-[反-4-(反-4-n-戊基環己基)環己基]苯氧基}苯 A3: 1,3-Diamino-4-{4-[trans-4-(trans-4-n-pentylcyclohexyl)cyclohexyl]phenoxy}benzene

A4:下述式[A4]之二胺 A4: Diamine of the following formula [A4]

Figure 104143876-A0202-12-0057-54
Figure 104143876-A0202-12-0057-54

(特定二胺(2)) (Specific diamine (2))

Figure 104143876-A0202-12-0057-55
Figure 104143876-A0202-12-0057-55

(特定二胺(3)) (Specific diamine (3))

Figure 104143876-A0202-12-0057-56
Figure 104143876-A0202-12-0057-56

(其他二胺) (Other diamines)

D1:p-伸苯基二胺、D2:m-伸苯基二胺 D1: p-phenylene diamine, D2: m-phenylene diamine

D3:1,3-二胺基-4-十八基氧基苯 D3: 1,3-diamino-4-octadecyloxybenzene

Figure 104143876-A0202-12-0058-57
Figure 104143876-A0202-12-0058-57

(特定四羧酸二酐) (Specific tetracarboxylic dianhydride)

E1:1,2,3,4-環丁烷四羧酸二酐 E1: 1,2,3,4-cyclobutane tetracarboxylic dianhydride

E2:雙環[3,3,0]辛烷-2,4,6,8-四羧酸二酐 E2: Bicyclo[3,3,0]octane-2,4,6,8-tetracarboxylic dianhydride

E3:下述式[E3]之四羧酸二酐 E3: tetracarboxylic dianhydride of the following formula [E3]

E4:下述式[E4]之四羧酸二酐 E4: tetracarboxylic dianhydride of the following formula [E4]

E5:下述式[E5]之四羧酸二酐 E5: tetracarboxylic dianhydride of the following formula [E5]

Figure 104143876-A0202-12-0058-58
Figure 104143876-A0202-12-0058-58

(交聯性化合物) (Crosslinkable compound)

Figure 104143876-A0202-12-0059-59
Figure 104143876-A0202-12-0059-59

(溶劑) (Solvent)

NMP:N-甲基-2-吡咯啶酮、NEP:N-乙基-2-吡咯啶酮 NMP: N-methyl-2-pyrrolidone, NEP: N-ethyl-2-pyrrolidone

γ-BL:γ-丁內酯、BCS:乙二醇單丁基醚、PB:丙二醇單丁基醚、DME:二丙二醇二甲基醚、DPM:二丙二醇單甲基醚 γ-BL: γ-butyrolactone, BCS: ethylene glycol monobutyl ether, PB: propylene glycol monobutyl ether, DME: dipropylene glycol dimethyl ether, DPM: dipropylene glycol monomethyl ether

「聚醯亞胺系聚合物之分子量測量」 "Molecular weight measurement of polyimide polymer"

使用常溫凝膠滲透層析(GPC)裝置(GPC-101、昭和電工公司製)、管柱(KD-803、KD-805、Shodex公司製),藉由以下操作進行測量。 Using a room temperature gel permeation chromatography (GPC) device (GPC-101, manufactured by Showa Denko Co., Ltd.) and a column (KD-803, KD-805, manufactured by Shodex), the measurement was performed by the following operation.

管柱溫度:50℃ Column temperature: 50℃

溶析液:N,N’-二甲基甲醯胺(作為添加劑,溴化鋰-水合物(LiBr‧H2O)為30mmol/L(公升)、磷酸‧無水結晶(o-磷酸)為30mmol/L、四氫呋喃(THF)為10ml/L) Eluate: N,N'-dimethylformamide (as additive, lithium bromide-hydrate (LiBr‧H 2 O) is 30mmol/L (liter)), phosphoric acid‧ anhydrous crystal (o-phosphoric acid) is 30mmol/ (L, tetrahydrofuran (THF) is 10ml/L)

流速:1.0ml/分 Flow rate: 1.0ml/min

製作檢量線用標準試樣:TSK標準聚環氧乙烷(分子量;約900,000、150,000、100,000及30,000、東曹公司 製)及聚乙二醇(分子量:約12,000、4,000及1,000、聚合物實驗室公司製)。 Standard sample for making calibration line: TSK standard polyethylene oxide (molecular weight; about 900,000, 150,000, 100,000 and 30,000, Tosoh Corporation System) and polyethylene glycol (molecular weight: approximately 12,000, 4,000, and 1,000, manufactured by Polymer Laboratories).

「聚醯亞胺系聚合物之醯亞胺化率之測量」 "Measurement of Amidation Rate of Polyimide-based Polymers"

將聚醯亞胺粉末20mg放入NMR(核磁共振)試樣管(NMR取樣管標準、

Figure 104143876-A0202-12-0060-81
5(草野科學公司製)),添加氘化二甲亞碸(DMSO-d6,0.05%TMS(四甲基矽烷)混合品)(0.53ml),施加超音波使其完全溶解。在NMR測量機(JNW-ECA500、日本電子資料公司製)中,測量此溶液之500MHz之質子NMR。醯亞胺化率係將源自醯亞胺化前後並未變化之構造之質子決定當作基準質子,使用此質子之波峰累算值,與源自出現在9.5ppm~10.0ppm附近之醯胺酸之NH基之質子波峰累算值,藉由以下之式而求得者。 Put 20 mg of polyimide powder in the NMR (nuclear magnetic resonance) sample tube (NMR sampling tube standard,
Figure 104143876-A0202-12-0060-81
5 (manufactured by Kusano Science Corporation)), deuterated dimethyl sulfoxide (DMSO-d6, 0.05% TMS (tetramethylsilane) mixed product) (0.53 ml) was added, and ultrasonic waves were applied to completely dissolve it. In a NMR measuring machine (JNW-ECA500, manufactured by Nippon Electronics Data Corporation), the 500 MHz proton NMR of this solution was measured. The rate of amide imidization is based on the determination of protons derived from the structure that has not changed before and after amide imidization as the reference protons, and the cumulative value of the peak of this proton is used, which is derived from the amides appearing in the vicinity of 9.5 ppm to 10.0 ppm. The cumulative value of the proton peak of the NH group of the acid is obtained by the following formula.

醯亞胺化率(%)=(1-α‧x/y)×100(x源自醯胺酸之NH基之質子波峰累算值、y為基準質子之波峰累算值、α為聚醯胺酸(醯亞胺化率為0%)之情況中基準質子對醯胺酸之NH基質子1個之個數比例)。 Acetylimidization rate (%) = (1-α‧x/y) × 100 (x is the cumulative value of the proton peak derived from the NH group of amide acid, y is the cumulative value of the peak of the reference proton, and α is the poly In the case of amide acid (acid imidization rate is 0%), the ratio of the reference proton to the number of NH matrix protons of amide acid is one).

「聚醯亞胺系聚合物之合成」 "Synthesis of Polyimide Polymers"

<合成例1> <Synthesis Example 1>

在NMP(16.8g)中混合E2(2.17g、8.67mmol)、A1(2.67g、7.02mmol)、B1(1.28g、5.28mmol)及D1(0.57g、5.27mmol),在80℃下反應5小時後,添加E1(1.70g、 8.67mmol)及NMP(8.39g),在40℃下反應6小時,而取得濃度(表示樹脂固形分濃度。以下之例皆為相同)為25%之聚醯胺酸溶液。 Mix E2 (2.17g, 8.67mmol), A1 (2.67g, 7.02mmol), B1 (1.28g, 5.28mmol) and D1 (0.57g, 5.27mmol) in NMP (16.8g), and react at 80°C for 5 After hours, add E1 (1.70g, 8.67mmol) and NMP (8.39g) were reacted at 40°C for 6 hours, and the concentration (representing the resin solid content concentration. The following examples are all the same) was 25% polyamic acid solution.

對取得之聚醯胺酸溶液(30.0g)添加NMP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸媒,在80℃下反應4小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物,在100℃下減壓乾燥而取得聚醯亞胺粉末(1)。此聚醯亞胺之醯亞胺化率為80%,數平均分子量(Mn)為17,400,重量平均分子量(Mw)為47,500。 After adding NMP to the obtained polyamic acid solution (30.0 g) and diluting it to 6%, anhydrous acetic acid (4.50 g) and pyridine (3.30 g) were added as an amide imidization catalyst, and the reaction was carried out at 80° C. for 4 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 100°C to obtain polyimide powder (1). The polyimide had an imidization rate of 80%, a number average molecular weight (Mn) of 17,400, and a weight average molecular weight (Mw) of 47,500.

<合成例2> <Synthesis Example 2>

在NMP(16.8g)中混合E2(0.89g、3.56mmol)、A3(2.35g、5.43mmol)、B1(1.75g、7.22mmol)及D1(0.59g、5.46mmol),在80℃下反應5小時後,添加E1(2.80g、14.3mmol)及NMP(8.38g),在40℃下反應6小時而取得濃度為25%之聚醯胺酸溶液。 Mix E2 (0.89g, 3.56mmol), A3 (2.35g, 5.43mmol), B1 (1.75g, 7.22mmol) and D1 (0.59g, 5.46mmol) in NMP (16.8g), and react at 80°C for 5 After 1 hour, E1 (2.80 g, 14.3 mmol) and NMP (8.38 g) were added and reacted at 40° C. for 6 hours to obtain a 25%-concentrated polyamic acid solution.

對取得之聚醯胺酸溶液(30.0g)添加NMP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸媒,在80℃下反應3.5小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物,在100℃下減壓乾燥而取得聚醯亞胺粉末(2)。此聚醯亞胺之醯亞胺化率為75%,Mn為16,100,Mw為44,400。 After adding NMP to the obtained polyamic acid solution (30.0 g) and diluting it to 6%, anhydrous acetic acid (4.50 g) and pyridine (3.30 g) were added as an amide imidization catalyst, and the reaction was carried out at 80° C. for 3.5 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 100°C to obtain polyimide powder (2). The polyimide has an imidization rate of 75%, Mn of 16,100, and Mw of 44,400.

<合成例3> <Synthesis Example 3>

在NEP(16.4g)中混合E2(3.06g、12.2mmol)、A2(2.61g、6.61mmol)、B1(1.20g、4.95mmol)及D1(0.54g、4.99mmol),在80℃下反應5小時後,添加E1(0.80g、4.08mmol)及NEP(8.21g),在40℃下反應6小時而取得濃度為25%之聚醯胺酸溶液。 E2 (3.06g, 12.2mmol), A2 (2.61g, 6.61mmol), B1 (1.20g, 4.95mmol) and D1 (0.54g, 4.99mmol) were mixed in NEP (16.4g), and reacted at 80°C for 5 After 1 hour, E1 (0.80 g, 4.08 mmol) and NEP (8.21 g) were added and reacted at 40° C. for 6 hours to obtain a polyamic acid solution with a concentration of 25%.

對取得之聚醯胺酸溶液(30.0g)添加NEP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸媒,在80℃下反應3小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物,在100℃下減壓乾燥而取得聚醯亞胺粉末(3)。此聚醯亞胺之醯亞胺化率為70%,Mn為17,800,Mw為47,600。 After adding NEP to the obtained polyamic acid solution (30.0 g) and diluting it to 6%, anhydrous acetic acid (4.50 g) and pyridine (3.30 g) were added as an amide imidization catalyst, and the reaction was carried out at 80° C. for 3 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 100°C to obtain polyimide powder (3). The polyimide has an imidization rate of 70%, Mn of 17,800, and Mw of 47,600.

<合成例4> <Synthesis Example 4>

在NMP(17.0g)中混合E2(2.17g、8.67mmol)、A4(2.16g、4.38mmol)、B1(1.91g、7.88mmol)及D1(0.57g、5.27mmol),在80℃下反應5小時後,添加E1(1.70g、8.67mmol)及NMP(8.52g),在40℃下反應6小時而取得濃度為25%之聚醯胺酸溶液。 Mix N2 (17.0g) with E2 (2.17g, 8.67mmol), A4 (2.16g, 4.38mmol), B1 (1.91g, 7.88mmol) and D1 (0.57g, 5.27mmol), and react at 80°C for 5 After 1 hour, E1 (1.70 g, 8.67 mmol) and NMP (8.52 g) were added and reacted at 40° C. for 6 hours to obtain a polyamic acid solution with a concentration of 25%.

對取得之聚醯胺酸溶液(30.0g)添加NMP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸媒,在80℃下反應2.5小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物,在100℃下減壓乾燥而取得聚醯亞胺粉末(4)。此聚醯亞胺 之醯亞胺化率為65%,Mn為15,300,Mw為42,100。 After adding NMP to the obtained polyamic acid solution (30.0 g) and diluting it to 6%, anhydrous acetic acid (4.50 g) and pyridine (3.30 g) were added as an amide imidization catalyst, and the reaction was carried out at 80° C. for 2.5 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 100°C to obtain polyimide powder (4). Polyimide The imidate ratio was 65%, Mn was 15,300, and Mw was 42,100.

<合成例5> <Synthesis Example 5>

在NEP(24.2g)中混合E3(3.80g、17.0mmol)、A2(2.03g、5.14mmol)、B1(1.66g、6.85mmol)及D2(0.56g、5.18mmol),在40℃下反應8小時而取得濃度為25%之聚醯胺酸溶液。 Mix E3 (3.80g, 17.0mmol), A2 (2.03g, 5.14mmol), B1 (1.66g, 6.85mmol) and D2 (0.56g, 5.18mmol) in NEP (24.2g), and react at 40°C for 8 Hours to obtain a 25% concentration of polyamic acid solution.

對取得之聚醯胺酸溶液(30.0g)添加NEP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸媒,在80℃下反應3小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物,在100℃下減壓乾燥而取得聚醯亞胺粉末(5)。此聚醯亞胺之醯亞胺化率為70%,Mn為18,600,Mw為48,800。 After adding NEP to the obtained polyamic acid solution (30.0 g) and diluting it to 6%, anhydrous acetic acid (4.50 g) and pyridine (3.30 g) were added as an amide imidization catalyst, and the reaction was carried out at 80° C. for 3 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 100°C to obtain polyimide powder (5). The polyimide has an imidization rate of 70%, Mn of 18,600, and Mw of 48,800.

<合成例6> <Synthesis Example 6>

在NMP(17.3g)中混合E4(2.60g、8.66mmol)、A2(2.08g、5.27mmol)、B1(1.70g、7.02mmol)及D1(0.57g、5.27mmol),在80℃下反應5小時後,添加E1(1.70g、8.67mmol)及NMP(8.65g),在40℃下反應6小時而取得濃度為25%之聚醯胺酸溶液。 E4 (2.60g, 8.66mmol), A2 (2.08g, 5.27mmol), B1 (1.70g, 7.02mmol) and D1 (0.57g, 5.27mmol) were mixed in NMP (17.3g), and reacted at 80°C for 5 After 1 hour, E1 (1.70 g, 8.67 mmol) and NMP (8.65 g) were added and reacted at 40° C. for 6 hours to obtain a 25%-concentrated polyamic acid solution.

對取得之聚醯胺酸溶液(30.0g)添加NMP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸媒,在80℃下反應4小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物, 在100℃下減壓乾燥而取得聚醯亞胺粉末(6)。此聚醯亞胺之醯亞胺化率為80%,Mn為16,300,Mw為45,400。 After adding NMP to the obtained polyamic acid solution (30.0 g) and diluting it to 6%, anhydrous acetic acid (4.50 g) and pyridine (3.30 g) were added as an amide imidization catalyst, and the reaction was carried out at 80° C. for 4 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. Wash this precipitate with methanol, It was dried under reduced pressure at 100°C to obtain polyimide powder (6). The polyimide has an imidization rate of 80%, Mn of 16,300, and Mw of 45,400.

<合成例7> <Synthesis Example 7>

在NMP(16.7g)中混合E2(0.89g、3.56mmol)、A1(2.75g、7.23mmol)、B1(1.31g、5.41mmol)及D2(0.59g、5.46mmol),在80℃下反應5小時後,添加E1(2.80g、14.3mmol)及NMP(8.35g),在40℃下反應6小時而取得濃度為25%之聚醯胺酸溶液。 Mix N2 (16.7g) with E2 (0.89g, 3.56mmol), A1 (2.75g, 7.23mmol), B1 (1.31g, 5.41mmol) and D2 (0.59g, 5.46mmol), and react at 80°C for 5 After 1 hour, E1 (2.80 g, 14.3 mmol) and NMP (8.35 g) were added and reacted at 40° C. for 6 hours to obtain a polyamic acid solution with a concentration of 25%.

對取得之聚醯胺酸溶液(30.0g)添加NMP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸媒,在80℃下反應3小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物,在100℃下減壓乾燥而取得聚醯亞胺粉末(7)。此聚醯亞胺之醯亞胺化率為70%,Mn為17,100,Mw為45,900。 After adding NMP to the obtained polyamic acid solution (30.0 g) and diluting it to 6%, anhydrous acetic acid (4.50 g) and pyridine (3.30 g) were added as an amide imidization catalyst, and the reaction was carried out at 80° C. for 3 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 100°C to obtain polyimide powder (7). The polyimide has an imidization rate of 70%, Mn of 17,100, and Mw of 45,900.

<合成例8> <Synthesis Example 8>

在NEP(16.6g)中混合E2(3.06g、12.2mmol)、A1(3.15g、8.28mmol)、B2(0.64g、2.47mmol)及D2(0.63g、5.83mmol),在80℃下反應5小時後,添加E1(0.80g、4.08mmol)及NEP(8.28g),在40℃下反應6小時而取得濃度為25%之聚醯胺酸溶液。 Mix E2 (3.06g, 12.2mmol), A1 (3.15g, 8.28mmol), B2 (0.64g, 2.47mmol) and D2 (0.63g, 5.83mmol) in NEP (16.6g), and react at 80°C for 5 After 1 hour, E1 (0.80 g, 4.08 mmol) and NEP (8.28 g) were added and reacted at 40° C. for 6 hours to obtain a 25%-concentrated polyamic acid solution.

對取得之聚醯胺酸溶液(30.0g)添加NEP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸 媒,在80℃下反應3小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物,在100℃下減壓乾燥而取得聚醯亞胺粉末(8)。此聚醯亞胺之醯亞胺化率為70%,Mn為15,800,Mw為42,100。 After adding NEP to the obtained polyamic acid solution (30.0g) and diluting it to 6%, anhydrous acetic acid (4.50g) and pyridine (3.30g) were added as the amide imidization contact The medium was reacted at 80°C for 3 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 100°C to obtain polyimide powder (8). The polyimide has an imidization rate of 70%, Mn of 15,800, and Mw of 42,100.

<合成例9> <Synthesis Example 9>

在NMP(16.2g)中混合E2(0.89g、3.56mmol)、B1(1.75g、7.22mmol)、D1(0.59g、5.46mmol)及D3(2.04g、5.42mmol),在80℃下反應5小時後,添加E1(2.80g、14.3mmol)及NMP(8.28g),在40℃下反應6小時而取得濃度為25%之聚醯胺酸溶液。 Mix E2 (0.89g, 3.56mmol), B1 (1.75g, 7.22mmol), D1 (0.59g, 5.46mmol) and D3 (2.04g, 5.42mmol) in NMP (16.2g), and react at 80°C for 5 After 1 hour, E1 (2.80 g, 14.3 mmol) and NMP (8.28 g) were added and reacted at 40° C. for 6 hours to obtain a polyamic acid solution having a concentration of 25%.

對取得之聚醯胺酸溶液(30.0g)添加NMP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸媒,在80℃下反應3.5小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物,在100℃下減壓乾燥而取得聚醯亞胺粉末(9)。此聚醯亞胺之醯亞胺化率為75%,Mn為16,500,Mw為43,300。 After adding NMP to the obtained polyamic acid solution (30.0 g) and diluting it to 6%, anhydrous acetic acid (4.50 g) and pyridine (3.30 g) were added as an amide imidization catalyst, and the reaction was carried out at 80° C. for 3.5 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 100°C to obtain polyimide powder (9). The polyimide has an imidization rate of 75%, Mn of 16,500, and Mw of 43,300.

<合成例10> <Synthesis Example 10>

在NMP(17.2g)中混合E2(0.89g、3.56mmol)、A1(1.38g、3.63mmol)及B1(3.50g、14.4mmol),在80℃下反應5小時後,添加E1(2.80g、14.3mmol)及NMP(8.57g),在40℃下反應6小時而取得濃度為25%之聚醯胺酸溶液。 E2 (0.89g, 3.56mmol), A1 (1.38g, 3.63mmol) and B1 (3.50g, 14.4mmol) were mixed with NMP (17.2g), and after reacting at 80°C for 5 hours, E1 (2.80g, 14.3mmol) and NMP (8.57g) were reacted at 40°C for 6 hours to obtain a polyamic acid solution with a concentration of 25%.

對取得之聚醯胺酸溶液(30.0g)添加NMP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸媒,在80℃下反應5小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物,在100℃下減壓乾燥而取得聚醯亞胺粉末(10)。此聚醯亞胺之醯亞胺化率為90%,Mn為17,800,Mw為46,900。 After adding NMP to the obtained polyamic acid solution (30.0 g) and diluting it to 6%, anhydrous acetic acid (4.50 g) and pyridine (3.30 g) were added as an amide imidization catalyst, and the reaction was carried out at 80° C. for 5 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 100°C to obtain polyimide powder (10). The polyimide had an imidization rate of 90%, Mn of 17,800, and Mw of 46,900.

<合成例11> <Synthesis Example 11>

在NMP(16.3g)中混合E2(0.96g、3.84mmol)、A1(1.47g、3.86mmol)、B1(1.88g、7.76mmol)及D1(0.84g、7.77mmol),在80℃下反應5小時後,添加E1(3.00g、15.3mmol)及NMP(8.15g),在40℃下反應6小時而取得濃度為25%之聚醯胺酸溶液。 Mix E2 (0.96g, 3.84mmol), A1 (1.47g, 3.86mmol), B1 (1.88g, 7.76mmol) and D1 (0.84g, 7.77mmol) in NMP (16.3g), and react at 80°C for 5 After 1 hour, E1 (3.00 g, 15.3 mmol) and NMP (8.15 g) were added and reacted at 40° C. for 6 hours to obtain a polyamic acid solution with a concentration of 25%.

對取得之聚醯胺酸溶液(30.0g)添加NMP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸媒,在80℃下反應3.5小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物,在100℃下減壓乾燥而取得聚醯亞胺粉末(11)。此聚醯亞胺之醯亞胺化率為75%,Mn為18,600,Mw為48,300。 After adding NMP to the obtained polyamic acid solution (30.0 g) and diluting it to 6%, anhydrous acetic acid (4.50 g) and pyridine (3.30 g) were added as an amide imidization catalyst, and the reaction was carried out at 80° C. for 3.5 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 100°C to obtain polyimide powder (11). The polyimide has an imidization rate of 75%, Mn of 18,600, and Mw of 48,300.

<合成例12> <Synthesis Example 12>

在NMP(16.7g)中混合E2(2.30g、9.19mmol)、B1(4.05g、16.7mmol)及D2(0.20g、1.85mmol),在80℃下反應5小時後,添加E1(1.80g、9.18mmol)及NMP(8.35g), 在40℃下反應6小時而取得濃度為25%之聚醯胺酸溶液。 E2 (2.30 g, 9.19 mmol), B1 (4.05 g, 16.7 mmol) and D2 (0.20 g, 1.85 mmol) were mixed with NMP (16.7 g), and after reacting at 80°C for 5 hours, E1 (1.80 g, 9.18mmol) and NMP (8.35g), The reaction was carried out at 40°C for 6 hours to obtain a solution of polyamide with a concentration of 25%.

對取得之聚醯胺酸溶液(30.0g)添加NMP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸媒,在80℃下反應2.5小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物,在100℃下減壓乾燥而取得聚醯亞胺粉末(12)。此聚醯亞胺之醯亞胺化率為65%,Mn為22,100,Mw為53,400。 After adding NMP to the obtained polyamic acid solution (30.0 g) and diluting it to 6%, anhydrous acetic acid (4.50 g) and pyridine (3.30 g) were added as an amide imidization catalyst, and the reaction was carried out at 80° C. for 2.5 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. This precipitate was washed with methanol and dried under reduced pressure at 100°C to obtain polyimide powder (12). The polyimide has an imidization rate of 65%, Mn of 22,100, and Mw of 53,400.

<合成例13> <Synthesis Example 13>

在NMP(17.1g)中混合E2(2.55g、10.2mmol)、A1(1.57g、4.13mmol)、B1(1.07g、4.13mmol)及D2(1.34g、12.4mmol),在80℃下反應5小時後,添加E1(2.00g、10.2mmol)及NMP(8.54g),在40℃下反應6小時而取得濃度為25%之聚醯胺酸溶液。 Mix N2 (17.1g) with E2 (2.55g, 10.2mmol), A1 (1.57g, 4.13mmol), B1 (1.07g, 4.13mmol) and D2 (1.34g, 12.4mmol), and react at 80°C for 5 After 1 hour, E1 (2.00 g, 10.2 mmol) and NMP (8.54 g) were added and reacted at 40° C. for 6 hours to obtain a 25%-concentrated polyamic acid solution.

對取得之聚醯胺酸溶液(30.0g)添加NMP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸媒,在80℃下反應3.5小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物,在100℃下減壓乾燥而取得聚醯亞胺粉末(13)。此聚醯亞胺之醯亞胺化率為75%,Mn為17,900,Mw為46,500。 After adding NMP to the obtained polyamic acid solution (30.0 g) and diluting it to 6%, anhydrous acetic acid (4.50 g) and pyridine (3.30 g) were added as an amide imidization catalyst, and the reaction was carried out at 80° C. for 3.5 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 100°C to obtain polyimide powder (13). The polyimide had an imidization rate of 75%, Mn of 17,900, and Mw of 46,500.

<合成例14> <Synthesis Example 14>

在NMP(16.9g)中混合E2(2.81g、11.2mmol)及C1 (3.46g、22.7mmol),在80℃下反應5小時後,添加E1(2.20g、11.2mmol)及NMP(8.46g),在40℃下反應6小時而取得濃度為25%之聚醯胺酸溶液。 Mix E2 (2.81g, 11.2mmol) and C1 in NMP (16.9g) (3.46g, 22.7mmol), after reacting at 80°C for 5 hours, E1 (2.20g, 11.2mmol) and NMP (8.46g) were added and reacted at 40°C for 6 hours to obtain a 25% concentration of polyamide Acid solution.

對取得之聚醯胺酸溶液(30.0g)添加NMP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸媒,在80℃下反應3.5小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物,在100℃下減壓乾燥而取得聚醯亞胺粉末(14)。此聚醯亞胺之醯亞胺化率為75%,Mn為21,800,Mw為52,100。 After adding NMP to the obtained polyamic acid solution (30.0 g) and diluting it to 6%, anhydrous acetic acid (4.50 g) and pyridine (3.30 g) were added as an amide imidization catalyst, and the reaction was carried out at 80° C. for 3.5 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 100°C to obtain polyimide powder (14). The polyimide has an imidization rate of 75%, Mn of 21,800, and Mw of 52,100.

<合成例15> <Synthesis Example 15>

在NMP(16.6g)中混合E2(2.81g、11.2mmol)、C1(2.94g、19.3mmol)及D2(0.37g、3.42mmol),在80℃下反應5小時後,添加E1(2.20g、11.2mmol)及NMP(8.31g),在40℃下反應6小時而取得濃度為25%之聚醯胺酸溶液。 E2 (2.81g, 11.2mmol), C1 (2.94g, 19.3mmol) and D2 (0.37g, 3.42mmol) were mixed in NMP (16.6g), and after reacting at 80°C for 5 hours, E1 (2.20g, 11.2mmol) and NMP (8.31g) were reacted at 40°C for 6 hours to obtain a polyamic acid solution with a concentration of 25%.

對取得之聚醯胺酸溶液(30.0g)添加NMP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸媒,在80℃下反應3小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物,在100℃下減壓乾燥而取得聚醯亞胺粉末(15)。此聚醯亞胺之醯亞胺化率為70%,Mn為23,200,Mw為54,200。 After adding NMP to the obtained polyamic acid solution (30.0 g) and diluting it to 6%, anhydrous acetic acid (4.50 g) and pyridine (3.30 g) were added as an amide imidization catalyst, and the reaction was carried out at 80° C. for 3 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 100°C to obtain polyimide powder (15). The polyimide has an imidization rate of 70%, Mn of 23,200, and Mw of 54,200.

<合成例16> <Synthesis Example 16>

在NEP(16.4g)中混合E5(2.30g、10.8mmol)、C1(2.84g、18.7mmol)及D2(0.36g、3.33mmol),在80℃下反應5小時後,添加E1(2.30g、10.8mmol)及NEP(8.21g),在40℃下反應6小時而取得濃度為25%之聚醯胺酸溶液。 E5 (2.30g, 10.8mmol), C1 (2.84g, 18.7mmol) and D2 (0.36g, 3.33mmol) were mixed with NEP (16.4g), and after reacting at 80°C for 5 hours, E1 (2.30g, 10.8 mmol) and NEP (8.21g) were reacted at 40°C for 6 hours to obtain a polyamic acid solution with a concentration of 25%.

對取得之聚醯胺酸溶液(30.0g)添加NEP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸媒,在80℃下反應3小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物,在100℃下減壓乾燥而取得聚醯亞胺粉末(16)。此聚醯亞胺之醯亞胺化率為70%,Mn為20,500,Mw為51,800。 After adding NEP to the obtained polyamic acid solution (30.0 g) and diluting it to 6%, anhydrous acetic acid (4.50 g) and pyridine (3.30 g) were added as an amide imidization catalyst, and the reaction was carried out at 80° C. for 3 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 100°C to obtain polyimide powder (16). The polyimide had an imidization rate of 70%, Mn of 20,500, and Mw of 51,800.

<合成例17> <Synthesis Example 17>

在NMP(17.2g)中混合E2(2.17g、8.67mmol)、A1(2.67g、7.02mmol)、B1(1.28g、5.28mmol)及C1(0.80g、5.26mmol),在80℃下反應5小時後,添加E1(1.70g、8.67mmol)及NMP(8.62g),在40℃下反應6小時而取得濃度為25%之聚醯胺酸溶液。 Mix E2 (2.17g, 8.67mmol), A1 (2.67g, 7.02mmol), B1 (1.28g, 5.28mmol) and C1 (0.80g, 5.26mmol) in NMP (17.2g), and react at 80°C for 5 After 1 hour, E1 (1.70 g, 8.67 mmol) and NMP (8.62 g) were added and reacted at 40° C. for 6 hours to obtain a polyamic acid solution with a concentration of 25%.

對取得之聚醯胺酸溶液(30.0g)添加NMP而稀釋成6%後,添加無水乙酸(4.50g)及吡啶(3.30g)作為醯亞胺化觸媒,在80℃下反應4小時。將此反應溶液投入甲醇(460ml)中,過濾分離取得之沉澱物。以甲醇洗淨此沉澱物,在100℃下減壓乾燥而取得聚醯亞胺粉末(17)。此聚醯亞胺之醯亞胺化率為80%,Mn為16,300,Mw為46,300。 After adding NMP to the obtained polyamic acid solution (30.0 g) and diluting it to 6%, anhydrous acetic acid (4.50 g) and pyridine (3.30 g) were added as an amide imidization catalyst, and the reaction was carried out at 80° C. for 4 hours. This reaction solution was poured into methanol (460 ml), and the obtained precipitate was separated by filtration. This precipitate was washed with methanol and dried under reduced pressure at 100°C to obtain polyimide powder (17). The polyimide has an imidization rate of 80%, Mn of 16,300, and Mw of 46,300.

各合成例中取得之聚醯亞胺系聚合物之詳細內容整理展示於表32、表33。 The details of the polyimide-based polymers obtained in each synthesis example are shown in Table 32 and Table 33.

Figure 104143876-A0202-12-0070-61
Figure 104143876-A0202-12-0070-61

Figure 104143876-A0202-12-0071-62
Figure 104143876-A0202-12-0071-62

「液晶配向處理劑之噴墨塗佈性之評價」 "Evaluation of Inkjet Coating Property of Liquid Crystal Alignment Treatment Agent"

使用後術實施例3及實施例8中取得之液晶配向處理劑,進行評價噴墨塗佈性。具體而言,使用細孔徑1μm之膜濾器加壓過濾此等液晶配向處理劑,於已受到純水及IPA(異丙基醇)洗淨之附ITO(氧化銦錫)電極基板(長100mm×寬100mm、厚度0.7mm)之ITO面上,在塗佈面積70×70mm、噴嘴間距0.423mm、掃描間距0.5mm、塗佈速度40mm/秒之條件下進行塗佈。此時,噴墨塗佈機係使用HIS-200(日立工業設備科技公司製)。又,由塗佈 至暫時乾燥為止之時間為60秒,暫時乾燥係在加熱板上在70℃且5分鐘之條件下進行。 The liquid crystal alignment treatment agents obtained in the post-operative Example 3 and Example 8 were used to evaluate inkjet coatability. Specifically, these liquid crystal alignment treatment agents are pressure-filtered using a membrane filter with a pore size of 1 μm, and the ITO (indium tin oxide) electrode substrate (length 100 mm×) that has been washed with pure water and IPA (isopropyl alcohol). 100 mm wide and 0.7 mm thick), the coating area was 70×70 mm, nozzle pitch 0.423 mm, scanning pitch 0.5 mm, and coating speed 40 mm/sec. In this case, HIS-200 (manufactured by Hitachi Industrial Equipment Technology Co., Ltd.) was used as the inkjet coater. Again, by coating The time until the temporary drying was 60 seconds. The temporary drying was performed on a hot plate at 70°C for 5 minutes.

塗佈性之評價係藉由目視觀察上述取得之附液晶配向膜之基板之塗膜面所實施者。具體而言,在鈉燈下目視觀察塗膜面,確認有無針孔。其結果係任意實施例中取得之液晶配向膜之塗膜面上皆未發現針孔,即取得塗膜性優異之液晶配向膜。 The evaluation of the coatability was carried out by visually observing the coating film surface of the substrate with a liquid crystal alignment film obtained above. Specifically, the coating film surface was visually observed under a sodium lamp to confirm the presence or absence of pinholes. As a result, no pinholes were found on the coating film surface of the liquid crystal alignment film obtained in any of the examples, that is, a liquid crystal alignment film having excellent coating properties was obtained.

「液晶晶胞之製作及預傾角之評價(通常晶胞)」 "Preparation of liquid crystal cell and evaluation of pretilt angle (normal cell)"

使用後述實施例及比較例中取得之液晶配向處理劑,進行製作液晶晶胞及評價預傾角。具體而言,使用細孔徑1μm之膜濾器加壓過濾此等液晶配向處理劑,旋轉塗佈於受到純水及IPA洗淨之附ITO電極基板(長40mm×寬30mm、厚度0.7mm)之ITO面上,在加熱板上以100℃加熱處理5分鐘,在熱循環型無塵烤箱中以230℃加熱處理30分鐘,而得到附有膜厚100nm之液晶配向膜之ITO基板。尚且,實施例3及實施例8之液晶配向處理劑係與上述「液晶配向處理劑之噴墨塗佈性之評價」相同之條件下製作基板,其後在熱循環型無塵烤箱中以230℃加熱處理30分鐘,而作成附有膜厚100nm之液晶配向膜之ITO基板。 Using the liquid crystal alignment treatment agents obtained in Examples and Comparative Examples described later, the preparation of liquid crystal cells and evaluation of the pretilt angle were performed. Specifically, these liquid crystal alignment treatment agents are pressure-filtered using a membrane filter with a pore size of 1 μm, and spin-coated on ITO electrode substrates (length 40 mm × width 30 mm, thickness 0.7 mm) washed with pure water and IPA On the surface, it was heat-treated at 100°C for 5 minutes on a hot plate, and heat-treated at 230°C for 30 minutes in a heat-circulating dust-free oven to obtain an ITO substrate with a liquid crystal alignment film having a film thickness of 100 nm. Furthermore, the liquid crystal alignment treatment agent of Example 3 and Example 8 was produced under the same conditions as the above "evaluation of the inkjet coatability of the liquid crystal alignment treatment agent", and then was subjected to 230 Heat treatment at ℃ for 30 minutes to prepare an ITO substrate with a liquid crystal alignment film with a film thickness of 100 nm.

其次,以輥徑120mm之摩擦裝置,使用嫘縈布,在輥旋轉數為1000rpm、輥進行速度為50mm/sec、押入量為0.1mm之條件下,對此基板之塗膜面進行摩擦處 理。 Next, using a rubbing device with a roller diameter of 120 mm, using a rayon cloth, the coating surface of the substrate was rubbed at a roller rotation speed of 1000 rpm, a roller speed of 50 mm/sec, and a plunging amount of 0.1 mm. Management.

其後,準備2枚摩擦處理後之基板,使塗膜面朝向內側,夾住6μm之間隔器並組合,使用密封劑接著周圍而製成空晶胞。藉由減壓注入法對此空晶胞注入MLC-6608(日本默克製),密封注入口而取得液晶晶胞。 After that, two substrates after the rubbing treatment were prepared, with the coating film surface facing inward, a 6 μm spacer was sandwiched and combined, and the surrounding was sealed with a sealant to form an empty cell. MLC-6608 (manufactured by Merck) was injected into this empty cell by a reduced pressure injection method, and the injection port was sealed to obtain a liquid crystal cell.

使用取得之液晶晶胞,進行測量預傾角。具體而言,使用施加液晶之均向處理(95℃下加熱處理5分鐘)後之液晶晶胞、及將此加熱處理(120℃下加熱處理5小時)後之液晶晶胞進行測量。 Use the obtained liquid crystal cell to measure the pretilt angle. Specifically, the liquid crystal cell after the liquid crystal cell was subjected to a homogenous treatment (heat treatment at 95°C for 5 minutes) and this heat treatment (heat treatment at 120°C for 5 hours) were used for measurement.

更進一步,亦測量對在與上述相同條件下製成之液晶晶胞進行均向處理,其後照射365nm換算下為10J/cm2之紫外線後之液晶晶胞。尚且,預傾角係使用PAS-301(ELSICON製)在室溫下進行測量。並且,紫外線之照射係使用桌上型UV硬化裝置(HCT3B28HEX-1)(Senlight製)所實施者。 Furthermore, the liquid crystal cell produced by subjecting the liquid crystal cell produced under the same conditions as above to the isotropic treatment and then irradiated with ultraviolet rays of 10 J/cm 2 in terms of 365 nm was also measured. In addition, the pretilt angle system was measured at room temperature using PAS-301 (manufactured by ELSICON). In addition, ultraviolet irradiation is implemented using a desktop UV curing device (HCT3B28HEX-1) (manufactured by Senlight).

評價係將相對於液晶之均向處理後(亦稱為初期)之預傾角,加熱處理後(亦稱為高溫處理後)及照射紫外線後(亦稱為紫外線照射後)之預傾角之變化越小者,當作本評價越為優異者。表37~表39中展示各預傾角之值。 The evaluation is based on the change of the pretilt angle with respect to the liquid crystal after the normal treatment (also called the initial stage), after the heat treatment (also called the high temperature treatment) and after the ultraviolet irradiation (also called the ultraviolet irradiation) The smaller one is regarded as the better the evaluation. Table 37 to Table 39 show the values of each pretilt angle.

「ODF方式下產生之液晶配向不均之評價」 "Evaluation of uneven alignment of liquid crystals generated under the ODF method"

使用後述實施例及比較例中取得之液晶配向處理劑,進行評價在ODF方式下產發之液晶配向不均。具體而言,使用細孔徑1μm之膜濾器加壓過濾此等液晶配向處 理劑,旋轉塗佈於受到純水及IPA洗淨之附ITO電極基板(長100mm×寬100mm、厚度0.7mm)之ITO面上,在加熱板上以100℃加熱處理5分鐘,在熱循環型無塵烤箱中以230℃加熱處理30分鐘,而得到附有膜厚100nm之液晶配向膜之ITO基板。尚且,實施例3及實施例8之液晶配向處理劑係與上述「液晶配向處理劑之噴墨塗佈性之評價」相同之條件下製作基板,其後在熱循環型無塵烤箱中以230℃加熱處理30分鐘,而作成附有膜厚100nm之液晶配向膜之ITO基板。 Using the liquid crystal alignment treatment agents obtained in the Examples and Comparative Examples described later, the liquid crystal alignment unevenness produced by the ODF method was evaluated. Specifically, a membrane filter with a pore size of 1 μm is used to pressure-filter these liquid crystal alignments The physic agent is spin-coated on the ITO surface of the ITO electrode substrate (100mm long x 100mm wide and 0.7mm thick) washed with pure water and IPA, heat-treated on a hot plate at 100°C for 5 minutes, and thermally cycled In a dust-free oven at 230°C for 30 minutes, an ITO substrate with a liquid crystal alignment film with a film thickness of 100 nm was obtained. Furthermore, the liquid crystal alignment treatment agent of Example 3 and Example 8 was produced under the same conditions as the above "evaluation of the inkjet coatability of the liquid crystal alignment treatment agent", and then was subjected to 230 Heat treatment at ℃ for 30 minutes to prepare an ITO substrate with a liquid crystal alignment film with a film thickness of 100 nm.

其次,以輥徑120mm之摩擦裝置,使用嫘縈布,在輥旋轉數為1000rpm、輥進行速度為50mm/sec、押入量為0.1mm之條件下,對此基板之塗膜面進行摩擦處理。 Next, using a rubbing device with a roller diameter of 120 mm, using a rayon cloth, the coating film surface of this substrate was subjected to a rubbing treatment under the conditions of a roller rotation speed of 1000 rpm, a roller speed of 50 mm/sec, and a plunging amount of 0.1 mm.

其後,準備已受到上述摩擦處理之基板予未受到處理之基板2枚,且在未處理之基板之塗膜面上散布6μm之間隔器。其後,對此基板周圍描繪紫外線硬化型之密封劑,使用ODF法,將向列液晶(MLC-6608、日本默克公司製)朝向密封劑內側之塗膜面滴下6點(作成縱2點×橫3點,且各點間隔係作成上下左右10mm),貼合受到摩擦處理之基板而取得液晶晶胞。其後,由於密封劑之硬化,使用照度60mW之金屬鹵素燈,遮蔽310nm以下之波長,對液晶晶胞照射365nm換算下為5J/cm2之紫外線,並且在熱循環型無塵烤箱中以120℃加熱處理60分鐘而取得液晶晶胞。 After that, two substrates that have been subjected to the above rubbing treatment to two substrates that have not been processed are prepared, and a spacer of 6 μm is spread on the coating film surface of the untreated substrate. After that, an ultraviolet-curable sealant was drawn around the substrate, and using the ODF method, 6 points of nematic liquid crystal (MLC-6608, manufactured by Merck Japan) toward the inside of the sealant were dropped at 6 points (2 points in length) ×3 points horizontally, and the interval between each point is made up, down, left, and right 10 mm), and the substrate subjected to the rubbing treatment is bonded to obtain a liquid crystal cell. Afterwards, due to the hardening of the sealant, a metal halogen lamp with an illuminance of 60mW was used to shield the wavelength below 310nm, and the liquid crystal cell was irradiated with ultraviolet rays of 5J/cm 2 in terms of 365nm conversion, and the temperature was 120 in a thermal cycle type dust-free oven. The liquid crystal cell was obtained by heat treatment at ℃ for 60 minutes.

使用取得之液晶晶胞,進行確認液晶滴下痕跡不均,即,進行確認液晶配向不均。具體而言,對液晶晶胞施加AC(交流驅動)5V之電壓,使用偏光板與背光,以目視觀察確認上述滴下有液晶之區域上有無液晶配向不均。 Using the obtained liquid crystal cell, it was confirmed that the liquid crystal dripping traces were uneven, that is, the liquid crystal alignment unevenness was confirmed. Specifically, an AC (alternating current drive) voltage of 5V was applied to the liquid crystal cell, and a polarizing plate and a backlight were used to visually confirm whether or not the liquid crystal alignment is uneven on the area where the liquid crystal is dropped.

本評價中,將在上述未發現液晶配向不均者評價為優異(表37~表39中標示良好)。 In this evaluation, those who did not find liquid crystal alignment unevenness as described above were evaluated as excellent (marked well in Table 37 to Table 39).

「電壓保持率之評價(通常晶胞)」 "Evaluation of voltage retention rate (usually unit cell)"

使用在與前述「液晶晶胞之製作及預傾角之評價(通常晶胞)」相同之條件下製成之液晶晶胞,進行電壓保持率之評價。具體而言,對藉由上述手法取得之液晶晶胞在80℃溫度下施加1V電壓60μs,測量50ms後之電壓,將電壓能保持之期間計算作為電壓保持率(亦稱為VHR)。尚且,測量係使用電壓保持率測量裝置(VHR-1、東陽技術公司製),在Voltage:±1V、Pulse Width:60μs、Flame Period:50ms之設定下進行。 Using the liquid crystal cell produced under the same conditions as the above-mentioned "Preparation of Liquid Crystal Cell and Evaluation of Pretilt Angle (Normal Cell)", the voltage retention rate was evaluated. Specifically, the liquid crystal cell obtained by the above method is applied with a voltage of 1 V for 60 μs at a temperature of 80° C. The voltage after 50 ms is measured, and the period during which the voltage can be maintained is calculated as the voltage retention rate (also referred to as VHR). In addition, the measurement was performed using a voltage retention measurement device (VHR-1, manufactured by Toyo Technology Co., Ltd.) under the settings of Voltage: ±1 V, Pulse Width: 60 μs, and Flame Period: 50 ms.

更進一步,使用桌上型UV硬化裝置(HCT3B28HEX-1、Senlight公司製),對上述已完成測量液晶晶胞剛製作後之電壓保持率之液晶晶胞,照射365nm換算下為50J/cm2之紫外線,在與上述相同之條件下進行測量電壓保持率。 Furthermore, using a desktop UV curing device (HCT3B28HEX-1, manufactured by Senlight), the above-mentioned liquid crystal cell having measured the voltage retention rate immediately after the production of the liquid crystal cell was irradiated at 365nm and converted to 50J/cm 2 For ultraviolet rays, the voltage retention rate was measured under the same conditions as above.

本評價中,將液晶晶胞剛製作後之電壓保持率之值為高,並且相對於液晶晶胞剛製作後之電壓保持率之值(亦稱為初期),紫外線照射後之值(亦稱為紫外線照射後)之降 低為越少者評價為優異。於表40~表42中展示各VHR之值。 In this evaluation, the value of the voltage retention ratio immediately after fabrication of the liquid crystal cell is high, and the value after ultraviolet irradiation (also known as the initial stage) is relative to the value of the voltage retention ratio immediately after fabrication of the liquid crystal cell (also known as the initial stage). After UV irradiation) The lower the number, the less the evaluation is excellent. The values of each VHR are shown in Table 40 to Table 42.

「殘留電荷之緩和之評價(通常晶胞)」 "Evaluation of the relaxation of residual charge (usually unit cell)"

使用在與前述「液晶晶胞之製作及預傾角之評價(通常晶胞)」相同之條件下製成之液晶晶胞,進行殘留電荷之緩和之評價。具體而言,對液晶晶胞施加30分鐘直流電壓10V,並使其短路1秒鐘後,測量液晶晶胞內產生之電位1800秒鐘。其中,使用50秒後之殘留電荷之值,作為殘留電荷之緩和之評價。尚且,測量係使用6254型液晶物性評價裝置(東陽技術公司製)。 Using the liquid crystal cell produced under the same conditions as the aforementioned "Preparation of Liquid Crystal Cell and Evaluation of Pretilt Angle (Normal Cell)", the evaluation of the relaxation of residual charge was performed. Specifically, after applying a DC voltage of 10 V to the liquid crystal cell for 30 minutes and short-circuiting it for 1 second, the potential generated in the liquid crystal cell was measured for 1800 seconds. Among them, the value of the residual charge after 50 seconds is used as an evaluation of the relaxation of the residual charge. In addition, the measurement system uses a 6254-type liquid crystal physical property evaluation device (manufactured by Toyo Technology Co., Ltd.).

更進一步,使用桌上型UV硬化裝置(HCT3B28HEX-1、Senlight公司製),對上述已完成測量液晶晶胞剛製作後之殘留電荷之液晶晶胞,照射365nm換算下為30J/cm2之紫外線,在與上述相同之條件下進行測量殘留電荷。 Furthermore, using a desktop UV curing device (HCT3B28HEX-1, manufactured by Senlight), the liquid crystal cell that has completed the measurement of the residual charge immediately after the production of the liquid crystal cell is irradiated with ultraviolet rays of 30J/cm 2 in 365nm conversion The residual charge is measured under the same conditions as above.

本評價中,將液晶晶胞剛製作直後之值(亦稱為初期)及紫外線照射後之殘留電荷之值(亦稱為紫外線照射後)為越小者評價為優異。於表40~表42中展示各殘留電荷之值。 In this evaluation, the smaller the value immediately after preparation of the liquid crystal cell (also referred to as the initial stage) and the value of the residual charge after ultraviolet irradiation (also referred to as after ultraviolet irradiation), the smaller the evaluation is, the superior. The values of each residual charge are shown in Table 40 to Table 42.

「液晶晶胞之製作及液晶配向性之評價(PSA晶胞)」 "Fabrication of liquid crystal cell and evaluation of liquid crystal alignment (PSA cell)"

使用後述實施例3及實施例9中取得之液晶配向處理劑,實施液晶晶胞之製作及液晶配向性之評價(PSA晶胞)。具體而言,使用細孔徑1μm之膜濾器進行加壓過濾 此等液晶配向處理劑,且分別旋轉塗佈在受到純水及IPA洗淨之在中心具有10×10mm之圖型間隔20μm之ITO的附ITO及電極之基板(縱40mm×橫30mm、厚度0.7mm)與在中心具有10×40mm之ITO之附ITO及電極之基板(縱40mm×橫30mm、厚度0.7mm)之ITO面上,再加熱板上以100℃加熱處理5分鐘,在熱循環型無塵烤箱中以230℃加熱處理30分鐘,而取得附有膜厚100nm之液晶配向膜之ITO基板。尚且,實施例3之液晶配向處理劑係與上述「液晶配向處理劑之噴墨塗佈性之評價」相同之條件下製作基板,其後在熱循環型無塵烤箱中以230℃加熱處理30分鐘,而作成附有膜厚100nm之液晶配向膜之ITO基板。 The liquid crystal alignment treatment agents obtained in Example 3 and Example 9 described later were used to prepare the liquid crystal cell and evaluate the liquid crystal alignment (PSA cell). Specifically, pressure filtration is performed using a membrane filter with a pore size of 1 μm These liquid crystal alignment treatment agents were spin-coated on substrates with ITO and electrodes (40mm in length×30mm in width and 0.7 in thickness) which were washed with pure water and IPA and had ITO with 10×10mm pattern spacing of 20μm in the center. mm) and the ITO surface of the substrate with ITO and electrodes with an ITO of 10×40mm in the center (40mm in length×30mm in width and 0.7mm in thickness), and then heat-treated at 100°C for 5 minutes on a hot plate. In a dust-free oven, heat treatment was performed at 230°C for 30 minutes to obtain an ITO substrate with a liquid crystal alignment film with a film thickness of 100 nm. Furthermore, the liquid crystal alignment treatment agent of Example 3 was produced under the same conditions as the above "evaluation of the inkjet coatability of the liquid crystal alignment treatment agent", and then heat-treated at 230°C for 30 in a heat-circulating dust-free oven. In minutes, an ITO substrate with a liquid crystal alignment film with a film thickness of 100 nm is prepared.

其次,將此2枚基板使塗膜面朝向內側夾住6μm間隔器而組合,使用密封劑接著周圍而製成空晶胞。藉由減壓注入法對此空晶胞注入混合液晶,該混合液晶係對向列液晶(MLC-6608、日本默克公司製)混合下述式聚合性化合物(1),以相對於向列液晶之100%,混合下述式聚合性化合物(1)0.3%者,其後密封注入口而取得液晶晶胞。 Next, the two substrates were combined with a 6 μm spacer sandwiched with the coating film surface facing inward, and then sealed with a sealant to form an empty cell. A mixed liquid crystal was injected into this empty cell by a decompression injection method. The mixed liquid crystal was a nematic liquid crystal (MLC-6608, manufactured by Merck Co., Ltd.). The polymerizable compound (1) of the following formula was mixed with respect to the nematic For 100% of the liquid crystal, 0.3% of the polymerizable compound (1) of the following formula was mixed, and then the injection port was sealed to obtain a liquid crystal cell.

Figure 104143876-A0202-12-0077-63
Figure 104143876-A0202-12-0077-63

對取得之液晶晶胞施加AC5V之電壓,並使用照度60mW之金屬鹵素燈,遮蔽350nm以下之波長,進行365nm換算下為20J/cm2之紫外線照射,進而取得液晶之配向方向受到控制之液晶晶胞。對液晶晶胞照射紫外線時之照射裝置內溫度為50℃。 Apply a voltage of AC5V to the obtained liquid crystal cell, and use a metal halogen lamp with an illuminance of 60mW to shield the wavelength below 350nm and perform ultraviolet irradiation of 20J/cm 2 under the conversion of 365nm, and then obtain a liquid crystal crystal whose alignment direction of the liquid crystal is controlled Cell. The temperature in the irradiation device when irradiating the liquid crystal cell with ultraviolet rays was 50°C.

其後,測量此液晶晶胞之紫外線照射前與紫外線照射後之液晶應答速度。應答速度係測量從穿透率90%至穿透率10%為止之T90→T10。 Thereafter, the response speed of the liquid crystal of the liquid crystal cell before and after ultraviolet irradiation was measured. The response speed is measured from T90→T10 from 90% penetration rate to 10% penetration rate.

任意實施例取得之液晶晶胞,由於在與紫外線照射前之液晶晶胞相比,紫外線照射後之液晶晶胞之應答速度快,故可確認液晶之配向方向受到控制。又,任意之液晶晶胞皆係藉由在偏光顯微鏡(ECLIPSE E600WPOL、Nikon公司製)下之觀察,確認到液晶為均勻地配向者。 In the liquid crystal cell obtained in any embodiment, since the response speed of the liquid crystal cell after ultraviolet irradiation is faster than that of the liquid crystal cell before ultraviolet irradiation, it can be confirmed that the alignment direction of the liquid crystal is controlled. Moreover, any liquid crystal cell was observed under a polarizing microscope (ECLIPSE E600WPOL, manufactured by Nikon), and it was confirmed that the liquid crystal was uniformly aligned.

<實施例1> <Example 1>

對合成例1中取得之聚醯亞胺粉末(1)(0.50g)添加NEP(3.92g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(3.92g),在40℃下攪拌4小時而取得溶液。 NEP (3.92 g) was added to the polyimide powder (1) (0.50 g) obtained in Synthesis Example 1, and stirred at 70° C. for 24 hours to dissolve. BCS (3.92g) was added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

另一方面,對合成例10中取得之聚醯亞胺粉末(10)(0.75g)添加NEP(5.88g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(5.88g),在40℃下攪拌4小時而取得溶液。 On the other hand, NEP (5.88 g) was added to the polyimide powder (10) (0.75 g) obtained in Synthesis Example 10, and stirred at 70° C. for 24 hours to dissolve. BCS (5.88g) was added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

並且,對合成例14中取得之聚醯亞胺粉末(14)(1.25g)添加NEP(9.79g),在70℃下攪拌24小時使其溶解。對 此溶液添加BCS(9.79g),在40℃下攪拌4小時而取得溶液。 Furthermore, NEP (9.79 g) was added to the polyimide powder (14) (1.25 g) obtained in Synthesis Example 14, and stirred at 70° C. for 24 hours to dissolve. Correct BCS (9.79g) was added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

混合上述取得之3種溶液,在40℃下攪拌4小時而取得液晶配配向處理劑(1)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 The three solutions obtained above were mixed and stirred at 40°C for 4 hours to obtain a liquid crystal alignment treatment agent (1). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<實施例2> <Example 2>

對合成例2中取得之聚醯亞胺粉末(2)(0.50g)添加NEP(3.92g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(2.35g)及PB(1.57g),在40℃下攪拌4小時而取得溶液。 NEP (3.92 g) was added to the polyimide powder (2) (0.50 g) obtained in Synthesis Example 2, and stirred at 70° C. for 24 hours to dissolve. BCS (2.35g) and PB (1.57g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

另一方面,合成例10中取得之聚醯亞胺粉末(10)(0.75g)添加NEP(5.88g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(3.53g)及PB(2.35g),在40℃下攪拌4小時而取得溶液。 On the other hand, NEP (5.88 g) was added to the polyimide powder (10) (0.75 g) obtained in Synthesis Example 10, and stirred at 70° C. for 24 hours to dissolve. BCS (3.53g) and PB (2.35g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

並且,對合成例14中取得之聚醯亞胺粉末(14)(1.25g)添加NEP(9.79g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(5.88g)及PB(3.92g),在40℃下攪拌4小時而取得溶液。 Furthermore, NEP (9.79 g) was added to the polyimide powder (14) (1.25 g) obtained in Synthesis Example 14, and stirred at 70° C. for 24 hours to dissolve. BCS (5.88g) and PB (3.92g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

混合上述取得之3種溶液,在40℃下攪拌4小時而取得液晶配配向處理劑(2)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 The three solutions obtained above were mixed and stirred at 40°C for 4 hours to obtain a liquid crystal alignment treatment agent (2). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<實施例3> <Example 3>

對合成例3中取得之聚醯亞胺粉末(3)(0.30g)、合成例10中取得之聚醯亞胺粉末(10)(0.45g)及合成例14中取得之聚醯亞胺粉末(14)(0.75g)添加NEP(16.5g)及γ-BL(4.18g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(8.27g)、PB(8.27g)及DME(4.14g),在40℃下攪拌4小時而取得液晶配向處理劑(3)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 For the polyimide powder (3) (0.30 g) obtained in Synthesis Example 3, the polyimide powder (10) (0.45 g) obtained in Synthesis Example 10, and the polyimide powder obtained in Synthesis Example 14 (14) (0.75g) NEP (16.5g) and γ-BL (4.18g) were added, and stirred at 70°C for 24 hours to dissolve. BCS (8.27g), PB (8.27g) and DME (4.14g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the liquid-crystal aligning agent (3). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<實施例4> <Example 4>

對合成例4中取得之聚醯亞胺粉末(4)(0.80g)添加NMP(6.27g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(5.02g)及DME(1.25g),在40℃下攪拌4小時而取得溶液。 NMP (6.27 g) was added to the polyimide powder (4) (0.80 g) obtained in Synthesis Example 4, and stirred at 70° C. for 24 hours to dissolve. BCS (5.02g) and DME (1.25g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

另一方面,對合成例12中取得之聚醯亞胺粉末(12)(0.80g)添加NMP(6.27g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(5.02g)及DME(1.25g),在40℃下攪拌4小時而取得溶液。 On the other hand, NMP (6.27 g) was added to the polyimide powder (12) (0.80 g) obtained in Synthesis Example 12, and stirred at 70° C. for 24 hours to dissolve. BCS (5.02g) and DME (1.25g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

並且,對合成例14中取得之聚醯亞胺粉末(14)(1.07g)添加NMP(8.36g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(6.68g)及DME(1.67g),在40℃下攪拌4小時而取得溶液。 Furthermore, NMP (8.36 g) was added to the polyimide powder (14) (1.07 g) obtained in Synthesis Example 14, and stirred at 70° C. for 24 hours to dissolve. BCS (6.68g) and DME (1.67g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

混合上述取得之3種溶液,在40℃下攪拌4小時而取得液晶配配向處理劑(4)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 The three solutions obtained above were mixed and stirred at 40°C for 4 hours to obtain a liquid crystal alignment treatment agent (4). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<實施例5> <Example 5>

對合成例5中取得之聚醯亞胺粉末(5)(0.80g)添加NEP(7.52g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(2.51g)及PB(2.51g),在40℃下攪拌4小時而取得溶液。 NEP (7.52 g) was added to the polyimide powder (5) (0.80 g) obtained in Synthesis Example 5, and stirred at 70° C. for 24 hours to dissolve. BCS (2.51g) and PB (2.51g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

另一方面,對合成例10中取得之聚醯亞胺粉末(10)(0.80g)添加NEP(7.52g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(2.51g)及PB(2.51g),在40℃下攪拌4小時而取得溶液。 On the other hand, NEP (7.52 g) was added to the polyimide powder (10) (0.80 g) obtained in Synthesis Example 10, and stirred at 70° C. for 24 hours to dissolve. BCS (2.51g) and PB (2.51g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

並且,對合成例14中取得之聚醯亞胺粉末(14)(1.07g)添加NEP(10.0g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(3.34g)及PB(3.34g),在40℃下攪拌4小時而取得溶液。 Furthermore, NEP (10.0 g) was added to the polyimide powder (14) (1.07 g) obtained in Synthesis Example 14, and stirred at 70° C. for 24 hours to dissolve. BCS (3.34g) and PB (3.34g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

混合上述取得之3種溶液,在40℃下攪拌4小時而取得液晶配配向處理劑(5)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 The three solutions obtained above were mixed and stirred at 40°C for 4 hours to obtain a liquid crystal alignment treatment agent (5). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<實施例6> <Example 6>

對合成例6中取得之聚醯亞胺粉末(6)(0.50g)、合成例10中取得之聚醯亞胺粉末(10)(0.75g)及合成例14中取得之聚醯亞胺粉末(14)(1.25g)添加NEP(21.5g),在70℃下攪拌24小時使其溶解。對此溶液添加PB(17.6g),在40℃下攪拌4小時而取得液晶配向處理劑(6)。此液晶配 向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 For the polyimide powder (6) (0.50 g) obtained in Synthesis Example 6, the polyimide powder (10) (0.75 g) obtained in Synthesis Example 10, and the polyimide powder obtained in Synthesis Example 14 (14) (1.25g) NEP (21.5g) was added, and it stirred for 24 hours and made it melt|dissolve at 70 degreeC. PB (17.6g) was added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the liquid-crystal aligning agent (6). This LCD is equipped with No abnormality such as turbidity or precipitation was found in the treatment agent, and it was confirmed to be a homogeneous solution.

<實施例7> <Example 7>

對合成例7中取得之聚醯亞胺粉末(7)(0.80g)添加NMP(3.76g)及NEP(3.76g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(2.51g)及PB(2.51g),在40℃下攪拌4小時而取得溶液。 NMP (3.76 g) and NEP (3.76 g) were added to the polyimide powder (7) (0.80 g) obtained in Synthesis Example 7, and stirred at 70° C. for 24 hours to dissolve. BCS (2.51g) and PB (2.51g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

另一方面,對合成例10中取得之聚醯亞胺粉末(10)(0.80g)添加NMP(3.76g)及NEP(3.76g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(2.51g)及PB(2.51g),在40℃下攪拌4小時而取得溶液。 On the other hand, NMP (3.76 g) and NEP (3.76 g) were added to the polyimide powder (10) (0.80 g) obtained in Synthesis Example 10, and stirred at 70° C. for 24 hours to dissolve. BCS (2.51g) and PB (2.51g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

並且,對合成例14中取得之聚醯亞胺粉末(14)(1.07g)添加NMP(5.02g)及NEP(5.02g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(3.34g)及PB(3.34g),在40℃下攪拌4小時而取得溶液。 Furthermore, NMP (5.02 g) and NEP (5.02 g) were added to the polyimide powder (14) (1.07 g) obtained in Synthesis Example 14, and stirred at 70° C. for 24 hours to dissolve. BCS (3.34g) and PB (3.34g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

混合上述取得之3種溶液,在40℃下攪拌4小時而取得液晶配配向處理劑(7)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 The three solutions obtained above were mixed and stirred at 40°C for 4 hours to obtain a liquid crystal alignment treatment agent (7). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<實施例8> <Example 8>

對合成例8中取得之聚醯亞胺粉末(8)(0.30g)、合成例10中取得之聚醯亞胺粉末(10)(0.45g)及合成例14中取得之聚醯亞胺粉末(14)(0.75g)添加NEP(12.4g)及γ-BL (6.21g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(8.27g)及PB(14.5g),在40℃下攪拌4小時而取得液晶配向處理劑(8)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 For the polyimide powder (8) (0.30 g) obtained in Synthesis Example 8, the polyimide powder (10) (0.45 g) obtained in Synthesis Example 10, and the polyimide powder obtained in Synthesis Example 14 (14) (0.75g) Add NEP (12.4g) and γ-BL (6.21g), stirred at 70°C for 24 hours to dissolve. BCS (8.27g) and PB (14.5g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the liquid-crystal aligning agent (8). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<實施例9> <Example 9>

對合成例1中取得之聚醯亞胺粉末(1)(0.50g)添加NEP(5.09g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(1.18g)及PB(1.57g),在40℃下攪拌4小時而取得溶液。 NEP (5.09 g) was added to the polyimide powder (1) (0.50 g) obtained in Synthesis Example 1, and stirred at 70° C. for 24 hours to dissolve. BCS (1.18g) and PB (1.57g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

另一方面,對合成例11中取得之聚醯亞胺粉末(11)(0.75g)添加NEP(7.64g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(1.76g)及PB(2.35g),在40℃下攪拌4小時而取得溶液。 On the other hand, NEP (7.64 g) was added to the polyimide powder (11) (0.75 g) obtained in Synthesis Example 11, and stirred at 70° C. for 24 hours to dissolve. BCS (1.76g) and PB (2.35g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

並且,對合成例14中取得之聚醯亞胺粉末(14)(1.25g)添加NEP(12.7g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(2.94g)及PB(3.92g),、在40℃下攪拌4小時而取得溶液。 Furthermore, NEP (12.7 g) was added to the polyimide powder (14) (1.25 g) obtained in Synthesis Example 14, and stirred at 70° C. for 24 hours to dissolve. BCS (2.94g) and PB (3.92g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

混合上述取得之3種溶液,在40℃下攪拌4小時而取得液晶配配向處理劑(9)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 The three solutions obtained above were mixed and stirred at 40°C for 4 hours to obtain a liquid crystal alignment treatment agent (9). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<實施例10> <Example 10>

對合成例5中取得之聚醯亞胺粉末(5)(0.50g)添加 NEP(4.70g),在70℃下攪拌24小時使其溶解。對此溶液添加PB(3.13g),在40℃下攪拌4小時而取得溶液。 Add to the polyimide powder (5) (0.50g) obtained in Synthesis Example 5 NEP (4.70g) was stirred at 70°C for 24 hours to dissolve. PB (3.13g) was added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

另一方面,對合成例12中取得之聚醯亞胺粉末(12)(0.75g)添加NEP(7.05g),在70℃下攪拌24小時使其溶解。對此溶液添加PB(4.70g),在40℃下攪拌4小時而取得溶液。 On the other hand, NEP (7.05 g) was added to the polyimide powder (12) (0.75 g) obtained in Synthesis Example 12, and stirred at 70° C. for 24 hours to dissolve. PB (4.70g) was added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

並且,對合成例14中取得之聚醯亞胺粉末(14)(1.25g)添加NEP(11.8g),在70℃下攪拌24小時使其溶解。對此溶液添加PB(7.83g),在40℃下攪拌4小時而取得溶液。 Furthermore, NEP (11.8 g) was added to the polyimide powder (14) (1.25 g) obtained in Synthesis Example 14, and stirred at 70° C. for 24 hours to dissolve. PB (7.83g) was added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

混合上述取得之3種溶液,在40℃下攪拌4小時而取得液晶配配向處理劑(10)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 The three solutions obtained above were mixed and stirred at 40°C for 4 hours to obtain a liquid crystal alignment treatment agent (10). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<實施例11> <Example 11>

對合成例1中取得之聚醯亞胺粉末(1)(0.50g)添加NEP(4.70g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(0.78g)及PB(2.35g),在40℃下攪拌4小時而取得溶液。 NEP (4.70 g) was added to the polyimide powder (1) (0.50 g) obtained in Synthesis Example 1, and stirred at 70° C. for 24 hours to dissolve. BCS (0.78g) and PB (2.35g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

另一方面,對合成例13中取得之聚醯亞胺粉末(13)(0.75g)添加NEP(7.05g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(1.18g)及PB(3.53g),在40℃下攪拌4小時而取得溶液。 On the other hand, NEP (7.05 g) was added to the polyimide powder (13) (0.75 g) obtained in Synthesis Example 13, and stirred at 70° C. for 24 hours to dissolve. BCS (1.18g) and PB (3.53g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

並且,對合成例14中取得之聚醯亞胺粉末(14)(1.25 g)添加NEP(11.8g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(1.96g)及PB(5.88g),在40℃下攪拌4小時而取得溶液。 In addition, the polyimide powder (14) obtained in Synthesis Example 14 (1.25) g) Add NEP (11.8g) and stir at 70°C for 24 hours to dissolve. BCS (1.96g) and PB (5.88g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

混合上述取得之3種溶液,在40℃下攪拌4小時而取得液晶配配向處理劑(11)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 The three solutions obtained above were mixed and stirred at 40°C for 4 hours to obtain a liquid crystal alignment treatment agent (11). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<實施例12> <Example 12>

對合成例1中取得之聚醯亞胺粉末(1)(0.80g)添加NMP(6.27g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(2.51g)及PB(3.76g),在40℃下攪拌4小時而取得溶液。 NMP (6.27 g) was added to the polyimide powder (1) (0.80 g) obtained in Synthesis Example 1, and stirred at 70° C. for 24 hours to dissolve. BCS (2.51g) and PB (3.76g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

另一方面,對合成例10中取得之聚醯亞胺粉末(10)(0.53g)添加NMP(4.18g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(1.67g)及PB(2.51g),在40℃下攪拌4小時而取得溶液。 On the other hand, NMP (4.18 g) was added to the polyimide powder (10) (0.53 g) obtained in Synthesis Example 10, and stirred at 70° C. for 24 hours to dissolve. BCS (1.67g) and PB (2.51g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

並且,對合成例15中取得之聚醯亞胺粉末(15)(1.33g)添加NMP(10.4g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(4.18g)及PB(6.27g),在40℃下攪拌4小時而取得溶液。 Furthermore, NMP (10.4 g) was added to the polyimide powder (15) (1.33 g) obtained in Synthesis Example 15, and stirred at 70° C. for 24 hours to dissolve. BCS (4.18g) and PB (6.27g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

混合上述取得之3種溶液,且又添加M1(0.19g),在40℃下攪拌6小時而取得液晶配配向處理劑(12)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 The three solutions obtained above were mixed, and M1 (0.19 g) was added, and stirred at 40°C for 6 hours to obtain a liquid crystal alignment treatment agent (12). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<實施例13> <Example 13>

對合成例1中取得之聚醯亞胺粉末(1)(0.80g)、合成例10中取得之聚醯亞胺粉末(10)(0.80g)及合成例16中取得之聚醯亞胺粉末(16)(1.07g)添加NEP(20.9g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(8.36g)及PB(12.5g),在40℃下攪拌4小時而取得液晶配向處理劑(13)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 For the polyimide powder (1) (0.80 g) obtained in Synthesis Example 1, the polyimide powder (10) (0.80 g) obtained in Synthesis Example 10, and the polyimide powder obtained in Synthesis Example 16 (16) (1.07g) NEP (20.9g) was added and stirred at 70°C for 24 hours to dissolve. BCS (8.36g) and PB (12.5g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the liquid-crystal aligning agent (13). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<實施例14> <Example 14>

對合成例1中取得之聚醯亞胺粉末(1)(0.80g)、合成例10中取得之聚醯亞胺粉末(10)(0.80g)及合成例16中取得之聚醯亞胺粉末(16)(1.07g)添加NEP(20.9g),在70℃下攪拌24小時使其溶解。對此溶液添加PB(12.5g)及DPM(8.36g),在40℃下攪拌4小時而取得液晶配向處理劑(22)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 For the polyimide powder (1) (0.80 g) obtained in Synthesis Example 1, the polyimide powder (10) (0.80 g) obtained in Synthesis Example 10, and the polyimide powder obtained in Synthesis Example 16 (16) (1.07g) NEP (20.9g) was added and stirred at 70°C for 24 hours to dissolve. PB (12.5g) and DPM (8.36g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the liquid-crystal aligning agent (22). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<比較例1> <Comparative Example 1>

對合成例1中取得之聚醯亞胺粉末(1)(2.50g)添加NEP(19.6g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(19.6g),在40℃下攪拌4小時而取得液晶配向處理劑(14)。此液晶配向處理劑並未發現混濁或析出等之 異常,且確認為均勻之溶液。 NEP (19.6 g) was added to the polyimide powder (1) (2.50 g) obtained in Synthesis Example 1, and stirred at 70° C. for 24 hours to dissolve. BCS (19.6g) was added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the liquid-crystal aligning agent (14). The liquid crystal alignment treatment agent did not find turbidity or precipitation, etc. Abnormal and confirmed as a homogeneous solution.

<比較例2> <Comparative Example 2>

對合成例10中取得之聚醯亞胺粉末(10)(2.50g)添加NEP(19.6g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(19.6g),在40℃下攪拌4小時而取得液晶配向處理劑(15)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 NEP (19.6 g) was added to the polyimide powder (10) (2.50 g) obtained in Synthesis Example 10, and stirred at 70° C. for 24 hours to dissolve. BCS (19.6g) was added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the liquid-crystal aligning agent (15). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<比較例3> <Comparative Example 3>

對合成例14中取得之聚醯亞胺粉末(14)(2.50g)添加NEP(19.6g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(19.6g),在40℃下攪拌4小時而取得液晶配向處理劑(16)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 NEP (19.6 g) was added to the polyimide powder (14) (2.50 g) obtained in Synthesis Example 14, and stirred at 70° C. for 24 hours to dissolve. BCS (19.6g) was added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the liquid-crystal aligning agent (16). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<比較例4> <Comparative Example 4>

對合成例1中取得之聚醯亞胺粉末(1)(1.30g)添加NEP(10.2g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(10.2g),在40℃下攪拌4小時而取得溶液。 NEP (10.2 g) was added to the polyimide powder (1) (1.30 g) obtained in Synthesis Example 1, and stirred at 70° C. for 24 hours to dissolve. BCS (10.2g) was added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

另一方面,對合成例10中取得之聚醯亞胺粉末(10)(1.30g)添加NEP(10.2g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(10.2g),在40℃下攪拌4小時而取得溶液。 On the other hand, NEP (10.2 g) was added to the polyimide powder (10) (1.30 g) obtained in Synthesis Example 10, and stirred at 70° C. for 24 hours to dissolve. BCS (10.2g) was added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

混合上述取得之2種溶液,在40℃下攪拌4小時而取得液晶配配向處理劑(17)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 The two solutions obtained above were mixed and stirred at 40°C for 4 hours to obtain a liquid crystal alignment treatment agent (17). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<比較例5> <Comparative Example 5>

對合成例1中取得之聚醯亞胺粉末(1)(1.30g)添加NEP(10.2g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(10.2g),在40℃下攪拌4小時而取得溶液。 NEP (10.2 g) was added to the polyimide powder (1) (1.30 g) obtained in Synthesis Example 1, and stirred at 70° C. for 24 hours to dissolve. BCS (10.2g) was added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

另一方面,對合成例14中取得之聚醯亞胺粉末(14)(1.30g)添加NEP(10.2g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(10.2g),在40℃下攪拌4小時而取得溶液。 On the other hand, NEP (10.2 g) was added to the polyimide powder (14) (1.30 g) obtained in Synthesis Example 14, and stirred at 70° C. for 24 hours to dissolve. BCS (10.2g) was added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

混合上述取得之2種溶液,在40℃下攪拌4小時而取得液晶配配向處理劑(18)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 The two solutions obtained above were mixed and stirred at 40°C for 4 hours to obtain a liquid crystal alignment treatment agent (18). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<比較例6> <Comparative Example 6>

對合成例10中取得之聚醯亞胺粉末(10)(1.30g)添加NEP(10.2g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(10.2g),在40℃下攪拌4小時而取得溶液。 NEP (10.2 g) was added to the polyimide powder (10) (1.30 g) obtained in Synthesis Example 10, and stirred at 70° C. for 24 hours to dissolve. BCS (10.2g) was added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

另一方面,對合成例14中取得之聚醯亞胺粉末(14)(1.30g)添加NEP(10.2g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(10.2g),在40℃下攪拌4小時而取得溶液。 On the other hand, NEP (10.2 g) was added to the polyimide powder (14) (1.30 g) obtained in Synthesis Example 14, and stirred at 70° C. for 24 hours to dissolve. BCS (10.2g) was added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

混合上述取得之2種溶液,在40℃下攪拌4小時而取得液晶配配向處理劑(19)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 The two solutions obtained above were mixed and stirred at 40°C for 4 hours to obtain a liquid crystal alignment treatment agent (19). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<比較例7> <Comparative Example 7>

對合成例9中取得之聚醯亞胺粉末(9)(0.50g)添加NEP(3.92g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(2.35g)及PB(1.57g),在40℃下攪拌4小時而取得溶液。 NEP (3.92 g) was added to the polyimide powder (9) (0.50 g) obtained in Synthesis Example 9, and stirred at 70° C. for 24 hours to dissolve. BCS (2.35g) and PB (1.57g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

另一方面,對合成例10中取得之聚醯亞胺粉末(10)(0.75g)添加NEP(5.88g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(3.53g)及PB(2.35g),在40℃下攪拌4小時而取得溶液。 On the other hand, NEP (5.88 g) was added to the polyimide powder (10) (0.75 g) obtained in Synthesis Example 10, and stirred at 70° C. for 24 hours to dissolve. BCS (3.53g) and PB (2.35g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

並且,對合成例14中取得之聚醯亞胺粉末(14)(1.25g)添加NEP(9.79g),在70℃下攪拌24小時使其溶解。對此溶液添加BCS(5.88g)及PB(3.92g),在40℃下攪拌4小時而取得溶液。 Furthermore, NEP (9.79 g) was added to the polyimide powder (14) (1.25 g) obtained in Synthesis Example 14, and stirred at 70° C. for 24 hours to dissolve. BCS (5.88g) and PB (3.92g) were added to this solution, and it stirred at 40 degreeC for 4 hours, and obtained the solution.

混合上述取得之3種溶液,在40℃下攪拌4小時而取得液晶配配向處理劑(20)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 The three solutions obtained above were mixed and stirred at 40°C for 4 hours to obtain a liquid crystal alignment treatment agent (20). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

<比較例8> <Comparative Example 8>

對合成例17中取得之聚醯亞胺粉末(17)(2.50g)添加NEP(19.6),在70℃下攪拌24小時使其溶解。對此溶液添 加BCS(19.6g),在40℃下攪拌4小時而取得液晶配向處理劑(21)。此液晶配向處理劑並未發現混濁或析出等之異常,且確認為均勻之溶液。 NEP (19.6) was added to the polyimide powder (17) (2.50 g) obtained in Synthesis Example 17, and stirred at 70°C for 24 hours to dissolve. Add this solution BCS (19.6g) was added, and it stirred at 40 degreeC for 4 hours, and obtained the liquid-crystal aligning agent (21). The liquid crystal alignment treatment agent was not found to be abnormal such as turbidity or precipitation, and was confirmed to be a homogeneous solution.

將上述實施例及比較例中取得之各液晶配向處理劑整理展示於表34~表36。又,將使用此等液晶配向處理劑之液晶顯示元件之評價結果展示於表表37~表42。 The liquid crystal alignment treatment agents obtained in the above examples and comparative examples are shown in Table 34 to Table 36. In addition, the evaluation results of the liquid crystal display elements using these liquid crystal alignment treatment agents are shown in Tables 37 to 42.

尚且,表中,* 1表示相對於全部聚合物100份之特定聚合物(A)之導入量(分)。 In addition, in the table, *1 represents the introduction amount (minute) of the specific polymer (A) with respect to 100 parts of all polymers.

* 2表示相對於全部聚合物100份之特定聚合物(B)之導入量(份),* 3表示相對於全部聚合物100份之特定聚合物(C)之導入量(份),* 4表示相對於全部聚合物100份之其他聚合物之導入量(份)、* 5表示液晶配向處理劑中之全部聚合物所占之含有比例(固體成分濃度)。 * 2 represents the introduction amount (part) of the specific polymer (B) with respect to 100 parts of all polymers, * 3 represents the introduction amount (part) of the specific polymer (C) with respect to 100 parts of all polymers, * 4 It shows the introduction amount (part) of other polymers with respect to 100 parts of all polymers. *5 shows the content ratio (solid content concentration) of all polymers in the liquid crystal alignment treatment agent.

Figure 104143876-A0202-12-0090-64
Figure 104143876-A0202-12-0090-64

Figure 104143876-A0202-12-0091-65
Figure 104143876-A0202-12-0091-65

Figure 104143876-A0202-12-0091-66
Figure 104143876-A0202-12-0091-66

Figure 104143876-A0202-12-0092-67
Figure 104143876-A0202-12-0092-67

Figure 104143876-A0202-12-0092-68
Figure 104143876-A0202-12-0092-68

Figure 104143876-A0202-12-0093-69
Figure 104143876-A0202-12-0093-69

Figure 104143876-A0202-12-0093-70
Figure 104143876-A0202-12-0093-70

Figure 104143876-A0202-12-0094-71
Figure 104143876-A0202-12-0094-71

Figure 104143876-A0202-12-0094-72
Figure 104143876-A0202-12-0094-72

從上述結果可清楚得知,與比較例之液晶配向處理劑,實施例之液晶配向處理劑即使對液晶晶胞進行高溫處理及紫外線照射,仍顯示安定之預傾角。又,能減輕ODF方式下產生之液晶配向不均。並且,即使對液晶晶胞進行紫外線照射,其結果仍係可抑制電壓保持率降低,且快速緩和因直流電壓所積之殘留電荷。 It is clear from the above results that the liquid crystal alignment treatment agent of the comparative example and the liquid crystal alignment treatment agent of the example still exhibit a stable pretilt angle even if the liquid crystal cell is subjected to high temperature treatment and ultraviolet irradiation. In addition, it can reduce the uneven alignment of the liquid crystal generated under the ODF method. Furthermore, even if the liquid crystal cell is irradiated with ultraviolet rays, as a result, it is possible to suppress the decrease in the voltage retention rate and quickly alleviate the residual charge accumulated by the DC voltage.

即,在使用3種特定聚合物(A)、(B)及(C)之液晶配向處理劑之實施例,與僅使用此等1種之比較例之比較中,比較例皆無法達成本發明之全部效果。具體而言,如實施例1與比較例1、2或3之比較,又,實施例1與比較例4、5或6之比較所示。 That is, in the examples using the liquid crystal alignment treatment agents of the three specific polymers (A), (B) and (C), compared with the comparative examples using only one of these, none of the comparative examples can achieve the invention. The full effect. Specifically, it is as shown in the comparison between Example 1 and Comparative Examples 1, 2 or 3, and the comparison between Example 1 and Comparative Examples 4, 5 or 6.

並且,在使用特定二胺(1)之實施例2,與使用過往之具有烷基型側鏈構造之二胺之比較例的比較中,比較例7之液晶配向處理劑並無法達成本發明之全部效果。 In addition, in Example 2 using a specific diamine (1) and comparing with a comparative example using a diamine having an alkyl side chain structure in the past, the liquid crystal alignment treatment agent of Comparative Example 7 cannot achieve the cost of the invention. All effects.

又,在實施例1與完全未使用特定二胺(1)、(2)及(3)之比較例8的比較中,比較例8之結果皆較差於本發明之全部效果,尤其對於ODF方式下產生之液晶配向不均之產生,與長時間暴露光照射下之後之電壓保持率降低,皆取得較差之結果。 In addition, in the comparison between Example 1 and Comparative Example 8 in which specific diamines (1), (2), and (3) are not used at all, the results of Comparative Example 8 are inferior to all the effects of the present invention, especially for the ODF method The occurrence of uneven alignment of the liquid crystal produced under the conditions and the reduction of the voltage retention rate after long-time exposure to light have both obtained poor results.

[產業上之可利用性] [Industry availability]

本發明之液晶配向處理劑係極有用在使用VA模式、PSA模式及SC-PVA模式之液晶顯示元件,尤其係TN元件、STN元件、TFT液晶元件,尤其係垂直配向型之液晶顯示元件。具有由本發明之液晶配向處理劑所得之液晶配向膜之液晶顯示元件係能適宜使用於大畫面且高精細之液晶電視、中小型之汽車導航系統、智慧型電話等。 The liquid crystal alignment treatment agent of the present invention is very useful for liquid crystal display elements using VA mode, PSA mode and SC-PVA mode, especially TN element, STN element, TFT liquid crystal element, and especially vertical alignment type liquid crystal display element. The liquid crystal display device having the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention can be suitably used in large-screen and high-definition LCD TVs, small and medium-sized car navigation systems, smart phones, and the like.

尚且,將2014年12月25日提出申請之日本 專利申請案2014-262605號之說明書、申請專利範圍、圖式、及摘要之全部內容引用至此作為本發明說明書之揭示內容,並予以導入者。 Not to mention, Japan will apply on December 25, 2014 The entire contents of the specification, patent application scope, drawings, and abstract of Patent Application No. 2014-262605 are hereby cited as the disclosure content of the specification of the present invention and incorporated.

Claims (18)

一種液晶配向處理劑,其特徵為含有下述之(A)成分、(B)成分及(C)成分;(A)成分:藉由含有具有下述式[1]構造之二胺及具有下述式[2]構造之二胺之二胺成分與四羧酸成分之反應而得之聚醯亞胺前驅物或將該聚醯亞胺前驅物予以醯亞胺化之聚醯亞胺;(B)成分:藉由含有具有下述式[2]構造之二胺之二胺成分與四羧酸成分之反應而得之聚醯亞胺前驅物或將該聚醯亞胺前驅物予以醯亞胺化之聚醯亞胺;(C):藉由含有具有選自由羧基(COOH基)及羥基(OH基)所成群之至少一種取代基之二胺之二胺成分與四羧酸成分之反應而得之聚醯亞胺前驅物或將該聚醯亞胺前驅物予以醯亞胺化之聚醯亞胺;但,前述具有選自由羧基(COOH基)及羥基(OH基)所成群之至少一種取代基之二胺係僅使用於前述(C)成分中之二胺成分;
Figure 104143876-A0305-02-0100-1
X1表示選自由單鍵、-(CH2)a-(a為1~15之整數)、-O-、-CH2O-、-CONH-、-NHCO-、-CON(CH3)-、-N(CH3)CO-、-COO-及-OCO-所成群之至少一種之結合基,X2表示單鍵或-(CH2)b-(b為1~15之整數),X3表示 選自由單鍵、-(CH2)c-(c為1~15之整數)、-O-、-CH2O-、-COO-及-OCO-所成群之至少一種,X4表示選自由苯環、環己烷環及雜環所成群之至少一種之2價環狀基或具有類固醇骨架之碳數17~51之2價有機基,且前述環狀基上之任意氫原子可被碳數1~3之烷基、碳數1~3之烷氧基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子所取代,X5表示選自由苯環、環己烷環及雜環所成群之至少一種之環狀基,且此等環狀基上之任意氫原子可被碳數1~3之烷基、碳數1~3之烷氧基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子所取代,n表示0~4之整數,X6表示選自由碳數1~18之烷基、碳數2~18之烯基、碳數1~18之含氟烷基、碳數1~18之烷氧基及碳數1~18之含氟烷氧基所成群之至少一種;-W 1 -W 2 -W 3 -W 4 [2]W1表示選自由-O-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-OCO-、-CON(CH3)-及-N(CH3)CO-所成群之至少一種之結合基,W2表示選自由單鍵、碳數1~20之伸烷基、非芳香族環及芳香族環所成群之至少一種,W3表示選自由單鍵、-O-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-COO-、-OCO-、-CON(CH3)-、-N(CH3)CO-及-O(CH2)m-(m表示1~5之整數)所成群之至少一種,W4表示含氮芳香族雜環。
A liquid crystal alignment treatment agent characterized by containing the following (A) component, (B) component and (C) component; (A) component: by containing a diamine having the structure of the following formula [1] and having the following The polyimide precursor obtained by the reaction of the diamine component of the diamine of the structure [2] and the tetracarboxylic acid component or the polyimide obtained by subjecting the polyimide precursor to imidization; ( B) Component: a polyimide precursor obtained by the reaction of a diamine component containing a diamine having the structure of the following formula [2] and a tetracarboxylic acid component or the polyimide precursor is obtained Aminated polyimide; (C): by containing a diamine component and a tetracarboxylic acid component of a diamine having at least one substituent selected from the group consisting of a carboxyl group (COOH group) and a hydroxyl group (OH group) The polyimide precursor obtained by the reaction or the polyimide obtained by imidizing the polyimide precursor; however, the foregoing has a group selected from the group consisting of a carboxyl group (COOH group) and a hydroxyl group (OH group) The diamine of at least one substituent is only used for the diamine component of the aforementioned (C) component;
Figure 104143876-A0305-02-0100-1
X 1 represents selected from a single bond, -(CH 2 ) a- (a is an integer from 1 to 15), -O-, -CH 2 O-, -CONH-, -NHCO-, -CON(CH 3 )- , -N(CH 3 )CO-, -COO- and -OCO- at least one kind of binding group, X 2 represents a single bond or -(CH 2 ) b -(b is an integer of 1~15), X 3 represents at least one selected from the group consisting of a single bond, -(CH 2 ) c- (c is an integer from 1 to 15), -O-, -CH 2 O-, -COO-, and -OCO-, X 4 represents a divalent cyclic group selected from at least one group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring or a divalent organic group having a steroid skeleton and a carbon number of 17 to 51, and any of the aforementioned cyclic groups The hydrogen atom can be replaced by an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom , X 5 represents at least one cyclic group selected from the group consisting of benzene ring, cyclohexane ring and heterocyclic ring, and any hydrogen atom on these cyclic groups may be Substituted by alkoxy groups of 1 to 3, fluorinated alkyl groups of 1 to 3 carbon atoms, fluorinated alkoxy groups of 1 to 3 carbon atoms or fluorine atoms, n represents an integer of 0 to 4, X 6 represents selected from C1-C18 alkyl, C2-C18 alkenyl, C1-C18 fluorine-containing alkyl, C1-C18 alkoxy and C1-C18 fluorine-containing alkoxy At least one of the groups; -W 1 -W 2 -W 3 -W 4 [2] W 1 represents selected from -O-, -NH-, -N(CH 3 )-, -CONH-, -NHCO- , -CH 2 O-, -OCO-, -CON(CH 3 )- and -N(CH 3 )CO-, at least one kind of binding group, W 2 represents selected from a single bond, carbon number 1~20 At least one of alkylene group, non-aromatic ring and aromatic ring group, W 3 represents selected from single bond, -O-, -NH-, -N(CH 3 )-, -CONH-, -NHCO -, -COO-, -OCO-, -CON(CH 3 )-, -N(CH 3 )CO- and -O(CH 2 ) m- (m represents an integer from 1 to 5) , W 4 represents a nitrogen-containing aromatic heterocyclic ring.
如請求項1之液晶配向處理劑,其中具有前述式 [1]構造之二胺係僅使用於前述(A)成分中之二胺成分。 The liquid crystal alignment treatment agent according to claim 1, which has the aforementioned formula [1] The diamine structure is used only for the diamine component of the aforementioned (A) component. 如請求項1之液晶配向處理劑,其中將前述(A)成分中之前述具有式[1]所示構造之二胺對二胺成分全體之使用比例(莫耳%)設成1.0時,前述(B)成分中之前述具有式[1]所示構造之二胺對二胺成分全體之使用比例(莫耳%)為0.01~0.8之比率。 The liquid crystal alignment treatment agent according to claim 1, wherein the use ratio (mol %) of the aforementioned diamine to the entire diamine component having the structure shown in formula [1] among the aforementioned (A) components is set to 1.0, (B) The use ratio (mol %) of the diamine to the whole diamine component which has the structure shown by Formula [1] among the components mentioned above is a ratio of 0.01 to 0.8. 如請求項1或3之液晶配向處理劑,其中將前述(A)成分中之具有前述式[1]所示構造之二胺對二胺成分全體之使用比例(莫耳%)設成1.0時,前述(C)成分中之前述具有式[1]所示構造之二胺對二胺成分全體之使用比例(莫耳%)為0.01~0.3之比率。 The liquid crystal alignment treatment agent according to claim 1 or 3, wherein the use ratio (mol %) of the diamine to the entire diamine component having the structure shown in the above formula [1] among the aforementioned (A) components is set to 1.0 In the (C) component, the use ratio (mol %) of the diamine having the structure represented by the formula [1] to the entire diamine component is 0.01 to 0.3. 如請求項1~3中任一項之液晶配向處理劑,其中前述具有式[1]構造之二胺為下述式[1a]所示者;
Figure 104143876-A0305-02-0102-2
X表示前述式[1]之構造,n1表示1~4之整數。
The liquid crystal alignment treatment agent according to any one of claims 1 to 3, wherein the aforementioned diamine having the structure of formula [1] is represented by the following formula [1a];
Figure 104143876-A0305-02-0102-2
X represents the structure of the aforementioned formula [1], and n1 represents an integer of 1 to 4.
如請求項1~3中任一項之液晶配向處理劑,其中前述具有式[2]構造之二胺為下述式[2a]所示者;
Figure 104143876-A0305-02-0102-3
W表示前述式[2]之構造,p1表示1~4之整數。
The liquid crystal alignment treatment agent according to any one of claims 1 to 3, wherein the aforementioned diamine having the structure of formula [2] is represented by the following formula [2a];
Figure 104143876-A0305-02-0102-3
W represents the structure of the aforementioned formula [2], and p1 represents an integer of 1 to 4.
如請求項1~3中任一項之液晶配向處理劑,其中前述具有選自由羧基及羥基所成群之至少一種取代基之二胺為下述式[3a]所示者;
Figure 104143876-A0305-02-0103-4
Y表示下述式[3-1]或式[3-2]之構造,m1表示1~4之整數;
Figure 104143876-A0305-02-0103-5
a及b分別表示0~4之整數。
The liquid crystal alignment treatment agent according to any one of claims 1 to 3, wherein the aforementioned diamine having at least one substituent selected from the group consisting of carboxyl groups and hydroxyl groups is represented by the following formula [3a];
Figure 104143876-A0305-02-0103-4
Y represents the structure of the following formula [3-1] or formula [3-2], m1 represents an integer of 1 to 4;
Figure 104143876-A0305-02-0103-5
a and b represent integers from 0 to 4, respectively.
如請求項1~3中任一項之液晶配向處理劑,其中前述(A)成分、(B)成分及(C)成分中之四羧酸成分包含下述式[4]之四羧酸二酐;
Figure 104143876-A0305-02-0103-6
Z表示選自由下述式[4a]~式[4k]所成群之至少一種構造;
Figure 104143876-A0305-02-0104-7
Z1~Z4各自獨立表示選自由氫原子、甲基、氯原子及苯環所成群之至少一種;Z5及Z6各自獨立表示氫原子或甲基。
The liquid crystal alignment treatment agent according to any one of claims 1 to 3, wherein the tetracarboxylic acid component of the aforementioned (A) component, (B) component and (C) component includes tetracarboxylic acid dicarboxylic acid of the following formula [4] anhydride;
Figure 104143876-A0305-02-0103-6
Z represents at least one structure selected from the group consisting of the following formula [4a] to formula [4k];
Figure 104143876-A0305-02-0104-7
Z 1 to Z 4 each independently represent at least one selected from the group consisting of a hydrogen atom, a methyl group, a chlorine atom, and a benzene ring; Z 5 and Z 6 each independently represent a hydrogen atom or a methyl group.
如請求項1~3中任一項之液晶配向處理劑,其中含有選自由N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮及γ-丁內酯所成群之至少一種之溶劑。 The liquid crystal alignment treatment agent according to any one of claims 1 to 3, which contains a group selected from the group consisting of N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone and γ-butyrolactone At least one solvent. 如請求項1~3中任一項之液晶配向處理劑,其中含有選自由1-己醇、環己醇、1,2-乙二醇、1,2-丙二醇、丙二醇單丁基醚、乙二醇單丁基醚、二丙二醇二甲基醚及下述式[D1]~式[D3]所成群之至少一種之溶劑;
Figure 104143876-A0305-02-0104-8
D1表示碳數1~3之烷基,D2表示碳數1~3之烷基,D3表示碳數1~4之烷基。
The liquid crystal alignment treatment agent according to any one of claims 1 to 3, which contains a compound selected from the group consisting of 1-hexanol, cyclohexanol, 1,2-ethylene glycol, 1,2-propylene glycol, propylene glycol monobutyl ether, and ethyl alcohol. Glycol monobutyl ether, dipropylene glycol dimethyl ether and at least one solvent grouped by the following formula [D1] to formula [D3];
Figure 104143876-A0305-02-0104-8
D 1 represents an alkyl group having 1 to 3 carbon atoms, D 2 represents an alkyl group having 1 to 3 carbon atoms, and D 3 represents an alkyl group having 1 to 4 carbon atoms.
如請求項1~3中任一項之液晶配向處理劑,其中含有具有選自由環氧基、異氰酸酯基、環氧丙烷基及環 碳酸酯基所成群之至少一種之基之交聯性化合物,具有選自由羥基、經基烷基及低級烷氧基烷基所成群之至少一種之基之交聯性化合物,或具有聚合性不飽和鍵基之交聯性化合物。 The liquid crystal alignment treatment agent according to any one of claims 1 to 3, which contains a compound selected from the group consisting of epoxy group, isocyanate group, glycidyl group and ring A crosslinkable compound of at least one kind of group consisting of carbonate groups, a crosslinkable compound having at least one kind of group selected from the group consisting of hydroxyl groups, alkyl groups and lower alkoxyalkyl groups, or having a polymerization Cross-linking compounds with unsaturated bond groups. 一種液晶配向膜,其係由如請求項1~11中任一項之液晶配向處理劑所得者。 A liquid crystal alignment film obtained from the liquid crystal alignment treatment agent according to any one of claims 1 to 11. 一種液晶配向膜,其係藉由噴墨法塗佈如請求項1~11中任一項之液晶配向處理劑所得者。 A liquid crystal alignment film obtained by applying the liquid crystal alignment treatment agent according to any one of claims 1 to 11 by an inkjet method. 一種液晶顯示元件,其係具有如請求項12或13之液晶配向膜。 A liquid crystal display element having a liquid crystal alignment film as in claim 12 or 13. 如請求項12或13之液晶配向膜,其係使用於液晶顯示元件,該液晶顯示元件係在具備電極之一對基板之間具有液晶層而成,並且係經由在前述一對基板之間配置包含因活性能量線及熱之至少一者而進行聚合之聚合性化合物之液晶組成物,對前述電極間施加電壓而使前述聚合性化合物進行聚合之步驟所製造者。 The liquid crystal alignment film according to claim 12 or 13, which is used for a liquid crystal display element which has a liquid crystal layer between a pair of substrates having electrodes and is arranged between the pair of substrates A liquid crystal composition containing a polymerizable compound polymerized by at least one of active energy rays and heat is manufactured by a step of applying a voltage between the electrodes to polymerize the polymerizable compound. 一種液晶顯示元件,其係具有如請求項15之液晶配向膜。 A liquid crystal display element having the liquid crystal alignment film according to claim 15. 如請求項12或13之液晶配向膜,其係使用於液晶顯示元件,該液晶顯示元件係在具備電極之一對基板之間具有液晶層而成,並且係經由在前述一對基板之間配置包含因活性能量線及熱之至少一者而進行聚合之聚合基之液晶配向膜,且對前述電極間施加電壓而使前述聚合性基進行聚合之步驟所製造者。 The liquid crystal alignment film according to claim 12 or 13, which is used for a liquid crystal display element having a liquid crystal layer between a pair of substrates provided with electrodes and arranged between the pair of substrates A liquid crystal alignment film including a polymer group polymerized by at least one of active energy rays and heat, and a step of applying a voltage between the electrodes to polymerize the polymerizable group. 一種液晶顯示元件,其係具有如請求項17之液晶配向膜。 A liquid crystal display element having the liquid crystal alignment film according to claim 17.
TW104143876A 2014-12-25 2015-12-25 Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element TWI681986B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014-262605 2014-12-25
JP2014262605 2014-12-25

Publications (2)

Publication Number Publication Date
TW201630979A TW201630979A (en) 2016-09-01
TWI681986B true TWI681986B (en) 2020-01-11

Family

ID=56150649

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104143876A TWI681986B (en) 2014-12-25 2015-12-25 Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element

Country Status (5)

Country Link
JP (1) JP6572912B2 (en)
KR (1) KR102478707B1 (en)
CN (1) CN107407839B (en)
TW (1) TWI681986B (en)
WO (1) WO2016104636A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200079314A (en) * 2017-11-21 2020-07-02 닛산 가가쿠 가부시키가이샤 Liquid crystal aligning agent, liquid crystal aligning film, manufacturing method of liquid crystal aligning film, and liquid crystal display element
KR20200136002A (en) * 2018-04-09 2020-12-04 닛산 가가쿠 가부시키가이샤 Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element using same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103959151A (en) * 2011-09-30 2014-07-30 日产化学工业株式会社 Liquid crystal orientation treatment agent, liquid crystal orientation membrane, and liquid crystal display element

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2762551B2 (en) 1989-04-25 1998-06-04 東レ株式会社 Liquid crystal alignment film and liquid crystal display device
JP3201172B2 (en) 1994-09-08 2001-08-20 ジェイエスアール株式会社 Liquid crystal alignment agent
JP4085206B2 (en) 1996-02-15 2008-05-14 日産化学工業株式会社 Diaminobenzene derivative, polyimide and liquid crystal alignment film using the same
JP3613421B2 (en) 1996-05-31 2005-01-26 Jsr株式会社 Liquid crystal alignment agent
JP3650982B2 (en) 1996-10-02 2005-05-25 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
WO2009093709A1 (en) * 2008-01-25 2009-07-30 Nissan Chemical Industries, Ltd. Liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element
KR101613751B1 (en) * 2008-09-24 2016-04-19 닛산 가가쿠 고교 가부시키 가이샤 Liquid crystal aligning agent and liquid crystal display element using same
JP5516863B2 (en) * 2009-03-18 2014-06-11 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
WO2012014898A1 (en) * 2010-07-26 2012-02-02 日産化学工業株式会社 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
KR102218510B1 (en) 2013-05-23 2021-02-19 닛산 가가쿠 가부시키가이샤 Treatment agent for liquid crystal orientation, liquid crystal orientation film, and liquid crystal display device
JP6561834B2 (en) * 2013-09-03 2019-08-21 日産化学株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103959151A (en) * 2011-09-30 2014-07-30 日产化学工业株式会社 Liquid crystal orientation treatment agent, liquid crystal orientation membrane, and liquid crystal display element

Also Published As

Publication number Publication date
TW201630979A (en) 2016-09-01
CN107407839B (en) 2020-09-18
JPWO2016104636A1 (en) 2017-11-02
CN107407839A (en) 2017-11-28
KR102478707B1 (en) 2022-12-16
KR20170099995A (en) 2017-09-01
WO2016104636A1 (en) 2016-06-30
JP6572912B2 (en) 2019-09-11

Similar Documents

Publication Publication Date Title
JP6627772B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device using the same
TWI471655B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI691547B (en) Composition containing polyamide-based polymer, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI628232B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element
JPWO2010074269A1 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI649362B (en) Composition, liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element
TW202035522A (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display device using same
TW202024755A (en) Liquid crystal alignment agent, production method thereof, liquid crystal alignment film, and liquid crystal display element
CN113015935A (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same
TW202035519A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device
TWI678385B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element
TWI681986B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element
WO2023286733A1 (en) Liquid crystal aligning agent, liquid crystal alignment film, method for producing liquid crystal display element, and liquid crystal display element
TW202311504A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI826504B (en) Liquid crystal alignment agent, manufacturing method thereof, liquid crystal alignment film and liquid crystal display element
TW202144552A (en) Liquid crystal alignment agent, liquid crystal alignment film, method for manufacturing liquid crystal alignment film, and liquid crystal device capable of obtaining a liquid crystal device that exhibits a low pretilt angle even when using a negative type liquid crystal, hardly produces an afterimage, has a high voltage retention rate, and is excellent in reliability
WO2020158819A1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
TWI824090B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element
JP7428138B2 (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
WO2022270287A1 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP7311047B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP7318826B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JPWO2018051923A1 (en) Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display device
WO2022181311A1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
CN111602088B (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same